id	sid	tid	token	lemma	pos
bjos-8650040	1	1	braz	braz	PROPN
bjos-8650040	1	2	j	j	PROPN
bjos-8650040	1	3	oral	oral	PROPN
bjos-8650040	1	4	sci	sci	PROPN
bjos-8650040	1	5	.	.	PUNCT
bjos-8650040	2	1	15(4):280	15(4):280	NUM
bjos-8650040	2	2	-	-	SYM
bjos-8650040	2	3	286	286	NUM
bjos-8650040	2	4	profiling	profiling	NOUN
bjos-8650040	2	5	of	of	ADP
bjos-8650040	2	6	pro	pro	ADJ
bjos-8650040	2	7	-	-	ADJ
bjos-8650040	2	8	inflammatory	inflammatory	ADJ
bjos-8650040	2	9	cytokines	cytokine	NOUN
bjos-8650040	2	10	in	in	ADP
bjos-8650040	2	11	radiation	radiation	NOUN
bjos-8650040	2	12	induced	induce	VERB
bjos-8650040	2	13	oral	oral	ADJ
bjos-8650040	2	14	mucositis	mucositis	NOUN
bjos-8650040	2	15	(	(	PUNCT
bjos-8650040	2	16	riom	riom	NOUN
bjos-8650040	2	17	)	)	PUNCT
bjos-8650040	2	18	among	among	ADP
bjos-8650040	2	19	indian	indian	ADJ
bjos-8650040	2	20	patients	patient	NOUN
bjos-8650040	2	21	akanksha	akanksha	VERB
bjos-8650040	2	22	marwah1	marwah1	PROPN
bjos-8650040	2	23	#	#	SYM
bjos-8650040	2	24	,	,	PUNCT
bjos-8650040	2	25	zafar	zafar	PROPN
bjos-8650040	2	26	iqbal2	iqbal2	PROPN
bjos-8650040	2	27	#	#	PROPN
bjos-8650040	2	28	,	,	PUNCT
bjos-8650040	2	29	md	md	PROPN
bjos-8650040	2	30	.	.	PUNCT
bjos-8650040	3	1	zafaryab3	zafaryab3	PROPN
bjos-8650040	3	2	,	,	PUNCT
bjos-8650040	3	3	mahesh	mahesh	PROPN
bjos-8650040	3	4	verma1	verma1	PROPN
bjos-8650040	3	5	,	,	PUNCT
bjos-8650040	3	6	m.m.a	m.m.a	PROPN
bjos-8650040	3	7	rizvi2	rizvi2	PROPN
bjos-8650040	3	8	,	,	PUNCT
bjos-8650040	3	9	sunita	sunita	PROPN
bjos-8650040	3	10	gupta1	gupta1	PROPN
bjos-8650040	3	11	1department	1department	NUM
bjos-8650040	3	12	of	of	ADP
bjos-8650040	3	13	oral	oral	ADJ
bjos-8650040	3	14	medicine	medicine	NOUN
bjos-8650040	3	15	&	&	CCONJ
bjos-8650040	3	16	radiology	radiology	NOUN
bjos-8650040	3	17	,	,	PUNCT
bjos-8650040	3	18	maulana	maulana	PROPN
bjos-8650040	3	19	azad	azad	PROPN
bjos-8650040	3	20	institute	institute	PROPN
bjos-8650040	3	21	of	of	ADP
bjos-8650040	3	22	dental	dental	ADJ
bjos-8650040	3	23	sciences	science	NOUN
bjos-8650040	3	24	,	,	PUNCT
bjos-8650040	3	25	bsz	bsz	NOUN
bjos-8650040	3	26	marg	marg	NOUN
bjos-8650040	3	27	,	,	PUNCT
bjos-8650040	3	28	new	new	PROPN
bjos-8650040	3	29	delhi	delhi	PROPN
bjos-8650040	3	30	–	–	PUNCT
bjos-8650040	3	31	110002	110002	NUM
bjos-8650040	3	32	,	,	PUNCT
bjos-8650040	3	33	india	india	PROPN
bjos-8650040	3	34	2department	2department	PROPN
bjos-8650040	3	35	of	of	ADP
bjos-8650040	3	36	biosciences	bioscience	NOUN
bjos-8650040	3	37	,	,	PUNCT
bjos-8650040	3	38	jamia	jamia	PROPN
bjos-8650040	3	39	millia	millia	PROPN
bjos-8650040	3	40	islamia	islamia	PROPN
bjos-8650040	3	41	,	,	PUNCT
bjos-8650040	3	42	new	new	ADJ
bjos-8650040	3	43	delhi-110025	delhi-110025	NOUN
bjos-8650040	3	44	,	,	PUNCT
bjos-8650040	3	45	india	india	PROPN
bjos-8650040	3	46	#	#	NOUN
bjos-8650040	3	47	both	both	DET
bjos-8650040	3	48	authors	author	NOUN
bjos-8650040	3	49	contributed	contribute	VERB
bjos-8650040	3	50	equaly	equaly	NOUN
bjos-8650040	3	51	correspondence	correspondence	NOUN
bjos-8650040	3	52	to	to	ADP
bjos-8650040	3	53	:	:	PUNCT
bjos-8650040	3	54	dr	dr	PROPN
bjos-8650040	3	55	.	.	PROPN
bjos-8650040	3	56	m.m.a	m.m.a	PROPN
bjos-8650040	3	57	rizvi	rizvi	PROPN
bjos-8650040	3	58	,	,	PUNCT
bjos-8650040	3	59	professor	professor	NOUN
bjos-8650040	3	60	department	department	PROPN
bjos-8650040	3	61	of	of	ADP
bjos-8650040	3	62	biosciences	bioscience	NOUN
bjos-8650040	3	63	,	,	PUNCT
bjos-8650040	3	64	jamia	jamia	PROPN
bjos-8650040	3	65	millia	millia	PROPN
bjos-8650040	3	66	islamia	islamia	PROPN
bjos-8650040	3	67	,	,	PUNCT
bjos-8650040	3	68	new	new	ADJ
bjos-8650040	3	69	delhi-110025	delhi-110025	NOUN
bjos-8650040	3	70	,	,	PUNCT
bjos-8650040	3	71	india	india	PROPN
bjos-8650040	3	72	.	.	PUNCT
bjos-8650040	4	1	email	email	NOUN
bjos-8650040	5	1	i	i	PROPN
bjos-8650040	5	2	d	d	PROPN
bjos-8650040	5	3	:	:	PUNCT
bjos-8650040	6	1	rizvijmi@gmail.com	rizvijmi@gmail.com	X
bjos-8650040	6	2	contact	contact	NOUN
bjos-8650040	6	3	number	number	NOUN
bjos-8650040	6	4	:	:	PUNCT
bjos-8650040	6	5	+91	+91	PROPN
bjos-8650040	6	6	-	-	PUNCT
bjos-8650040	6	7	9911661657	9911661657	NUM
bjos-8650040	6	8	abstract	abstract	ADJ
bjos-8650040	6	9	radiation	radiation	NOUN
bjos-8650040	6	10	-	-	PUNCT
bjos-8650040	6	11	induced	induce	VERB
bjos-8650040	6	12	oral	oral	ADJ
bjos-8650040	6	13	mucositis	mucositis	NOUN
bjos-8650040	6	14	(	(	PUNCT
bjos-8650040	6	15	riom	riom	NOUN
bjos-8650040	6	16	)	)	PUNCT
bjos-8650040	6	17	is	be	AUX
bjos-8650040	6	18	aimed	aim	VERB
bjos-8650040	6	19	at	at	ADP
bjos-8650040	6	20	evaluating	evaluate	VERB
bjos-8650040	6	21	the	the	DET
bjos-8650040	6	22	expression	expression	NOUN
bjos-8650040	6	23	of	of	ADP
bjos-8650040	6	24	nf	nf	NOUN
bjos-8650040	6	25	-	-	PUNCT
bjos-8650040	6	26	κβ	κβ	NOUN
bjos-8650040	6	27	,	,	PUNCT
bjos-8650040	6	28	il-1α	il-1α	NOUN
bjos-8650040	6	29	,	,	PUNCT
bjos-8650040	6	30	il-6	il-6	NUM
bjos-8650040	6	31	,	,	PUNCT
bjos-8650040	6	32	il-8	il-8	PUNCT
bjos-8650040	6	33	and	and	CCONJ
bjos-8650040	6	34	tnf	tnf	PROPN
bjos-8650040	6	35	-	-	PUNCT
bjos-8650040	6	36	α	α	PROPN
bjos-8650040	6	37	in	in	ADP
bjos-8650040	6	38	patients	patient	NOUN
bjos-8650040	6	39	with	with	ADP
bjos-8650040	6	40	riom	riom	NOUN
bjos-8650040	6	41	so	so	SCONJ
bjos-8650040	6	42	as	as	SCONJ
bjos-8650040	6	43	to	to	PART
bjos-8650040	6	44	validate	validate	VERB
bjos-8650040	6	45	their	their	PRON
bjos-8650040	6	46	role	role	NOUN
bjos-8650040	6	47	in	in	ADP
bjos-8650040	6	48	the	the	DET
bjos-8650040	6	49	pathobiology	pathobiology	NOUN
bjos-8650040	6	50	of	of	ADP
bjos-8650040	6	51	the	the	DET
bjos-8650040	6	52	disease	disease	NOUN
bjos-8650040	6	53	.	.	PUNCT
bjos-8650040	7	1	blood	blood	NOUN
bjos-8650040	7	2	samples	sample	NOUN
bjos-8650040	7	3	were	be	AUX
bjos-8650040	7	4	collected	collect	VERB
bjos-8650040	7	5	and	and	CCONJ
bjos-8650040	7	6	serum	serum	NOUN
bjos-8650040	7	7	of	of	ADP
bjos-8650040	7	8	45	45	NUM
bjos-8650040	7	9	patients	patient	NOUN
bjos-8650040	7	10	isolated	isolate	VERB
bjos-8650040	7	11	with	with	ADP
bjos-8650040	7	12	clinical	clinical	ADJ
bjos-8650040	7	13	signs	sign	NOUN
bjos-8650040	7	14	and	and	CCONJ
bjos-8650040	7	15	symptoms	symptom	NOUN
bjos-8650040	7	16	of	of	ADP
bjos-8650040	7	17	mucositis	mucositis	NOUN
bjos-8650040	7	18	and	and	CCONJ
bjos-8650040	7	19	10	10	NUM
bjos-8650040	7	20	healthy	healthy	ADJ
bjos-8650040	7	21	controls	control	NOUN
bjos-8650040	7	22	were	be	AUX
bjos-8650040	7	23	also	also	ADV
bjos-8650040	7	24	included	include	VERB
bjos-8650040	7	25	in	in	ADP
bjos-8650040	7	26	the	the	DET
bjos-8650040	7	27	study	study	NOUN
bjos-8650040	7	28	.	.	PUNCT
bjos-8650040	8	1	the	the	DET
bjos-8650040	8	2	expression	expression	NOUN
bjos-8650040	8	3	level	level	NOUN
bjos-8650040	8	4	of	of	ADP
bjos-8650040	8	5	nf	nf	NOUN
bjos-8650040	8	6	-	-	PUNCT
bjos-8650040	8	7	κβ	κβ	NOUN
bjos-8650040	8	8	,	,	PUNCT
bjos-8650040	8	9	il-1α	il-1α	NOUN
bjos-8650040	8	10	,	,	PUNCT
bjos-8650040	8	11	il-6	il-6	NOUN
bjos-8650040	8	12	,	,	PUNCT
bjos-8650040	8	13	il-8	il-8	NOUN
bjos-8650040	8	14	,	,	PUNCT
bjos-8650040	8	15	tnf	tnf	PROPN
bjos-8650040	8	16	-	-	PUNCT
bjos-8650040	8	17	α	α	PROPN
bjos-8650040	8	18	was	be	AUX
bjos-8650040	8	19	investigated	investigate	VERB
bjos-8650040	8	20	using	use	VERB
bjos-8650040	8	21	elisa	elisa	PROPN
bjos-8650040	8	22	.	.	PUNCT
bjos-8650040	9	1	mann	mann	PROPN
bjos-8650040	9	2	whitney	whitney	PROPN
bjos-8650040	9	3	u	u	PROPN
bjos-8650040	9	4	test	test	NOUN
bjos-8650040	9	5	was	be	AUX
bjos-8650040	9	6	applied	apply	VERB
bjos-8650040	9	7	to	to	PART
bjos-8650040	9	8	find	find	VERB
bjos-8650040	9	9	the	the	DET
bjos-8650040	9	10	significance	significance	NOUN
bjos-8650040	9	11	of	of	ADP
bjos-8650040	9	12	the	the	DET
bjos-8650040	9	13	expression	expression	NOUN
bjos-8650040	9	14	of	of	ADP
bjos-8650040	9	15	these	these	DET
bjos-8650040	9	16	markers	marker	NOUN
bjos-8650040	9	17	in	in	ADP
bjos-8650040	9	18	riom	riom	NOUN
bjos-8650040	9	19	patients	patient	NOUN
bjos-8650040	9	20	as	as	SCONJ
bjos-8650040	9	21	compared	compare	VERB
bjos-8650040	9	22	to	to	ADP
bjos-8650040	9	23	normal	normal	ADJ
bjos-8650040	9	24	healthy	healthy	ADJ
bjos-8650040	9	25	controls	control	NOUN
bjos-8650040	9	26	and	and	CCONJ
bjos-8650040	9	27	significant	significant	ADJ
bjos-8650040	9	28	expression	expression	NOUN
bjos-8650040	9	29	(	(	PUNCT
bjos-8650040	9	30	p	p	X
bjos-8650040	9	31	<	<	X
bjos-8650040	9	32	0.05	0.05	NUM
bjos-8650040	9	33	)	)	PUNCT
bjos-8650040	9	34	for	for	ADP
bjos-8650040	9	35	nf	nf	NOUN
bjos-8650040	9	36	-	-	PUNCT
bjos-8650040	9	37	κβ	κβ	NOUN
bjos-8650040	9	38	,	,	PUNCT
bjos-8650040	9	39	il-6	il-6	NUM
bjos-8650040	9	40	,	,	PUNCT
bjos-8650040	9	41	tnf	tnf	PROPN
bjos-8650040	9	42	-	-	PUNCT
bjos-8650040	9	43	α	α	PROPN
bjos-8650040	9	44	and	and	CCONJ
bjos-8650040	9	45	non	non	ADJ
bjos-8650040	9	46	-	-	ADJ
bjos-8650040	9	47	significant	significant	ADJ
bjos-8650040	9	48	expression	expression	NOUN
bjos-8650040	9	49	(	(	PUNCT
bjos-8650040	9	50	p	p	X
bjos-8650040	9	51	>	>	X
bjos-8650040	9	52	0.05	0.05	NUM
bjos-8650040	9	53	)	)	PUNCT
bjos-8650040	9	54	il-1α	il-1α	NOUN
bjos-8650040	9	55	and	and	CCONJ
bjos-8650040	9	56	il-8	il-8	NOUN
bjos-8650040	9	57	was	be	AUX
bjos-8650040	9	58	found	find	VERB
bjos-8650040	9	59	.	.	PUNCT
bjos-8650040	10	1	no	no	DET
bjos-8650040	10	2	significant	significant	ADJ
bjos-8650040	10	3	change	change	NOUN
bjos-8650040	10	4	in	in	ADP
bjos-8650040	10	5	the	the	DET
bjos-8650040	10	6	expression	expression	NOUN
bjos-8650040	10	7	level	level	NOUN
bjos-8650040	10	8	of	of	ADP
bjos-8650040	10	9	the	the	DET
bjos-8650040	10	10	cytokines	cytokine	NOUN
bjos-8650040	10	11	was	be	AUX
bjos-8650040	10	12	observed	observe	VERB
bjos-8650040	10	13	for	for	ADP
bjos-8650040	10	14	patients	patient	NOUN
bjos-8650040	10	15	undergoing	undergo	VERB
bjos-8650040	10	16	chemotherapy	chemotherapy	NOUN
bjos-8650040	10	17	and	and	CCONJ
bjos-8650040	10	18	radiation	radiation	NOUN
bjos-8650040	10	19	therapy	therapy	NOUN
bjos-8650040	10	20	as	as	ADV
bjos-8650040	10	21	well	well	ADV
bjos-8650040	10	22	as	as	ADP
bjos-8650040	10	23	those	those	PRON
bjos-8650040	10	24	receiving	receive	VERB
bjos-8650040	10	25	only	only	ADV
bjos-8650040	10	26	the	the	DET
bjos-8650040	10	27	radiation	radiation	NOUN
bjos-8650040	10	28	therapy	therapy	NOUN
bjos-8650040	10	29	as	as	ADP
bjos-8650040	10	30	a	a	DET
bjos-8650040	10	31	part	part	NOUN
bjos-8650040	10	32	of	of	ADP
bjos-8650040	10	33	their	their	PRON
bjos-8650040	10	34	treatment	treatment	NOUN
bjos-8650040	10	35	.	.	PUNCT
bjos-8650040	11	1	we	we	PRON
bjos-8650040	11	2	have	have	AUX
bjos-8650040	11	3	also	also	ADV
bjos-8650040	11	4	found	find	VERB
bjos-8650040	11	5	less	less	ADJ
bjos-8650040	11	6	expression	expression	NOUN
bjos-8650040	11	7	in	in	ADP
bjos-8650040	11	8	grade	grade	NOUN
bjos-8650040	11	9	1	1	NUM
bjos-8650040	11	10	of	of	ADP
bjos-8650040	11	11	mucositis	mucositis	NOUN
bjos-8650040	11	12	as	as	SCONJ
bjos-8650040	11	13	compared	compare	VERB
bjos-8650040	11	14	to	to	ADP
bjos-8650040	11	15	grade	grade	NOUN
bjos-8650040	11	16	4	4	NUM
bjos-8650040	11	17	.	.	PUNCT
bjos-8650040	11	18	proinflammatory	proinflammatory	ADJ
bjos-8650040	11	19	cytokines	cytokine	NOUN
bjos-8650040	11	20	indeed	indeed	ADV
bjos-8650040	11	21	play	play	VERB
bjos-8650040	11	22	a	a	DET
bjos-8650040	11	23	vital	vital	ADJ
bjos-8650040	11	24	role	role	NOUN
bjos-8650040	11	25	in	in	ADP
bjos-8650040	11	26	the	the	DET
bjos-8650040	11	27	pathogenesis	pathogenesis	NOUN
bjos-8650040	11	28	as	as	ADV
bjos-8650040	11	29	well	well	ADV
bjos-8650040	11	30	as	as	ADP
bjos-8650040	11	31	progression	progression	NOUN
bjos-8650040	11	32	of	of	ADP
bjos-8650040	11	33	riom	riom	NOUN
bjos-8650040	11	34	.	.	PUNCT
bjos-8650040	12	1	keywords	keyword	NOUN
bjos-8650040	12	2	:	:	PUNCT
bjos-8650040	13	1	mucositis	mucositis	NOUN
bjos-8650040	13	2	,	,	PUNCT
bjos-8650040	13	3	nf	nf	NOUN
bjos-8650040	13	4	-	-	PUNCT
bjos-8650040	13	5	κβ	κβ	NOUN
bjos-8650040	13	6	,	,	PUNCT
bjos-8650040	13	7	proinflammatory	proinflammatory	ADJ
bjos-8650040	13	8	cytokines	cytokine	NOUN
bjos-8650040	13	9	,	,	PUNCT
bjos-8650040	13	10	radiation	radiation	NOUN
bjos-8650040	13	11	therapy	therapy	NOUN
bjos-8650040	13	12	received	receive	VERB
bjos-8650040	13	13	for	for	ADP
bjos-8650040	13	14	publication	publication	NOUN
bjos-8650040	13	15	:	:	PUNCT
bjos-8650040	13	16	december	december	PROPN
bjos-8650040	13	17	29	29	NUM
bjos-8650040	13	18	,	,	PUNCT
bjos-8650040	13	19	2016	2016	NUM
bjos-8650040	13	20	accepted	accept	VERB
bjos-8650040	13	21	:	:	PUNCT
bjos-8650040	13	22	july	july	PROPN
bjos-8650040	13	23	26	26	NUM
bjos-8650040	13	24	,	,	PUNCT
bjos-8650040	13	25	2017	2017	NUM
bjos-8650040	13	26	original	original	ADJ
bjos-8650040	13	27	article	article	NOUN
bjos-8650040	13	28	braz	braz	PROPN
bjos-8650040	13	29	j	j	PROPN
bjos-8650040	13	30	oral	oral	PROPN
bjos-8650040	13	31	sci	sci	PROPN
bjos-8650040	14	1	.	.	PROPN
bjos-8650040	14	2	october	october	PROPN
bjos-8650040	15	1	|	|	ADV
bjos-8650040	15	2	december	december	PROPN
bjos-8650040	15	3	2016	2016	NUM
bjos-8650040	15	4	volume	volume	NOUN
bjos-8650040	15	5	15	15	NUM
bjos-8650040	15	6	,	,	PUNCT
bjos-8650040	15	7	number	number	NOUN
bjos-8650040	15	8	4	4	NUM
bjos-8650040	15	9	http://dx.doi.org/10.20396/bjos.v15i4.8650040	http://dx.doi.org/10.20396/bjos.v15i4.8650040	NOUN
bjos-8650040	15	10	introduction	introduction	NOUN
bjos-8650040	15	11	incidence	incidence	NOUN
bjos-8650040	15	12	of	of	ADP
bjos-8650040	15	13	various	various	ADJ
bjos-8650040	15	14	cancer	cancer	NOUN
bjos-8650040	15	15	types	type	NOUN
bjos-8650040	15	16	have	have	AUX
bjos-8650040	15	17	been	be	AUX
bjos-8650040	15	18	reported	report	VERB
bjos-8650040	15	19	to	to	PART
bjos-8650040	15	20	increase	increase	VERB
bjos-8650040	15	21	multifold	multifold	ADV
bjos-8650040	15	22	in	in	ADP
bjos-8650040	15	23	recent	recent	ADJ
bjos-8650040	15	24	times1,2	times1,2	PROPN
bjos-8650040	15	25	with	with	ADP
bjos-8650040	15	26	oral	oral	ADJ
bjos-8650040	15	27	mucositis	mucositis	NOUN
bjos-8650040	15	28	being	be	AUX
bjos-8650040	15	29	one	one	NUM
bjos-8650040	15	30	of	of	ADP
bjos-8650040	15	31	the	the	DET
bjos-8650040	15	32	most	most	ADV
bjos-8650040	15	33	recurrent	recurrent	ADJ
bjos-8650040	15	34	,	,	PUNCT
bjos-8650040	15	35	symptomatic	symptomatic	ADJ
bjos-8650040	15	36	,	,	PUNCT
bjos-8650040	15	37	and	and	CCONJ
bjos-8650040	15	38	troubling	troubling	ADJ
bjos-8650040	15	39	complication	complication	NOUN
bjos-8650040	15	40	of	of	ADP
bjos-8650040	15	41	the	the	DET
bjos-8650040	15	42	conventional	conventional	ADJ
bjos-8650040	15	43	cancer	cancer	NOUN
bjos-8650040	15	44	treatments	treatment	NOUN
bjos-8650040	15	45	,	,	PUNCT
bjos-8650040	15	46	viz	viz	PROPN
bjos-8650040	15	47	.	.	PROPN
bjos-8650040	15	48	,	,	PUNCT
bjos-8650040	15	49	radiation	radiation	NOUN
bjos-8650040	15	50	and/or	and/or	CCONJ
bjos-8650040	15	51	chemotherapy3,4	chemotherapy3,4	PROPN
bjos-8650040	15	52	.	.	PUNCT
bjos-8650040	16	1	it	it	PRON
bjos-8650040	16	2	can	can	AUX
bjos-8650040	16	3	be	be	AUX
bjos-8650040	16	4	defined	define	VERB
bjos-8650040	16	5	as	as	ADP
bjos-8650040	16	6	inflammatory	inflammatory	ADJ
bjos-8650040	16	7	and/or	and/or	CCONJ
bjos-8650040	16	8	ulcerative	ulcerative	ADJ
bjos-8650040	16	9	lesions	lesion	NOUN
bjos-8650040	16	10	of	of	ADP
bjos-8650040	16	11	the	the	DET
bjos-8650040	16	12	oral	oral	ADJ
bjos-8650040	16	13	and/or	and/or	CCONJ
bjos-8650040	16	14	gastrointestinal	gastrointestinal	ADJ
bjos-8650040	16	15	tract	tract	NOUN
bjos-8650040	16	16	usually	usually	ADV
bjos-8650040	16	17	caused	cause	VERB
bjos-8650040	16	18	by	by	ADP
bjos-8650040	16	19	cancer	cancer	NOUN
bjos-8650040	16	20	therapies5	therapies5	PROPN
bjos-8650040	16	21	.	.	PUNCT
bjos-8650040	17	1	it	it	PRON
bjos-8650040	17	2	is	be	AUX
bjos-8650040	17	3	mostly	mostly	ADV
bjos-8650040	17	4	associated	associate	VERB
bjos-8650040	17	5	with	with	ADP
bjos-8650040	17	6	pain	pain	NOUN
bjos-8650040	17	7	and	and	CCONJ
bjos-8650040	17	8	increased	increase	VERB
bjos-8650040	17	9	risk	risk	NOUN
bjos-8650040	17	10	of	of	ADP
bjos-8650040	17	11	infection	infection	NOUN
bjos-8650040	17	12	thus	thus	ADV
bjos-8650040	17	13	leading	lead	VERB
bjos-8650040	17	14	to	to	ADP
bjos-8650040	17	15	impaired	impaired	ADJ
bjos-8650040	17	16	nutritional	nutritional	ADJ
bjos-8650040	17	17	status	status	NOUN
bjos-8650040	17	18	and	and	CCONJ
bjos-8650040	17	19	inadequate	inadequate	ADJ
bjos-8650040	17	20	hydration3,6	hydration3,6	PROPN
bjos-8650040	17	21	.	.	PUNCT
bjos-8650040	18	1	it	it	PRON
bjos-8650040	18	2	may	may	AUX
bjos-8650040	18	3	also	also	ADV
bjos-8650040	18	4	be	be	AUX
bjos-8650040	18	5	associated	associate	VERB
bjos-8650040	18	6	with	with	ADP
bjos-8650040	18	7	increased	increase	VERB
bjos-8650040	18	8	risk	risk	NOUN
bjos-8650040	18	9	for	for	ADP
bjos-8650040	18	10	poorer	poor	ADJ
bjos-8650040	18	11	outcome	outcome	NOUN
bjos-8650040	18	12	of	of	ADP
bjos-8650040	18	13	cancer	cancer	NOUN
bjos-8650040	18	14	treatment	treatment	NOUN
bjos-8650040	18	15	due	due	ADP
bjos-8650040	18	16	to	to	ADP
bjos-8650040	18	17	the	the	DET
bjos-8650040	18	18	need	need	NOUN
bjos-8650040	18	19	for	for	ADP
bjos-8650040	18	20	treatment	treatment	NOUN
bjos-8650040	18	21	interruption	interruption	NOUN
bjos-8650040	18	22	in	in	ADP
bjos-8650040	18	23	some	some	DET
bjos-8650040	18	24	patient	patient	NOUN
bjos-8650040	18	25	cohorts6,7	cohorts6,7	PROPN
bjos-8650040	18	26	.	.	PUNCT
bjos-8650040	19	1	the	the	DET
bjos-8650040	19	2	incidence	incidence	NOUN
bjos-8650040	19	3	of	of	ADP
bjos-8650040	19	4	oral	oral	ADJ
bjos-8650040	19	5	mucositis	mucositis	NOUN
bjos-8650040	19	6	can	can	AUX
bjos-8650040	19	7	be	be	AUX
bjos-8650040	19	8	close	close	ADJ
bjos-8650040	19	9	to	to	PART
bjos-8650040	19	10	80	80	NUM
bjos-8650040	19	11	%	%	NOUN
bjos-8650040	19	12	in	in	ADP
bjos-8650040	19	13	patients	patient	NOUN
bjos-8650040	19	14	receiving	receive	VERB
bjos-8650040	19	15	radiation	radiation	NOUN
bjos-8650040	19	16	therapy	therapy	NOUN
bjos-8650040	19	17	,	,	PUNCT
bjos-8650040	19	18	with	with	ADP
bjos-8650040	19	19	or	or	CCONJ
bjos-8650040	19	20	without	without	ADP
bjos-8650040	19	21	chemotherapy	chemotherapy	NOUN
bjos-8650040	19	22	having	have	VERB
bjos-8650040	19	23	head	head	NOUN
bjos-8650040	19	24	and	and	CCONJ
bjos-8650040	19	25	neck	neck	VERB
bjos-8650040	19	26	cancer8,9	cancer8,9	PROPN
bjos-8650040	19	27	with	with	ADP
bjos-8650040	19	28	25	25	NUM
bjos-8650040	19	29	-	-	SYM
bjos-8650040	19	30	45	45	NUM
bjos-8650040	19	31	%	%	NOUN
bjos-8650040	19	32	of	of	ADP
bjos-8650040	19	33	the	the	DET
bjos-8650040	19	34	patients	patient	NOUN
bjos-8650040	19	35	reporting	report	VERB
bjos-8650040	19	36	with	with	ADP
bjos-8650040	19	37	grade	grade	NOUN
bjos-8650040	19	38	3	3	NUM
bjos-8650040	19	39	or	or	CCONJ
bjos-8650040	19	40	4	4	NUM
bjos-8650040	19	41	mucositis10	mucositis10	NOUN
bjos-8650040	19	42	.	.	PUNCT
bjos-8650040	20	1	the	the	DET
bjos-8650040	20	2	process	process	NOUN
bjos-8650040	20	3	of	of	ADP
bjos-8650040	20	4	mucositis	mucositis	PROPN
bjos-8650040	20	5	occurs	occur	VERB
bjos-8650040	20	6	in	in	ADP
bjos-8650040	20	7	five	five	NUM
bjos-8650040	20	8	stages	stage	NOUN
bjos-8650040	20	9	or	or	CCONJ
bjos-8650040	20	10	phases	phase	NOUN
bjos-8650040	20	11	:	:	PUNCT
bjos-8650040	20	12	initiation	initiation	NOUN
bjos-8650040	20	13	,	,	PUNCT
bjos-8650040	20	14	message	message	NOUN
bjos-8650040	20	15	generation	generation	NOUN
bjos-8650040	20	16	,	,	PUNCT
bjos-8650040	20	17	signal	signal	ADJ
bjos-8650040	20	18	amplification	amplification	NOUN
bjos-8650040	20	19	,	,	PUNCT
bjos-8650040	20	20	ulceration	ulceration	NOUN
bjos-8650040	20	21	,	,	PUNCT
bjos-8650040	20	22	and	and	CCONJ
bjos-8650040	20	23	healing11,12	healing11,12	NOUN
bjos-8650040	20	24	.	.	PUNCT
bjos-8650040	21	1	there	there	PRON
bjos-8650040	21	2	are	be	VERB
bjos-8650040	21	3	numerous	numerous	ADJ
bjos-8650040	21	4	transcription	transcription	NOUN
bjos-8650040	21	5	factors	factor	NOUN
bjos-8650040	21	6	involved	involve	VERB
bjos-8650040	21	7	in	in	ADP
bjos-8650040	21	8	the	the	DET
bjos-8650040	21	9	establishment	establishment	NOUN
bjos-8650040	21	10	of	of	ADP
bjos-8650040	21	11	mucositis	mucositis	NOUN
bjos-8650040	21	12	,	,	PUNCT
bjos-8650040	21	13	one	one	NUM
bjos-8650040	21	14	of	of	ADP
bjos-8650040	21	15	the	the	DET
bjos-8650040	21	16	most	most	ADV
bjos-8650040	21	17	important	important	ADJ
bjos-8650040	21	18	is	be	AUX
bjos-8650040	21	19	nuclear	nuclear	ADJ
bjos-8650040	21	20	factor	factor	NOUN
bjos-8650040	21	21	-	-	PUNCT
bjos-8650040	21	22	kappa	kappa	NOUN
bjos-8650040	21	23	β	β	PROPN
bjos-8650040	21	24	(	(	PUNCT
bjos-8650040	21	25	nf	nf	PROPN
bjos-8650040	21	26	-	-	PUNCT
bjos-8650040	21	27	κβ	κβ	NOUN
bjos-8650040	21	28	)	)	PUNCT
bjos-8650040	21	29	.	.	PUNCT
bjos-8650040	22	1	nf	nf	X
bjos-8650040	22	2	-	-	PUNCT
bjos-8650040	22	3	κβ	κβ	NOUN
bjos-8650040	22	4	activation	activation	NOUN
bjos-8650040	22	5	can	can	AUX
bjos-8650040	22	6	upregulate	upregulate	VERB
bjos-8650040	22	7	the	the	DET
bjos-8650040	22	8	expression	expression	NOUN
bjos-8650040	22	9	of	of	ADP
bjos-8650040	22	10	pro	pro	ADJ
bjos-8650040	22	11	-	-	ADJ
bjos-8650040	22	12	inflammatory	inflammatory	ADJ
bjos-8650040	22	13	cytokines	cytokine	NOUN
bjos-8650040	22	14	including	include	VERB
bjos-8650040	22	15	tumor	tumor	NOUN
bjos-8650040	22	16	necrosis	necrosis	NOUN
bjos-8650040	22	17	factor	factor	NOUN
bjos-8650040	22	18	-	-	PUNCT
bjos-8650040	22	19	α	α	X
bjos-8650040	22	20	(	(	PUNCT
bjos-8650040	22	21	tnf	tnf	PROPN
bjos-8650040	22	22	-	-	PUNCT
bjos-8650040	22	23	α	α	NOUN
bjos-8650040	22	24	)	)	PUNCT
bjos-8650040	22	25	,	,	PUNCT
bjos-8650040	22	26	assay	assay	NOUN
bjos-8650040	22	27	employs	employ	VERB
bjos-8650040	22	28	the	the	DET
bjos-8650040	22	29	quantitative	quantitative	ADJ
bjos-8650040	22	30	sandwich	sandwich	NOUN
bjos-8650040	22	31	enzyme	enzyme	NOUN
bjos-8650040	22	32	immunoassay	immunoassay	ADJ
bjos-8650040	22	33	technique	technique	NOUN
bjos-8650040	22	34	performed	perform	VERB
bjos-8650040	22	35	using	use	VERB
bjos-8650040	22	36	human	human	ADJ
bjos-8650040	22	37	recombinant	recombinant	ADJ
bjos-8650040	22	38	standards	standard	NOUN
bjos-8650040	22	39	according	accord	VERB
bjos-8650040	22	40	to	to	ADP
bjos-8650040	22	41	the	the	DET
bjos-8650040	22	42	manufacturer	manufacturer	NOUN
bjos-8650040	22	43	’s	’s	PART
bjos-8650040	22	44	instructions	instruction	NOUN
bjos-8650040	22	45	.	.	PUNCT
bjos-8650040	23	1	a	a	DET
bjos-8650040	23	2	monoclonal	monoclonal	NOUN
bjos-8650040	23	3	antibody	antibody	NOUN
bjos-8650040	23	4	specific	specific	ADJ
bjos-8650040	23	5	for	for	ADP
bjos-8650040	23	6	the	the	DET
bjos-8650040	23	7	respective	respective	ADJ
bjos-8650040	23	8	cytokines	cytokine	NOUN
bjos-8650040	23	9	was	be	AUX
bjos-8650040	23	10	precoated	precoate	VERB
bjos-8650040	23	11	onto	onto	ADP
bjos-8650040	23	12	the	the	DET
bjos-8650040	23	13	microplate	microplate	NOUN
bjos-8650040	23	14	.	.	PROPN
bjos-8650040	23	15	standards	standard	NOUN
bjos-8650040	23	16	and	and	CCONJ
bjos-8650040	23	17	samples	sample	NOUN
bjos-8650040	23	18	(	(	PUNCT
bjos-8650040	23	19	100	100	NUM
bjos-8650040	23	20	μl	μl	ADP
bjos-8650040	23	21	each	each	PRON
bjos-8650040	23	22	)	)	PUNCT
bjos-8650040	23	23	were	be	AUX
bjos-8650040	23	24	pipetted	pipette	VERB
bjos-8650040	23	25	into	into	ADP
bjos-8650040	23	26	the	the	DET
bjos-8650040	23	27	wells	well	NOUN
bjos-8650040	23	28	in	in	ADP
bjos-8650040	23	29	duplicate	duplicate	NOUN
bjos-8650040	23	30	and	and	CCONJ
bjos-8650040	23	31	incubated	incubate	VERB
bjos-8650040	23	32	for	for	ADP
bjos-8650040	23	33	2.5	2.5	NUM
bjos-8650040	23	34	hrs	hrs	NOUN
bjos-8650040	23	35	.	.	PUNCT
bjos-8650040	24	1	so	so	SCONJ
bjos-8650040	24	2	that	that	SCONJ
bjos-8650040	24	3	any	any	PRON
bjos-8650040	24	4	of	of	ADP
bjos-8650040	24	5	the	the	DET
bjos-8650040	24	6	proteins	protein	NOUN
bjos-8650040	24	7	,	,	PUNCT
bjos-8650040	24	8	i.e.	i.e.	X
bjos-8650040	24	9	,	,	PUNCT
bjos-8650040	24	10	nf	nf	NOUN
bjos-8650040	24	11	-	-	PUNCT
bjos-8650040	24	12	κβ	κβ	NOUN
bjos-8650040	24	13	,	,	PUNCT
bjos-8650040	24	14	il-1α	il-1α	NOUN
bjos-8650040	24	15	,	,	PUNCT
bjos-8650040	24	16	il-6	il-6	NUM
bjos-8650040	24	17	,	,	PUNCT
bjos-8650040	24	18	il-8	il-8	PUNCT
bjos-8650040	24	19	and	and	CCONJ
bjos-8650040	24	20	tnf	tnf	PROPN
bjos-8650040	24	21	-	-	PUNCT
bjos-8650040	24	22	α	α	PROPN
bjos-8650040	24	23	,	,	PUNCT
bjos-8650040	24	24	if	if	SCONJ
bjos-8650040	24	25	present	present	ADJ
bjos-8650040	24	26	in	in	ADP
bjos-8650040	24	27	the	the	DET
bjos-8650040	24	28	sample	sample	NOUN
bjos-8650040	24	29	can	can	AUX
bjos-8650040	24	30	bind	bind	VERB
bjos-8650040	24	31	to	to	ADP
bjos-8650040	24	32	the	the	DET
bjos-8650040	24	33	immobilized	immobilized	ADJ
bjos-8650040	24	34	antibody	antibody	NOUN
bjos-8650040	24	35	.	.	PUNCT
bjos-8650040	25	1	after	after	ADP
bjos-8650040	25	2	washing	wash	VERB
bjos-8650040	25	3	away	away	ADV
bjos-8650040	25	4	any	any	DET
bjos-8650040	25	5	unbound	unbound	NOUN
bjos-8650040	25	6	substances	substance	NOUN
bjos-8650040	25	7	biotinylated	biotinylate	VERB
bjos-8650040	25	8	antibody	antibody	NOUN
bjos-8650040	25	9	(	(	PUNCT
bjos-8650040	25	10	100	100	NUM
bjos-8650040	25	11	μl	μl	PRON
bjos-8650040	25	12	)	)	PUNCT
bjos-8650040	25	13	was	be	AUX
bjos-8650040	25	14	added	add	VERB
bjos-8650040	25	15	to	to	ADP
bjos-8650040	25	16	the	the	DET
bjos-8650040	25	17	wells	well	NOUN
bjos-8650040	25	18	and	and	CCONJ
bjos-8650040	25	19	incubated	incubate	VERB
bjos-8650040	25	20	again	again	ADV
bjos-8650040	25	21	for	for	ADP
bjos-8650040	25	22	an	an	DET
bjos-8650040	25	23	hour	hour	NOUN
bjos-8650040	25	24	.	.	PUNCT
bjos-8650040	26	1	after	after	ADP
bjos-8650040	26	2	washing	wash	VERB
bjos-8650040	26	3	100	100	NUM
bjos-8650040	26	4	μl	μl	ADP
bjos-8650040	26	5	of	of	ADP
bjos-8650040	26	6	hrp	hrp	PROPN
bjos-8650040	26	7	-	-	PUNCT
bjos-8650040	26	8	streptavidin	streptavidin	NOUN
bjos-8650040	26	9	solution	solution	NOUN
bjos-8650040	26	10	was	be	AUX
bjos-8650040	26	11	added	add	VERB
bjos-8650040	26	12	to	to	ADP
bjos-8650040	26	13	each	each	DET
bjos-8650040	26	14	well	well	ADV
bjos-8650040	26	15	followed	follow	VERB
bjos-8650040	26	16	by	by	ADP
bjos-8650040	26	17	45	45	NUM
bjos-8650040	26	18	min	min	NOUN
bjos-8650040	26	19	.	.	PROPN
bjos-8650040	26	20	incubation	incubation	NOUN
bjos-8650040	26	21	.	.	PUNCT
bjos-8650040	27	1	following	follow	VERB
bjos-8650040	27	2	a	a	DET
bjos-8650040	27	3	wash	wash	NOUN
bjos-8650040	27	4	to	to	PART
bjos-8650040	27	5	remove	remove	VERB
bjos-8650040	27	6	any	any	DET
bjos-8650040	27	7	unbound	unbound	NOUN
bjos-8650040	27	8	antibody	antibody	NOUN
bjos-8650040	27	9	-	-	PUNCT
bjos-8650040	27	10	enzyme	enzyme	NOUN
bjos-8650040	27	11	reagent	reagent	NOUN
bjos-8650040	27	12	a	a	DET
bjos-8650040	27	13	substrate	substrate	NOUN
bjos-8650040	27	14	solution	solution	NOUN
bjos-8650040	27	15	(	(	PUNCT
bjos-8650040	27	16	100	100	NUM
bjos-8650040	27	17	μl	μl	PRON
bjos-8650040	27	18	)	)	PUNCT
bjos-8650040	27	19	was	be	AUX
bjos-8650040	27	20	added	add	VERB
bjos-8650040	27	21	to	to	ADP
bjos-8650040	27	22	the	the	DET
bjos-8650040	27	23	wells	well	NOUN
bjos-8650040	27	24	and	and	CCONJ
bjos-8650040	27	25	incubated	incubate	VERB
bjos-8650040	27	26	for	for	ADP
bjos-8650040	27	27	30	30	NUM
bjos-8650040	27	28	min	min	NOUN
bjos-8650040	27	29	.	.	PUNCT
bjos-8650040	28	1	the	the	DET
bjos-8650040	28	2	color	color	NOUN
bjos-8650040	28	3	developed	develop	VERB
bjos-8650040	28	4	in	in	ADP
bjos-8650040	28	5	proportion	proportion	NOUN
bjos-8650040	28	6	to	to	ADP
bjos-8650040	28	7	the	the	DET
bjos-8650040	28	8	amount	amount	NOUN
bjos-8650040	28	9	of	of	ADP
bjos-8650040	28	10	protein	protein	NOUN
bjos-8650040	28	11	bound	bind	VERB
bjos-8650040	28	12	to	to	ADP
bjos-8650040	28	13	the	the	DET
bjos-8650040	28	14	immobilized	immobilized	ADJ
bjos-8650040	28	15	antibody	antibody	NOUN
bjos-8650040	28	16	in	in	ADP
bjos-8650040	28	17	the	the	DET
bjos-8650040	28	18	initial	initial	ADJ
bjos-8650040	28	19	step	step	NOUN
bjos-8650040	28	20	.	.	PUNCT
bjos-8650040	29	1	the	the	DET
bjos-8650040	29	2	yellow	yellow	ADJ
bjos-8650040	29	3	color	color	NOUN
bjos-8650040	29	4	development	development	NOUN
bjos-8650040	29	5	was	be	AUX
bjos-8650040	29	6	stopped	stop	VERB
bjos-8650040	29	7	and	and	CCONJ
bjos-8650040	29	8	the	the	DET
bjos-8650040	29	9	intensity	intensity	NOUN
bjos-8650040	29	10	of	of	ADP
bjos-8650040	29	11	the	the	DET
bjos-8650040	29	12	blue	blue	ADJ
bjos-8650040	29	13	color	color	NOUN
bjos-8650040	29	14	was	be	AUX
bjos-8650040	29	15	measured	measure	VERB
bjos-8650040	29	16	by	by	ADP
bjos-8650040	29	17	determining	determine	VERB
bjos-8650040	29	18	its	its	PRON
bjos-8650040	29	19	absorbance	absorbance	NOUN
bjos-8650040	29	20	at	at	ADP
bjos-8650040	29	21	450	450	NUM
bjos-8650040	29	22	nm	nm	NOUN
bjos-8650040	29	23	using	use	VERB
bjos-8650040	29	24	an	an	DET
bjos-8650040	29	25	elisa	elisa	NOUN
bjos-8650040	29	26	plate	plate	NOUN
bjos-8650040	29	27	reader	reader	NOUN
bjos-8650040	29	28	(	(	PUNCT
bjos-8650040	29	29	bio	bio	NOUN
bjos-8650040	29	30	-	-	PROPN
bjos-8650040	29	31	rad	rad	NOUN
bjos-8650040	29	32	)	)	PUNCT
bjos-8650040	29	33	.	.	PUNCT
bjos-8650040	30	1	the	the	DET
bjos-8650040	30	2	concentration	concentration	NOUN
bjos-8650040	30	3	of	of	ADP
bjos-8650040	30	4	proteins	protein	NOUN
bjos-8650040	30	5	in	in	ADP
bjos-8650040	30	6	the	the	DET
bjos-8650040	30	7	samples	sample	NOUN
bjos-8650040	30	8	was	be	AUX
bjos-8650040	30	9	calculated	calculate	VERB
bjos-8650040	30	10	from	from	ADP
bjos-8650040	30	11	the	the	DET
bjos-8650040	30	12	standard	standard	ADJ
bjos-8650040	30	13	curve	curve	NOUN
bjos-8650040	30	14	and	and	CCONJ
bjos-8650040	30	15	the	the	DET
bjos-8650040	30	16	results	result	NOUN
bjos-8650040	30	17	were	be	AUX
bjos-8650040	30	18	presented	present	VERB
bjos-8650040	30	19	in	in	ADP
bjos-8650040	30	20	picogram	picogram	PROPN
bjos-8650040	30	21	per	per	ADP
bjos-8650040	30	22	milliliter	milliliter	NOUN
bjos-8650040	30	23	(	(	PUNCT
bjos-8650040	30	24	pg	pg	NOUN
bjos-8650040	30	25	/	/	SYM
bjos-8650040	30	26	ml	ml	VERB
bjos-8650040	30	27	)	)	PUNCT
bjos-8650040	30	28	for	for	ADP
bjos-8650040	30	29	il-1α	il-1α	PROPN
bjos-8650040	30	30	,	,	PUNCT
bjos-8650040	30	31	il-6	il-6	NOUN
bjos-8650040	30	32	,	,	PUNCT
bjos-8650040	30	33	il-8	il-8	PUNCT
bjos-8650040	30	34	and	and	CCONJ
bjos-8650040	30	35	tnf	tnf	PROPN
bjos-8650040	30	36	-	-	PUNCT
bjos-8650040	30	37	α	α	PROPN
bjos-8650040	30	38	and	and	CCONJ
bjos-8650040	30	39	in	in	ADP
bjos-8650040	30	40	nanogram	nanogram	PROPN
bjos-8650040	30	41	per	per	ADP
bjos-8650040	30	42	milliliter	milliliter	X
bjos-8650040	30	43	(	(	PUNCT
bjos-8650040	30	44	ng	ng	PROPN
bjos-8650040	30	45	/	/	SYM
bjos-8650040	30	46	ml	ml	NOUN
bjos-8650040	30	47	)	)	PUNCT
bjos-8650040	30	48	for	for	ADP
bjos-8650040	30	49	nf	nf	NOUN
bjos-8650040	30	50	-	-	PUNCT
bjos-8650040	30	51	κβ	κβ	NOUN
bjos-8650040	30	52	.	.	PUNCT
bjos-8650040	31	1	the	the	DET
bjos-8650040	31	2	standard	standard	ADJ
bjos-8650040	31	3	curves	curve	NOUN
bjos-8650040	31	4	for	for	ADP
bjos-8650040	31	5	nf	nf	NOUN
bjos-8650040	31	6	-	-	PUNCT
bjos-8650040	31	7	κβ	κβ	NOUN
bjos-8650040	31	8	,	,	PUNCT
bjos-8650040	31	9	il-1α	il-1α	NOUN
bjos-8650040	31	10	,	,	PUNCT
bjos-8650040	31	11	il-6	il-6	NUM
bjos-8650040	31	12	,	,	PUNCT
bjos-8650040	31	13	il-8	il-8	PUNCT
bjos-8650040	31	14	and	and	CCONJ
bjos-8650040	31	15	tnf	tnf	PROPN
bjos-8650040	31	16	-	-	PUNCT
bjos-8650040	31	17	α	α	PROPN
bjos-8650040	31	18	ranged	range	VERB
bjos-8650040	31	19	from	from	ADP
bjos-8650040	31	20	(	(	PUNCT
bjos-8650040	31	21	0–500	0–500	PROPN
bjos-8650040	31	22	ng	ng	PROPN
bjos-8650040	31	23	/	/	SYM
bjos-8650040	31	24	ml	ml	PROPN
bjos-8650040	31	25	)	)	PUNCT
bjos-8650040	31	26	,	,	PUNCT
bjos-8650040	31	27	(	(	PUNCT
bjos-8650040	31	28	0–300	0–300	NUM
bjos-8650040	31	29	pg	pg	NOUN
bjos-8650040	31	30	/	/	SYM
bjos-8650040	31	31	ml	ml	NOUN
bjos-8650040	31	32	)	)	PUNCT
bjos-8650040	31	33	,	,	PUNCT
bjos-8650040	31	34	(	(	PUNCT
bjos-8650040	31	35	0–1000	0–1000	NOUN
bjos-8650040	31	36	pg	pg	PROPN
bjos-8650040	31	37	/	/	SYM
bjos-8650040	31	38	ml	ml	VERB
bjos-8650040	31	39	)	)	PUNCT
bjos-8650040	31	40	,	,	PUNCT
bjos-8650040	31	41	(	(	PUNCT
bjos-8650040	31	42	0–1000	0–1000	NOUN
bjos-8650040	31	43	pg	pg	PROPN
bjos-8650040	31	44	/	/	SYM
bjos-8650040	31	45	ml	ml	PROPN
bjos-8650040	31	46	)	)	PUNCT
bjos-8650040	31	47	and	and	CCONJ
bjos-8650040	31	48	(	(	PUNCT
bjos-8650040	31	49	0–600	0–600	X
bjos-8650040	31	50	pg	pg	X
bjos-8650040	31	51	/	/	SYM
bjos-8650040	31	52	ml	ml	VERB
bjos-8650040	31	53	)	)	PUNCT
bjos-8650040	31	54	respectively	respectively	ADV
bjos-8650040	31	55	.	.	PUNCT
bjos-8650040	32	1	statistical	statistical	ADJ
bjos-8650040	32	2	analysis	analysis	NOUN
bjos-8650040	32	3	data	datum	NOUN
bjos-8650040	32	4	were	be	AUX
bjos-8650040	32	5	analyzed	analyze	VERB
bjos-8650040	32	6	with	with	ADP
bjos-8650040	32	7	descriptive	descriptive	ADJ
bjos-8650040	32	8	statistical	statistical	ADJ
bjos-8650040	32	9	methods	method	NOUN
bjos-8650040	32	10	(	(	PUNCT
bjos-8650040	32	11	frequency	frequency	NOUN
bjos-8650040	32	12	percentage	percentage	NOUN
bjos-8650040	32	13	and	and	CCONJ
bjos-8650040	32	14	mean	mean	ADJ
bjos-8650040	32	15	±	±	NUM
bjos-8650040	32	16	standard	standard	ADJ
bjos-8650040	32	17	deviation	deviation	NOUN
bjos-8650040	32	18	)	)	PUNCT
bjos-8650040	32	19	and	and	CCONJ
bjos-8650040	32	20	mann	mann	PROPN
bjos-8650040	32	21	–	–	PUNCT
bjos-8650040	32	22	whitney	whitney	PROPN
bjos-8650040	32	23	u	u	PROPN
bjos-8650040	32	24	test	test	NOUN
bjos-8650040	32	25	(	(	PUNCT
bjos-8650040	32	26	a	a	DET
bjos-8650040	32	27	non	non	ADJ
bjos-8650040	32	28	-	-	ADJ
bjos-8650040	32	29	parametric	parametric	ADJ
bjos-8650040	32	30	method	method	NOUN
bjos-8650040	32	31	)	)	PUNCT
bjos-8650040	32	32	using	use	VERB
bjos-8650040	32	33	spss	spss	PROPN
bjos-8650040	32	34	(	(	PUNCT
bjos-8650040	32	35	statistical	statistical	ADJ
bjos-8650040	32	36	package	package	NOUN
bjos-8650040	32	37	for	for	ADP
bjos-8650040	32	38	social	social	ADJ
bjos-8650040	32	39	sciences	science	NOUN
bjos-8650040	32	40	)	)	PUNCT
bjos-8650040	32	41	software	software	NOUN
bjos-8650040	32	42	version	version	NOUN
bjos-8650040	32	43	19.0	19.0	NUM
bjos-8650040	32	44	for	for	ADP
bjos-8650040	32	45	windows	window	NOUN
bjos-8650040	32	46	.	.	PUNCT
bjos-8650040	33	1	statistical	statistical	ADJ
bjos-8650040	33	2	significance	significance	NOUN
bjos-8650040	33	3	was	be	AUX
bjos-8650040	33	4	defined	define	VERB
bjos-8650040	33	5	at	at	ADP
bjos-8650040	33	6	p	p	NOUN
bjos-8650040	33	7	<	<	X
bjos-8650040	33	8	0.05	0.05	NUM
bjos-8650040	33	9	.	.	PUNCT
bjos-8650040	34	1	results	result	VERB
bjos-8650040	34	2	serum	serum	NOUN
bjos-8650040	34	3	levels	level	NOUN
bjos-8650040	34	4	of	of	ADP
bjos-8650040	34	5	nf	nf	NOUN
bjos-8650040	34	6	-	-	PUNCT
bjos-8650040	34	7	κβ	κβ	NOUN
bjos-8650040	34	8	and	and	CCONJ
bjos-8650040	34	9	pro	pro	ADJ
bjos-8650040	34	10	-	-	ADJ
bjos-8650040	34	11	inflammatory	inflammatory	ADJ
bjos-8650040	34	12	cytokines	cytokine	VERB
bjos-8650040	34	13	detectable	detectable	ADJ
bjos-8650040	34	14	levels	level	NOUN
bjos-8650040	34	15	of	of	ADP
bjos-8650040	34	16	nf	nf	NOUN
bjos-8650040	34	17	-	-	PUNCT
bjos-8650040	34	18	κβ	κβ	NOUN
bjos-8650040	34	19	,	,	PUNCT
bjos-8650040	34	20	il-1α	il-1α	NOUN
bjos-8650040	34	21	,	,	PUNCT
bjos-8650040	34	22	il-6	il-6	NUM
bjos-8650040	34	23	,	,	PUNCT
bjos-8650040	34	24	il-8	il-8	PUNCT
bjos-8650040	34	25	and	and	CCONJ
bjos-8650040	34	26	tnf	tnf	PROPN
bjos-8650040	34	27	-	-	PUNCT
bjos-8650040	34	28	α	α	NOUN
bjos-8650040	34	29	proteins	protein	NOUN
bjos-8650040	34	30	were	be	AUX
bjos-8650040	34	31	present	present	ADJ
bjos-8650040	34	32	in	in	ADP
bjos-8650040	34	33	serum	serum	NOUN
bjos-8650040	34	34	samples	sample	NOUN
bjos-8650040	34	35	obtained	obtain	VERB
bjos-8650040	34	36	from	from	ADP
bjos-8650040	34	37	the	the	DET
bjos-8650040	34	38	control	control	NOUN
bjos-8650040	34	39	group	group	NOUN
bjos-8650040	34	40	(	(	PUNCT
bjos-8650040	34	41	group	group	NOUN
bjos-8650040	34	42	ii	ii	PROPN
bjos-8650040	34	43	)	)	PUNCT
bjos-8650040	34	44	.	.	PUNCT
bjos-8650040	35	1	serum	serum	PROPN
bjos-8650040	35	2	levels	level	NOUN
bjos-8650040	35	3	of	of	ADP
bjos-8650040	35	4	nf	nf	NOUN
bjos-8650040	35	5	-	-	PUNCT
bjos-8650040	35	6	κβ	κβ	NOUN
bjos-8650040	35	7	,	,	PUNCT
bjos-8650040	35	8	il-1α	il-1α	NOUN
bjos-8650040	35	9	,	,	PUNCT
bjos-8650040	35	10	il-6	il-6	NUM
bjos-8650040	35	11	,	,	PUNCT
bjos-8650040	35	12	il-8	il-8	PUNCT
bjos-8650040	35	13	and	and	CCONJ
bjos-8650040	35	14	tnf	tnf	PROPN
bjos-8650040	35	15	-	-	PUNCT
bjos-8650040	35	16	α	α	PROPN
bjos-8650040	35	17	were	be	AUX
bjos-8650040	35	18	elevated	elevate	VERB
bjos-8650040	35	19	in	in	ADP
bjos-8650040	35	20	100	100	NUM
bjos-8650040	35	21	%	%	NOUN
bjos-8650040	35	22	(	(	PUNCT
bjos-8650040	35	23	45/45	45/45	NUM
bjos-8650040	35	24	)	)	PUNCT
bjos-8650040	35	25	,	,	PUNCT
bjos-8650040	35	26	60	60	NUM
bjos-8650040	35	27	%	%	NOUN
bjos-8650040	35	28	(	(	PUNCT
bjos-8650040	35	29	27/45	27/45	NUM
bjos-8650040	35	30	)	)	PUNCT
bjos-8650040	35	31	,	,	PUNCT
bjos-8650040	35	32	100	100	NUM
bjos-8650040	35	33	%	%	NOUN
bjos-8650040	35	34	(	(	PUNCT
bjos-8650040	35	35	45/45	45/45	NUM
bjos-8650040	35	36	)	)	PUNCT
bjos-8650040	35	37	,	,	PUNCT
bjos-8650040	35	38	53.34	53.34	NUM
bjos-8650040	35	39	%	%	NOUN
bjos-8650040	35	40	(	(	PUNCT
bjos-8650040	35	41	24/45	24/45	NUM
bjos-8650040	35	42	)	)	PUNCT
bjos-8650040	35	43	,	,	PUNCT
bjos-8650040	35	44	100	100	NUM
bjos-8650040	35	45	%	%	NOUN
bjos-8650040	35	46	(	(	PUNCT
bjos-8650040	35	47	45/45	45/45	NUM
bjos-8650040	35	48	)	)	PUNCT
bjos-8650040	35	49	of	of	ADP
bjos-8650040	35	50	the	the	DET
bjos-8650040	35	51	patients	patient	NOUN
bjos-8650040	35	52	respectively	respectively	ADV
bjos-8650040	35	53	as	as	SCONJ
bjos-8650040	35	54	compared	compare	VERB
bjos-8650040	35	55	to	to	ADP
bjos-8650040	35	56	their	their	PRON
bjos-8650040	35	57	concentration	concentration	NOUN
bjos-8650040	35	58	in	in	ADP
bjos-8650040	35	59	the	the	DET
bjos-8650040	35	60	serum	serum	NOUN
bjos-8650040	35	61	of	of	ADP
bjos-8650040	35	62	healthy	healthy	ADJ
bjos-8650040	35	63	subjects	subject	NOUN
bjos-8650040	35	64	.	.	PUNCT
bjos-8650040	36	1	the	the	DET
bjos-8650040	36	2	mean	mean	ADJ
bjos-8650040	36	3	values	value	NOUN
bjos-8650040	36	4	of	of	ADP
bjos-8650040	36	5	nf	nf	NOUN
bjos-8650040	36	6	-	-	PUNCT
bjos-8650040	36	7	κβ	κβ	NOUN
bjos-8650040	36	8	(	(	PUNCT
bjos-8650040	36	9	262.65±169.91	262.65±169.91	PROPN
bjos-8650040	36	10	ng/	ng/	VERB
bjos-8650040	36	11	ml	ml	NOUN
bjos-8650040	36	12	)	)	PUNCT
bjos-8650040	36	13	,	,	PUNCT
bjos-8650040	36	14	il-6	il-6	NUM
bjos-8650040	37	1	(	(	PUNCT
bjos-8650040	37	2	112.56±309.07	112.56±309.07	PROPN
bjos-8650040	37	3	pg	pg	PROPN
bjos-8650040	37	4	/	/	SYM
bjos-8650040	37	5	ml	ml	NOUN
bjos-8650040	37	6	)	)	PUNCT
bjos-8650040	37	7	and	and	CCONJ
bjos-8650040	37	8	tnf	tnf	PROPN
bjos-8650040	37	9	-	-	PUNCT
bjos-8650040	37	10	α	α	PROPN
bjos-8650040	37	11	(	(	PUNCT
bjos-8650040	37	12	372.28±472.39	372.28±472.39	PROPN
bjos-8650040	37	13	pg	pg	NOUN
bjos-8650040	37	14	/	/	SYM
bjos-8650040	37	15	ml	ml	VERB
bjos-8650040	37	16	)	)	PUNCT
bjos-8650040	37	17	in	in	ADP
bjos-8650040	37	18	serum	serum	NOUN
bjos-8650040	37	19	of	of	ADP
bjos-8650040	37	20	the	the	DET
bjos-8650040	37	21	patients	patient	NOUN
bjos-8650040	37	22	were	be	AUX
bjos-8650040	37	23	significantly	significantly	ADV
bjos-8650040	37	24	(	(	PUNCT
bjos-8650040	37	25	p<0.05	p<0.05	NOUN
bjos-8650040	37	26	)	)	PUNCT
bjos-8650040	37	27	higher	high	ADJ
bjos-8650040	37	28	in	in	ADP
bjos-8650040	37	29	comparison	comparison	NOUN
bjos-8650040	37	30	with	with	ADP
bjos-8650040	37	31	the	the	DET
bjos-8650040	37	32	values	value	NOUN
bjos-8650040	37	33	obtained	obtain	VERB
bjos-8650040	37	34	from	from	ADP
bjos-8650040	37	35	control	control	NOUN
bjos-8650040	37	36	subjects	subject	NOUN
bjos-8650040	37	37	that	that	PRON
bjos-8650040	37	38	were	be	AUX
bjos-8650040	37	39	25.66±9.502	25.66±9.502	PROPN
bjos-8650040	37	40	ng	ng	PROPN
bjos-8650040	37	41	/	/	SYM
bjos-8650040	37	42	ml	ml	PROPN
bjos-8650040	37	43	,	,	PUNCT
bjos-8650040	37	44	4.880±2.95	4.880±2.95	PROPN
bjos-8650040	37	45	pg	pg	NOUN
bjos-8650040	37	46	/	/	SYM
bjos-8650040	37	47	ml	ml	PROPN
bjos-8650040	37	48	and	and	CCONJ
bjos-8650040	37	49	12.00±7.0590	12.00±7.0590	NUM
bjos-8650040	37	50	pg	pg	VERB
bjos-8650040	37	51	/	/	SYM
bjos-8650040	37	52	ml	ml	X
bjos-8650040	37	53	for	for	ADP
bjos-8650040	37	54	nf	nf	NOUN
bjos-8650040	37	55	-	-	PUNCT
bjos-8650040	37	56	κβ	κβ	NOUN
bjos-8650040	37	57	,	,	PUNCT
bjos-8650040	37	58	il-6	il-6	NOUN
bjos-8650040	37	59	and	and	CCONJ
bjos-8650040	37	60	tnf	tnf	PROPN
bjos-8650040	37	61	-	-	PUNCT
bjos-8650040	37	62	α	α	PROPN
bjos-8650040	37	63	,	,	PUNCT
bjos-8650040	37	64	respectively	respectively	ADV
bjos-8650040	37	65	,	,	PUNCT
bjos-8650040	37	66	as	as	SCONJ
bjos-8650040	37	67	revealed	reveal	VERB
bjos-8650040	37	68	by	by	ADP
bjos-8650040	37	69	mann	mann	PROPN
bjos-8650040	37	70	–	–	PUNCT
bjos-8650040	37	71	whitney	whitney	PROPN
bjos-8650040	37	72	u	u	PROPN
bjos-8650040	37	73	test2	test2	PROPN
bjos-8650040	37	74	(	(	PUNCT
bjos-8650040	37	75	figure	figure	NOUN
bjos-8650040	37	76	1	1	NUM
bjos-8650040	37	77	)	)	PUNCT
bjos-8650040	37	78	mean	mean	ADJ
bjos-8650040	37	79	values	value	NOUN
bjos-8650040	37	80	for	for	ADP
bjos-8650040	37	81	il-1α	il-1α	PROPN
bjos-8650040	37	82	(	(	PUNCT
bjos-8650040	37	83	38.919±	38.919±	NUM
bjos-8650040	37	84	69.99	69.99	NUM
bjos-8650040	37	85	pg	pg	NOUN
bjos-8650040	37	86	/	/	SYM
bjos-8650040	37	87	ml	ml	NOUN
bjos-8650040	37	88	)	)	PUNCT
bjos-8650040	37	89	and	and	CCONJ
bjos-8650040	37	90	il-8	il-8	NOUN
bjos-8650040	37	91	(	(	PUNCT
bjos-8650040	37	92	53.38±137.88	53.38±137.88	NUM
bjos-8650040	37	93	pg	pg	NOUN
bjos-8650040	37	94	/	/	SYM
bjos-8650040	37	95	ml	ml	VERB
bjos-8650040	37	96	)	)	PUNCT
bjos-8650040	37	97	were	be	AUX
bjos-8650040	37	98	also	also	ADV
bjos-8650040	37	99	increased	increase	VERB
bjos-8650040	37	100	as	as	SCONJ
bjos-8650040	37	101	compared	compare	VERB
bjos-8650040	37	102	to	to	ADP
bjos-8650040	37	103	their	their	PRON
bjos-8650040	37	104	values	value	NOUN
bjos-8650040	37	105	in	in	ADP
bjos-8650040	37	106	the	the	DET
bjos-8650040	37	107	control	control	NOUN
bjos-8650040	37	108	group	group	NOUN
bjos-8650040	37	109	(	(	PUNCT
bjos-8650040	37	110	il-1α=26.790±10.055	il-1α=26.790±10.055	PROPN
bjos-8650040	37	111	pg	pg	PROPN
bjos-8650040	37	112	/	/	SYM
bjos-8650040	37	113	ml	ml	PROPN
bjos-8650040	37	114	and	and	CCONJ
bjos-8650040	37	115	il-8=8.690±2.534pg	il-8=8.690±2.534pg	PROPN
bjos-8650040	37	116	/	/	SYM
bjos-8650040	37	117	ml	ml	NOUN
bjos-8650040	37	118	)	)	PUNCT
bjos-8650040	37	119	but	but	CCONJ
bjos-8650040	37	120	statistically	statistically	ADV
bjos-8650040	37	121	a	a	DET
bjos-8650040	37	122	non	non	ADJ
bjos-8650040	37	123	-	-	ADJ
bjos-8650040	37	124	significant	significant	ADJ
bjos-8650040	37	125	difference	difference	NOUN
bjos-8650040	37	126	was	be	AUX
bjos-8650040	37	127	obtained	obtain	VERB
bjos-8650040	37	128	between	between	ADP
bjos-8650040	37	129	the	the	DET
bjos-8650040	37	130	two	two	NUM
bjos-8650040	37	131	groups	group	NOUN
bjos-8650040	37	132	(	(	PUNCT
bjos-8650040	37	133	figure	figure	NOUN
bjos-8650040	37	134	1	1	NUM
bjos-8650040	37	135	)	)	PUNCT
bjos-8650040	37	136	.	.	PUNCT
bjos-8650040	38	1	281	281	NUM
bjos-8650040	38	2	interleukin-1α	interleukin-1α	NOUN
bjos-8650040	38	3	(	(	PUNCT
bjos-8650040	38	4	il-1α	il-1α	PROPN
bjos-8650040	38	5	)	)	PUNCT
bjos-8650040	38	6	,	,	PUNCT
bjos-8650040	38	7	il-6	il-6	NOUN
bjos-8650040	38	8	and	and	CCONJ
bjos-8650040	38	9	il-813,14	il-813,14	ADV
bjos-8650040	38	10	.	.	PUNCT
bjos-8650040	39	1	the	the	DET
bjos-8650040	39	2	increased	increase	VERB
bjos-8650040	39	3	levels	level	NOUN
bjos-8650040	39	4	of	of	ADP
bjos-8650040	39	5	these	these	DET
bjos-8650040	39	6	cytokines	cytokine	NOUN
bjos-8650040	39	7	induce	induce	VERB
bjos-8650040	39	8	inflammatory	inflammatory	ADJ
bjos-8650040	39	9	reactions	reaction	NOUN
bjos-8650040	39	10	in	in	ADP
bjos-8650040	39	11	oral	oral	ADJ
bjos-8650040	39	12	mucosa	mucosa	NOUN
bjos-8650040	39	13	and	and	CCONJ
bjos-8650040	39	14	promote	promote	VERB
bjos-8650040	39	15	the	the	DET
bjos-8650040	39	16	damage	damage	NOUN
bjos-8650040	39	17	of	of	ADP
bjos-8650040	39	18	the	the	DET
bjos-8650040	39	19	underlying	underlie	VERB
bjos-8650040	39	20	connective	connective	ADJ
bjos-8650040	39	21	tissues	tissue	NOUN
bjos-8650040	39	22	reduce	reduce	VERB
bjos-8650040	39	23	epithelial	epithelial	ADJ
bjos-8650040	39	24	oxygenation	oxygenation	NOUN
bjos-8650040	39	25	and	and	CCONJ
bjos-8650040	39	26	ultimately	ultimately	ADV
bjos-8650040	39	27	result	result	VERB
bjos-8650040	39	28	in	in	ADP
bjos-8650040	39	29	epithelial	epithelial	ADJ
bjos-8650040	39	30	basal	basal	NOUN
bjos-8650040	39	31	cell	cell	NOUN
bjos-8650040	39	32	death	death	NOUN
bjos-8650040	39	33	and	and	CCONJ
bjos-8650040	39	34	injury4,15	injury4,15	PROPN
bjos-8650040	39	35	.	.	PROPN
bjos-8650040	40	1	since	since	SCONJ
bjos-8650040	40	2	tnf	tnf	PROPN
bjos-8650040	40	3	-	-	PUNCT
bjos-8650040	40	4	α	α	PROPN
bjos-8650040	40	5	,	,	PUNCT
bjos-8650040	40	6	il-1α	il-1α	PROPN
bjos-8650040	40	7	and	and	CCONJ
bjos-8650040	40	8	il-6	il-6	NOUN
bjos-8650040	40	9	are	be	AUX
bjos-8650040	40	10	efficient	efficient	ADJ
bjos-8650040	40	11	activators	activator	NOUN
bjos-8650040	40	12	of	of	ADP
bjos-8650040	40	13	nf	nf	NOUN
bjos-8650040	40	14	-	-	PUNCT
bjos-8650040	40	15	κβ	κβ	NOUN
bjos-8650040	40	16	and	and	CCONJ
bjos-8650040	40	17	the	the	DET
bjos-8650040	40	18	repeated	repeat	VERB
bjos-8650040	40	19	nf	nf	NOUN
bjos-8650040	40	20	-	-	PUNCT
bjos-8650040	40	21	κβ	κβ	NOUN
bjos-8650040	40	22	activation	activation	NOUN
bjos-8650040	40	23	by	by	ADP
bjos-8650040	40	24	them	they	PRON
bjos-8650040	40	25	may	may	AUX
bjos-8650040	40	26	amplify	amplify	VERB
bjos-8650040	40	27	the	the	DET
bjos-8650040	40	28	mucosal	mucosal	NOUN
bjos-8650040	40	29	damage	damage	NOUN
bjos-8650040	40	30	in	in	ADP
bjos-8650040	40	31	a	a	DET
bjos-8650040	40	32	vicious	vicious	ADJ
bjos-8650040	40	33	circle4,13,14	circle4,13,14	ADV
bjos-8650040	40	34	which	which	PRON
bjos-8650040	40	35	hence	hence	ADV
bjos-8650040	40	36	would	would	AUX
bjos-8650040	40	37	ultimately	ultimately	ADV
bjos-8650040	40	38	lead	lead	VERB
bjos-8650040	40	39	to	to	ADP
bjos-8650040	40	40	the	the	DET
bjos-8650040	40	41	development	development	NOUN
bjos-8650040	40	42	of	of	ADP
bjos-8650040	40	43	mucositis	mucositis	PROPN
bjos-8650040	40	44	as	as	ADP
bjos-8650040	40	45	an	an	DET
bjos-8650040	40	46	after	after	ADP
bjos-8650040	40	47	effect	effect	NOUN
bjos-8650040	40	48	of	of	ADP
bjos-8650040	40	49	radiation	radiation	NOUN
bjos-8650040	40	50	therapy	therapy	NOUN
bjos-8650040	40	51	.	.	PUNCT
bjos-8650040	41	1	the	the	DET
bjos-8650040	41	2	aim	aim	NOUN
bjos-8650040	41	3	of	of	ADP
bjos-8650040	41	4	this	this	DET
bjos-8650040	41	5	study	study	NOUN
bjos-8650040	41	6	is	be	AUX
bjos-8650040	41	7	to	to	PART
bjos-8650040	41	8	analyze	analyze	VERB
bjos-8650040	41	9	the	the	DET
bjos-8650040	41	10	cytokine	cytokine	ADJ
bjos-8650040	41	11	expression	expression	NOUN
bjos-8650040	41	12	of	of	ADP
bjos-8650040	41	13	nf	nf	NOUN
bjos-8650040	41	14	-	-	PUNCT
bjos-8650040	41	15	κβ	κβ	NOUN
bjos-8650040	41	16	and	and	CCONJ
bjos-8650040	41	17	its	its	PRON
bjos-8650040	41	18	associated	associated	ADJ
bjos-8650040	41	19	cytokines	cytokine	NOUN
bjos-8650040	41	20	(	(	PUNCT
bjos-8650040	41	21	il-1α	il-1α	NOUN
bjos-8650040	41	22	,	,	PUNCT
bjos-8650040	41	23	il-6	il-6	NOUN
bjos-8650040	41	24	,	,	PUNCT
bjos-8650040	41	25	il-8	il-8	NOUN
bjos-8650040	41	26	,	,	PUNCT
bjos-8650040	41	27	tnf	tnf	PROPN
bjos-8650040	41	28	-	-	PUNCT
bjos-8650040	41	29	α	α	NOUN
bjos-8650040	41	30	)	)	PUNCT
bjos-8650040	41	31	in	in	ADP
bjos-8650040	41	32	the	the	DET
bjos-8650040	41	33	serum	serum	NOUN
bjos-8650040	41	34	of	of	ADP
bjos-8650040	41	35	patients	patient	NOUN
bjos-8650040	41	36	with	with	ADP
bjos-8650040	41	37	radiation	radiation	NOUN
bjos-8650040	41	38	induced	induce	VERB
bjos-8650040	41	39	oral	oral	ADJ
bjos-8650040	41	40	mucositis	mucositis	NOUN
bjos-8650040	41	41	after	after	ADP
bjos-8650040	41	42	undergoing	undergo	VERB
bjos-8650040	41	43	radiation	radiation	NOUN
bjos-8650040	41	44	therapy	therapy	NOUN
bjos-8650040	41	45	for	for	ADP
bjos-8650040	41	46	head	head	NOUN
bjos-8650040	41	47	and	and	CCONJ
bjos-8650040	41	48	neck	neck	NOUN
bjos-8650040	41	49	cancers	cancer	NOUN
bjos-8650040	41	50	so	so	SCONJ
bjos-8650040	41	51	as	as	SCONJ
bjos-8650040	41	52	to	to	PART
bjos-8650040	41	53	validate	validate	VERB
bjos-8650040	41	54	their	their	PRON
bjos-8650040	41	55	role	role	NOUN
bjos-8650040	41	56	in	in	ADP
bjos-8650040	41	57	the	the	DET
bjos-8650040	41	58	pathobiology	pathobiology	NOUN
bjos-8650040	41	59	of	of	ADP
bjos-8650040	41	60	the	the	DET
bjos-8650040	41	61	disease	disease	NOUN
bjos-8650040	41	62	.	.	PUNCT
bjos-8650040	42	1	materials	material	NOUN
bjos-8650040	42	2	and	and	CCONJ
bjos-8650040	42	3	methods	method	NOUN
bjos-8650040	42	4	sample	sample	NOUN
bjos-8650040	42	5	selection	selection	NOUN
bjos-8650040	42	6	45	45	NUM
bjos-8650040	42	7	patients	patient	NOUN
bjos-8650040	42	8	(	(	PUNCT
bjos-8650040	42	9	group	group	NOUN
bjos-8650040	42	10	i	i	PROPN
bjos-8650040	42	11	)	)	PUNCT
bjos-8650040	42	12	reported	report	VERB
bjos-8650040	42	13	to	to	ADP
bjos-8650040	42	14	department	department	NOUN
bjos-8650040	42	15	of	of	ADP
bjos-8650040	42	16	radiation	radiation	NOUN
bjos-8650040	42	17	therapy	therapy	NOUN
bjos-8650040	42	18	,	,	PUNCT
bjos-8650040	42	19	lnjp	lnjp	ADJ
bjos-8650040	42	20	hospital	hospital	NOUN
bjos-8650040	42	21	,	,	PUNCT
bjos-8650040	42	22	delhi	delhi	ADJ
bjos-8650040	42	23	with	with	ADP
bjos-8650040	42	24	head	head	PROPN
bjos-8650040	42	25	&	&	CCONJ
bjos-8650040	42	26	neck	neck	NOUN
bjos-8650040	42	27	cancer	cancer	NOUN
bjos-8650040	42	28	undergoing	undergo	VERB
bjos-8650040	42	29	radiation	radiation	NOUN
bjos-8650040	42	30	therapy	therapy	NOUN
bjos-8650040	42	31	with	with	ADP
bjos-8650040	42	32	/	/	SYM
bjos-8650040	42	33	without	without	ADP
bjos-8650040	42	34	chemotherapy	chemotherapy	NOUN
bjos-8650040	42	35	and	and	CCONJ
bjos-8650040	42	36	showing	show	VERB
bjos-8650040	42	37	clinical	clinical	ADJ
bjos-8650040	42	38	symptoms	symptom	NOUN
bjos-8650040	42	39	of	of	ADP
bjos-8650040	42	40	oral	oral	ADJ
bjos-8650040	42	41	mucositis	mucositis	NOUN
bjos-8650040	42	42	were	be	AUX
bjos-8650040	42	43	selected	select	VERB
bjos-8650040	42	44	for	for	ADP
bjos-8650040	42	45	the	the	DET
bjos-8650040	42	46	study	study	NOUN
bjos-8650040	42	47	.	.	PUNCT
bjos-8650040	43	1	around	around	ADV
bjos-8650040	43	2	2	2	NUM
bjos-8650040	43	3	ml	ml	NOUN
bjos-8650040	43	4	blood	blood	NOUN
bjos-8650040	43	5	was	be	AUX
bjos-8650040	43	6	collected	collect	VERB
bjos-8650040	43	7	and	and	CCONJ
bjos-8650040	43	8	centrifuged	centrifuge	VERB
bjos-8650040	43	9	at	at	ADP
bjos-8650040	43	10	5000rpm	5000rpm	NUM
bjos-8650040	43	11	.	.	PUNCT
bjos-8650040	44	1	their	their	PRON
bjos-8650040	44	2	serum	serum	NOUN
bjos-8650040	44	3	was	be	AUX
bjos-8650040	44	4	separated	separate	VERB
bjos-8650040	44	5	and	and	CCONJ
bjos-8650040	44	6	stored	store	VERB
bjos-8650040	44	7	at	at	ADP
bjos-8650040	44	8	-80oc	-80oc	PROPN
bjos-8650040	44	9	until	until	ADP
bjos-8650040	44	10	further	further	ADJ
bjos-8650040	44	11	use	use	NOUN
bjos-8650040	44	12	.	.	PUNCT
bjos-8650040	45	1	serum	serum	NOUN
bjos-8650040	45	2	samples	sample	NOUN
bjos-8650040	45	3	from	from	ADP
bjos-8650040	45	4	10	10	NUM
bjos-8650040	45	5	healthy	healthy	ADJ
bjos-8650040	45	6	volunteers	volunteer	NOUN
bjos-8650040	45	7	with	with	ADP
bjos-8650040	45	8	no	no	DET
bjos-8650040	45	9	history	history	NOUN
bjos-8650040	45	10	of	of	ADP
bjos-8650040	45	11	cancer	cancer	NOUN
bjos-8650040	45	12	or	or	CCONJ
bjos-8650040	45	13	previous	previous	ADJ
bjos-8650040	45	14	radiation	radiation	NOUN
bjos-8650040	45	15	therapy	therapy	NOUN
bjos-8650040	45	16	served	serve	VERB
bjos-8650040	45	17	as	as	ADP
bjos-8650040	45	18	the	the	DET
bjos-8650040	45	19	control	control	NOUN
bjos-8650040	45	20	group	group	NOUN
bjos-8650040	45	21	(	(	PUNCT
bjos-8650040	45	22	group	group	NOUN
bjos-8650040	45	23	ii	ii	PROPN
bjos-8650040	45	24	)	)	PUNCT
bjos-8650040	45	25	.	.	PUNCT
bjos-8650040	46	1	approval	approval	NOUN
bjos-8650040	46	2	from	from	ADP
bjos-8650040	46	3	institutional	institutional	ADJ
bjos-8650040	46	4	ethical	ethical	PROPN
bjos-8650040	46	5	committee	committee	PROPN
bjos-8650040	46	6	&	&	CCONJ
bjos-8650040	46	7	prior	prior	ADV
bjos-8650040	46	8	informed	informed	ADJ
bjos-8650040	46	9	consent	consent	NOUN
bjos-8650040	46	10	was	be	AUX
bjos-8650040	46	11	taken	take	VERB
bjos-8650040	46	12	from	from	ADP
bjos-8650040	46	13	all	all	DET
bjos-8650040	46	14	the	the	DET
bjos-8650040	46	15	patients	patient	NOUN
bjos-8650040	46	16	.	.	PUNCT
bjos-8650040	47	1	patient	patient	ADJ
bjos-8650040	47	2	characteristics	characteristic	NOUN
bjos-8650040	47	3	in	in	ADP
bjos-8650040	47	4	group	group	NOUN
bjos-8650040	47	5	i	i	PRON
bjos-8650040	47	6	33	33	NUM
bjos-8650040	47	7	male	male	ADJ
bjos-8650040	47	8	and	and	CCONJ
bjos-8650040	47	9	12	12	NUM
bjos-8650040	47	10	female	female	NOUN
bjos-8650040	47	11	with	with	ADP
bjos-8650040	47	12	a	a	DET
bjos-8650040	47	13	mean	mean	ADJ
bjos-8650040	47	14	age	age	NOUN
bjos-8650040	47	15	of	of	ADP
bjos-8650040	47	16	49.82	49.82	NUM
bjos-8650040	47	17	years	year	NOUN
bjos-8650040	47	18	were	be	AUX
bjos-8650040	47	19	enrolled	enrol	VERB
bjos-8650040	47	20	.	.	PUNCT
bjos-8650040	48	1	group	group	PROPN
bjos-8650040	48	2	ii	ii	PROPN
bjos-8650040	48	3	included	include	VERB
bjos-8650040	48	4	10	10	NUM
bjos-8650040	48	5	healthy	healthy	ADJ
bjos-8650040	48	6	controls	control	NOUN
bjos-8650040	48	7	(	(	PUNCT
bjos-8650040	48	8	5	5	NUM
bjos-8650040	48	9	male	male	NOUN
bjos-8650040	48	10	and	and	CCONJ
bjos-8650040	48	11	5	5	NUM
bjos-8650040	48	12	female	female	NOUN
bjos-8650040	48	13	)	)	PUNCT
bjos-8650040	48	14	with	with	ADP
bjos-8650040	48	15	a	a	DET
bjos-8650040	48	16	mean	mean	ADJ
bjos-8650040	48	17	age	age	NOUN
bjos-8650040	48	18	of	of	ADP
bjos-8650040	48	19	44.9	44.9	NUM
bjos-8650040	48	20	years	year	NOUN
bjos-8650040	48	21	with	with	ADP
bjos-8650040	48	22	no	no	DET
bjos-8650040	48	23	prior	prior	ADJ
bjos-8650040	48	24	history	history	NOUN
bjos-8650040	48	25	of	of	ADP
bjos-8650040	48	26	undergoing	undergo	VERB
bjos-8650040	48	27	any	any	DET
bjos-8650040	48	28	radiation	radiation	NOUN
bjos-8650040	48	29	treatment	treatment	NOUN
bjos-8650040	48	30	.	.	PUNCT
bjos-8650040	49	1	39	39	NUM
bjos-8650040	49	2	out	out	ADP
bjos-8650040	49	3	of	of	ADP
bjos-8650040	49	4	45	45	NUM
bjos-8650040	49	5	patients	patient	NOUN
bjos-8650040	49	6	developed	develop	VERB
bjos-8650040	49	7	symptoms	symptom	NOUN
bjos-8650040	49	8	of	of	ADP
bjos-8650040	49	9	mucositis	mucositis	NOUN
bjos-8650040	49	10	during	during	ADP
bjos-8650040	49	11	/after	/after	PUNCT
bjos-8650040	49	12	the	the	DET
bjos-8650040	49	13	treatment	treatment	NOUN
bjos-8650040	49	14	therapy	therapy	NOUN
bjos-8650040	49	15	while	while	SCONJ
bjos-8650040	49	16	about	about	ADV
bjos-8650040	49	17	6	6	NUM
bjos-8650040	49	18	patients	patient	NOUN
bjos-8650040	49	19	showed	show	VERB
bjos-8650040	49	20	no	no	DET
bjos-8650040	49	21	visible	visible	ADJ
bjos-8650040	49	22	signs	sign	NOUN
bjos-8650040	49	23	of	of	ADP
bjos-8650040	49	24	any	any	DET
bjos-8650040	49	25	such	such	ADJ
bjos-8650040	49	26	complications	complication	NOUN
bjos-8650040	49	27	(	(	PUNCT
bjos-8650040	49	28	grade	grade	NOUN
bjos-8650040	49	29	0	0	NUM
bjos-8650040	49	30	)	)	PUNCT
bjos-8650040	49	31	.	.	PUNCT
bjos-8650040	50	1	27	27	NUM
bjos-8650040	50	2	out	out	ADP
bjos-8650040	50	3	of	of	ADP
bjos-8650040	50	4	39	39	NUM
bjos-8650040	50	5	patients	patient	NOUN
bjos-8650040	50	6	had	have	AUX
bjos-8650040	50	7	developed	develop	VERB
bjos-8650040	50	8	early	early	ADJ
bjos-8650040	50	9	signs	sign	NOUN
bjos-8650040	50	10	of	of	ADP
bjos-8650040	50	11	mucositis	mucositis	NOUN
bjos-8650040	50	12	(	(	PUNCT
bjos-8650040	50	13	grades	grade	NOUN
bjos-8650040	50	14	1	1	NUM
bjos-8650040	50	15	&	&	CCONJ
bjos-8650040	50	16	2	2	NUM
bjos-8650040	50	17	)	)	PUNCT
bjos-8650040	50	18	with	with	ADP
bjos-8650040	50	19	symptomatic	symptomatic	ADJ
bjos-8650040	50	20	redness	redness	NOUN
bjos-8650040	50	21	and	and	CCONJ
bjos-8650040	50	22	erythema	erythema	ADJ
bjos-8650040	50	23	,	,	PUNCT
bjos-8650040	50	24	loss	loss	NOUN
bjos-8650040	50	25	of	of	ADP
bjos-8650040	50	26	taste	taste	NOUN
bjos-8650040	50	27	,	,	PUNCT
bjos-8650040	50	28	mouth	mouth	NOUN
bjos-8650040	50	29	dryness	dryness	NOUN
bjos-8650040	50	30	.	.	PUNCT
bjos-8650040	51	1	12	12	NUM
bjos-8650040	51	2	out	out	ADP
bjos-8650040	51	3	of	of	ADP
bjos-8650040	51	4	39	39	NUM
bjos-8650040	51	5	patients	patient	NOUN
bjos-8650040	51	6	had	have	AUX
bjos-8650040	51	7	developed	develop	VERB
bjos-8650040	51	8	severe	severe	ADJ
bjos-8650040	51	9	signs	sign	NOUN
bjos-8650040	51	10	of	of	ADP
bjos-8650040	51	11	mucositis	mucositis	NOUN
bjos-8650040	51	12	(	(	PUNCT
bjos-8650040	51	13	grades	grade	NOUN
bjos-8650040	51	14	3	3	NUM
bjos-8650040	51	15	&	&	CCONJ
bjos-8650040	51	16	4	4	NUM
bjos-8650040	51	17	)	)	PUNCT
bjos-8650040	51	18	during	during	ADP
bjos-8650040	51	19	the	the	DET
bjos-8650040	51	20	course	course	NOUN
bjos-8650040	51	21	of	of	ADP
bjos-8650040	51	22	their	their	PRON
bjos-8650040	51	23	treatment	treatment	NOUN
bjos-8650040	51	24	,	,	PUNCT
bjos-8650040	51	25	with	with	ADP
bjos-8650040	51	26	painful	painful	ADJ
bjos-8650040	51	27	contiguous	contiguous	ADJ
bjos-8650040	51	28	pseudo	pseudo	NOUN
bjos-8650040	51	29	membraneous	membraneous	ADJ
bjos-8650040	51	30	lesions	lesion	NOUN
bjos-8650040	51	31	developed	develop	VERB
bjos-8650040	51	32	along	along	ADV
bjos-8650040	51	33	with	with	ADP
bjos-8650040	51	34	associated	associated	ADJ
bjos-8650040	51	35	dysphagia	dysphagia	NOUN
bjos-8650040	51	36	and	and	CCONJ
bjos-8650040	51	37	decreased	decrease	VERB
bjos-8650040	51	38	oral	oral	ADJ
bjos-8650040	51	39	intake	intake	NOUN
bjos-8650040	51	40	.	.	PUNCT
bjos-8650040	52	1	26	26	NUM
bjos-8650040	52	2	out	out	ADP
bjos-8650040	52	3	of	of	ADP
bjos-8650040	52	4	45	45	NUM
bjos-8650040	52	5	patients	patient	NOUN
bjos-8650040	52	6	had	have	AUX
bjos-8650040	52	7	undergone	undergo	VERB
bjos-8650040	52	8	chemotherapy	chemotherapy	NOUN
bjos-8650040	52	9	along	along	ADP
bjos-8650040	52	10	with	with	ADP
bjos-8650040	52	11	the	the	DET
bjos-8650040	52	12	radiation	radiation	NOUN
bjos-8650040	52	13	treatment	treatment	NOUN
bjos-8650040	52	14	,	,	PUNCT
bjos-8650040	52	15	while	while	SCONJ
bjos-8650040	52	16	19	19	NUM
bjos-8650040	52	17	out	out	ADP
bjos-8650040	52	18	of	of	ADP
bjos-8650040	52	19	45	45	NUM
bjos-8650040	52	20	patients	patient	NOUN
bjos-8650040	52	21	undertook	undertake	VERB
bjos-8650040	52	22	just	just	ADV
bjos-8650040	52	23	the	the	DET
bjos-8650040	52	24	radiation	radiation	NOUN
bjos-8650040	52	25	therapy	therapy	NOUN
bjos-8650040	52	26	as	as	ADP
bjos-8650040	52	27	a	a	DET
bjos-8650040	52	28	part	part	NOUN
bjos-8650040	52	29	of	of	ADP
bjos-8650040	52	30	their	their	PRON
bjos-8650040	52	31	cancer	cancer	NOUN
bjos-8650040	52	32	treatment	treatment	NOUN
bjos-8650040	52	33	.	.	PUNCT
bjos-8650040	53	1	detection	detection	NOUN
bjos-8650040	53	2	of	of	ADP
bjos-8650040	53	3	serum	serum	NOUN
bjos-8650040	53	4	levels	level	NOUN
bjos-8650040	53	5	of	of	ADP
bjos-8650040	53	6	nf	nf	NOUN
bjos-8650040	53	7	-	-	PUNCT
bjos-8650040	53	8	κβ	κβ	NOUN
bjos-8650040	53	9	,	,	PUNCT
bjos-8650040	53	10	il-1α	il-1α	NOUN
bjos-8650040	53	11	,	,	PUNCT
bjos-8650040	53	12	il-6	il-6	NUM
bjos-8650040	53	13	,	,	PUNCT
bjos-8650040	53	14	il-8	il-8	PUNCT
bjos-8650040	53	15	and	and	CCONJ
bjos-8650040	53	16	tnf	tnf	PROPN
bjos-8650040	53	17	-	-	PUNCT
bjos-8650040	53	18	α	α	PRON
bjos-8650040	53	19	the	the	DET
bjos-8650040	53	20	concentration	concentration	NOUN
bjos-8650040	53	21	of	of	ADP
bjos-8650040	53	22	the	the	DET
bjos-8650040	53	23	studied	study	VERB
bjos-8650040	53	24	biomarkers	biomarker	NOUN
bjos-8650040	53	25	were	be	AUX
bjos-8650040	53	26	assessed	assess	VERB
bjos-8650040	53	27	in	in	ADP
bjos-8650040	53	28	the	the	DET
bjos-8650040	53	29	serum	serum	NOUN
bjos-8650040	53	30	collected	collect	VERB
bjos-8650040	53	31	from	from	ADP
bjos-8650040	53	32	patients	patient	NOUN
bjos-8650040	53	33	and	and	CCONJ
bjos-8650040	53	34	healthy	healthy	ADJ
bjos-8650040	53	35	subjects	subject	NOUN
bjos-8650040	53	36	by	by	ADP
bjos-8650040	53	37	elisa	elisa	NOUN
bjos-8650040	53	38	by	by	ADP
bjos-8650040	53	39	using	use	VERB
bjos-8650040	53	40	a	a	DET
bjos-8650040	53	41	commercially	commercially	ADV
bjos-8650040	53	42	available	available	ADJ
bjos-8650040	53	43	enzyme	enzyme	NOUN
bjos-8650040	53	44	-	-	PUNCT
bjos-8650040	53	45	linked	link	VERB
bjos-8650040	53	46	immunosorbent	immunosorbent	NOUN
bjos-8650040	53	47	assay	assay	PROPN
bjos-8650040	53	48	(	(	PUNCT
bjos-8650040	53	49	elisa	elisa	NOUN
bjos-8650040	53	50	)	)	PUNCT
bjos-8650040	53	51	kit	kit	NOUN
bjos-8650040	53	52	(	(	PUNCT
bjos-8650040	53	53	ray	ray	NOUN
bjos-8650040	53	54	biotech	biotech	PROPN
bjos-8650040	53	55	,	,	PUNCT
bjos-8650040	53	56	inc	inc	PROPN
bjos-8650040	53	57	.	.	PROPN
bjos-8650040	53	58	)	)	PUNCT
bjos-8650040	53	59	.	.	PUNCT
bjos-8650040	54	1	this	this	DET
bjos-8650040	54	2	cytokine	cytokine	ADJ
bjos-8650040	54	3	expression	expression	NOUN
bjos-8650040	54	4	in	in	ADP
bjos-8650040	54	5	riom	riom	ADJ
bjos-8650040	54	6	patients	patient	NOUN
bjos-8650040	54	7	braz	braz	PROPN
bjos-8650040	54	8	j	j	PROPN
bjos-8650040	54	9	oral	oral	PROPN
bjos-8650040	54	10	sci	sci	PROPN
bjos-8650040	54	11	.	.	PUNCT
bjos-8650040	55	1	15(4):280	15(4):280	NUM
bjos-8650040	55	2	-	-	PUNCT
bjos-8650040	55	3	286	286	NUM
bjos-8650040	55	4	282cytokine	282cytokine	PROPN
bjos-8650040	55	5	expression	expression	NOUN
bjos-8650040	55	6	in	in	ADP
bjos-8650040	55	7	riom	riom	ADJ
bjos-8650040	55	8	patients	patient	NOUN
bjos-8650040	55	9	table	table	VERB
bjos-8650040	55	10	1	1	NUM
bjos-8650040	55	11	clinical	clinical	ADJ
bjos-8650040	55	12	detail	detail	NOUN
bjos-8650040	55	13	of	of	ADP
bjos-8650040	55	14	patients	patient	NOUN
bjos-8650040	55	15	.	.	PUNCT
bjos-8650040	56	1	s.no	s.no	NOUN
bjos-8650040	56	2	.	.	PROPN
bjos-8650040	56	3	sex	sex	NOUN
bjos-8650040	56	4	age	age	NOUN
bjos-8650040	56	5	tumour	tumour	NOUN
bjos-8650040	56	6	type	type	NOUN
bjos-8650040	56	7	radiation	radiation	NOUN
bjos-8650040	56	8	therapy	therapy	NOUN
bjos-8650040	56	9	chemo	chemo	NOUN
bjos-8650040	56	10	-	-	PUNCT
bjos-8650040	56	11	therapy	therapy	NOUN
bjos-8650040	56	12	mucositis	mucositis	NOUN
bjos-8650040	56	13	grade	grade	NOUN
bjos-8650040	56	14	1	1	NUM
bjos-8650040	56	15	f	f	SYM
bjos-8650040	56	16	40	40	NUM
bjos-8650040	56	17	tongue	tongue	NOUN
bjos-8650040	57	1	yes	yes	INTJ
bjos-8650040	57	2	no	no	INTJ
bjos-8650040	58	1	no	no	DET
bjos-8650040	58	2	0	0	NUM
bjos-8650040	58	3	2	2	NUM
bjos-8650040	58	4	m	m	NUM
bjos-8650040	58	5	30	30	NUM
bjos-8650040	58	6	tongue	tongue	NOUN
bjos-8650040	58	7	&	&	CCONJ
bjos-8650040	58	8	fossa	fossa	VERB
bjos-8650040	59	1	yes	yes	INTJ
bjos-8650040	60	1	yes	yes	INTJ
bjos-8650040	61	1	yes	yes	INTJ
bjos-8650040	62	1	4	4	NUM
bjos-8650040	62	2	3	3	NUM
bjos-8650040	62	3	f	f	PROPN
bjos-8650040	62	4	64	64	NUM
bjos-8650040	62	5	larynx	larynx	NOUN
bjos-8650040	63	1	yes	yes	INTJ
bjos-8650040	64	1	yes	yes	INTJ
bjos-8650040	65	1	yes	yes	INTJ
bjos-8650040	66	1	1	1	NUM
bjos-8650040	66	2	4	4	NUM
bjos-8650040	66	3	m	m	NOUN
bjos-8650040	66	4	60	60	NUM
bjos-8650040	66	5	tonsil	tonsil	NOUN
bjos-8650040	66	6	-	-	PUNCT
bjos-8650040	66	7	r	r	NOUN
bjos-8650040	67	1	yes	yes	INTJ
bjos-8650040	68	1	yes	yes	INTJ
bjos-8650040	69	1	yes	yes	INTJ
bjos-8650040	70	1	1	1	NUM
bjos-8650040	70	2	5	5	NUM
bjos-8650040	70	3	f	f	NOUN
bjos-8650040	70	4	55	55	NUM
bjos-8650040	70	5	tonsil	tonsil	NOUN
bjos-8650040	70	6	-	-	PUNCT
bjos-8650040	70	7	l	l	NOUN
bjos-8650040	71	1	yes	yes	INTJ
bjos-8650040	72	1	yes	yes	INTJ
bjos-8650040	73	1	yes	yes	INTJ
bjos-8650040	74	1	1	1	NUM
bjos-8650040	74	2	6	6	NUM
bjos-8650040	74	3	m	m	NUM
bjos-8650040	74	4	26	26	NUM
bjos-8650040	74	5	buccal	buccal	ADJ
bjos-8650040	74	6	mucosa	mucosa	NOUN
bjos-8650040	75	1	yes	yes	INTJ
bjos-8650040	76	1	no	no	INTJ
bjos-8650040	76	2	yes	yes	INTJ
bjos-8650040	76	3	2	2	NUM
bjos-8650040	76	4	7	7	NUM
bjos-8650040	76	5	m	m	NUM
bjos-8650040	76	6	40	40	NUM
bjos-8650040	76	7	gingivae	gingivae	NOUN
bjos-8650040	77	1	yes	yes	INTJ
bjos-8650040	77	2	no	no	INTJ
bjos-8650040	78	1	yes	yes	INTJ
bjos-8650040	78	2	2	2	NUM
bjos-8650040	78	3	8	8	NUM
bjos-8650040	78	4	m	m	NUM
bjos-8650040	78	5	65	65	NUM
bjos-8650040	78	6	base	base	NOUN
bjos-8650040	78	7	of	of	ADP
bjos-8650040	78	8	tongue	tongue	NOUN
bjos-8650040	79	1	yes	yes	INTJ
bjos-8650040	80	1	yes	yes	INTJ
bjos-8650040	81	1	yes	yes	INTJ
bjos-8650040	81	2	4	4	NUM
bjos-8650040	81	3	9	9	NUM
bjos-8650040	81	4	m	m	NUM
bjos-8650040	81	5	50	50	NUM
bjos-8650040	81	6	soft	soft	ADJ
bjos-8650040	81	7	palate	palate	NOUN
bjos-8650040	82	1	yes	yes	INTJ
bjos-8650040	83	1	no	no	INTJ
bjos-8650040	83	2	yes	yes	INTJ
bjos-8650040	84	1	3	3	NUM
bjos-8650040	84	2	10	10	NUM
bjos-8650040	84	3	m	m	PROPN
bjos-8650040	84	4	48	48	NUM
bjos-8650040	84	5	larynx	larynx	NOUN
bjos-8650040	85	1	yes	yes	INTJ
bjos-8650040	86	1	yes	yes	INTJ
bjos-8650040	86	2	no	no	DET
bjos-8650040	86	3	0	0	NUM
bjos-8650040	86	4	11	11	NUM
bjos-8650040	86	5	f	f	NOUN
bjos-8650040	86	6	60	60	NUM
bjos-8650040	86	7	base	base	NOUN
bjos-8650040	86	8	of	of	ADP
bjos-8650040	86	9	tongue	tongue	NOUN
bjos-8650040	87	1	yes	yes	INTJ
bjos-8650040	88	1	yes	yes	INTJ
bjos-8650040	89	1	yes	yes	INTJ
bjos-8650040	89	2	3	3	NUM
bjos-8650040	89	3	12	12	NUM
bjos-8650040	89	4	m	m	NOUN
bjos-8650040	89	5	35	35	NUM
bjos-8650040	89	6	base	base	NOUN
bjos-8650040	89	7	of	of	ADP
bjos-8650040	89	8	tongue	tongue	NOUN
bjos-8650040	90	1	yes	yes	INTJ
bjos-8650040	91	1	no	no	INTJ
bjos-8650040	92	1	yes	yes	INTJ
bjos-8650040	92	2	3	3	NUM
bjos-8650040	92	3	13	13	NUM
bjos-8650040	92	4	m	m	NOUN
bjos-8650040	92	5	76	76	NUM
bjos-8650040	92	6	base	base	NOUN
bjos-8650040	92	7	of	of	ADP
bjos-8650040	92	8	tongue	tongue	NOUN
bjos-8650040	93	1	yes	yes	INTJ
bjos-8650040	93	2	no	no	INTJ
bjos-8650040	94	1	no	no	DET
bjos-8650040	94	2	0	0	NUM
bjos-8650040	94	3	14	14	NUM
bjos-8650040	94	4	f	f	NUM
bjos-8650040	94	5	45	45	NUM
bjos-8650040	94	6	tongue	tongue	NOUN
bjos-8650040	95	1	yes	yes	INTJ
bjos-8650040	96	1	yes	yes	INTJ
bjos-8650040	97	1	yes	yes	INTJ
bjos-8650040	98	1	3	3	NUM
bjos-8650040	98	2	15	15	NUM
bjos-8650040	98	3	m	m	NOUN
bjos-8650040	98	4	65	65	NUM
bjos-8650040	98	5	body	body	NOUN
bjos-8650040	98	6	of	of	ADP
bjos-8650040	98	7	tongue	tongue	NOUN
bjos-8650040	99	1	yes	yes	INTJ
bjos-8650040	100	1	yes	yes	INTJ
bjos-8650040	101	1	yes	yes	INTJ
bjos-8650040	101	2	1	1	NUM
bjos-8650040	101	3	16	16	NUM
bjos-8650040	101	4	m	m	NUM
bjos-8650040	101	5	40	40	NUM
bjos-8650040	101	6	pharynx	pharynx	NOUN
bjos-8650040	102	1	yes	yes	INTJ
bjos-8650040	103	1	yes	yes	INTJ
bjos-8650040	104	1	yes	yes	INTJ
bjos-8650040	105	1	1	1	NUM
bjos-8650040	105	2	17	17	NUM
bjos-8650040	105	3	m	m	NUM
bjos-8650040	105	4	68	68	NUM
bjos-8650040	105	5	tonsil	tonsil	NOUN
bjos-8650040	106	1	yes	yes	INTJ
bjos-8650040	107	1	yes	yes	INTJ
bjos-8650040	107	2	yes	yes	INTJ
bjos-8650040	107	3	1	1	NUM
bjos-8650040	107	4	18	18	NUM
bjos-8650040	107	5	m	m	NUM
bjos-8650040	107	6	32	32	NUM
bjos-8650040	107	7	buccal	buccal	ADJ
bjos-8650040	107	8	mucosa	mucosa	NOUN
bjos-8650040	107	9	&	&	CCONJ
bjos-8650040	107	10	border	border	NOUN
bjos-8650040	107	11	of	of	ADP
bjos-8650040	107	12	tongue	tongue	NOUN
bjos-8650040	108	1	yes	yes	INTJ
bjos-8650040	109	1	yes	yes	INTJ
bjos-8650040	110	1	yes	yes	INTJ
bjos-8650040	111	1	1	1	NUM
bjos-8650040	111	2	19	19	NUM
bjos-8650040	111	3	m	m	NUM
bjos-8650040	111	4	63	63	NUM
bjos-8650040	111	5	soft	soft	ADJ
bjos-8650040	111	6	palate	palate	NOUN
bjos-8650040	112	1	yes	yes	INTJ
bjos-8650040	112	2	no	no	INTJ
bjos-8650040	113	1	no	no	DET
bjos-8650040	113	2	0	0	NUM
bjos-8650040	113	3	20	20	NUM
bjos-8650040	113	4	f	f	PROPN
bjos-8650040	113	5	45	45	NUM
bjos-8650040	113	6	larynx	larynx	NOUN
bjos-8650040	114	1	yes	yes	INTJ
bjos-8650040	115	1	yes	yes	INTJ
bjos-8650040	116	1	yes	yes	INTJ
bjos-8650040	117	1	1	1	NUM
bjos-8650040	117	2	21	21	NUM
bjos-8650040	117	3	m	m	NUM
bjos-8650040	117	4	28	28	NUM
bjos-8650040	117	5	tongue	tongue	NOUN
bjos-8650040	118	1	yes	yes	INTJ
bjos-8650040	119	1	yes	yes	INTJ
bjos-8650040	120	1	yes	yes	INTJ
bjos-8650040	121	1	3	3	NUM
bjos-8650040	121	2	22	22	NUM
bjos-8650040	121	3	m	m	NUM
bjos-8650040	121	4	45	45	NUM
bjos-8650040	121	5	nasopharynx	nasopharynx	NOUN
bjos-8650040	122	1	yes	yes	INTJ
bjos-8650040	123	1	yes	yes	INTJ
bjos-8650040	124	1	yes	yes	INTJ
bjos-8650040	125	1	1	1	NUM
bjos-8650040	125	2	23	23	NUM
bjos-8650040	125	3	m	m	NUM
bjos-8650040	125	4	36	36	NUM
bjos-8650040	125	5	buccoalveolar	buccoalveolar	ADJ
bjos-8650040	125	6	region	region	NOUN
bjos-8650040	125	7	-	-	PUNCT
bjos-8650040	125	8	r	r	NOUN
bjos-8650040	125	9	yes	yes	INTJ
bjos-8650040	126	1	no	no	INTJ
bjos-8650040	127	1	yes	yes	INTJ
bjos-8650040	128	1	4	4	NUM
bjos-8650040	128	2	24	24	NUM
bjos-8650040	128	3	m	m	NUM
bjos-8650040	128	4	22	22	NUM
bjos-8650040	128	5	buccal	buccal	ADJ
bjos-8650040	128	6	mucosa	mucosa	NOUN
bjos-8650040	128	7	&	&	CCONJ
bjos-8650040	128	8	border	border	NOUN
bjos-8650040	128	9	of	of	ADP
bjos-8650040	128	10	tongue	tongue	NOUN
bjos-8650040	129	1	yes	yes	INTJ
bjos-8650040	130	1	yes	yes	INTJ
bjos-8650040	131	1	yes	yes	INTJ
bjos-8650040	132	1	1	1	NUM
bjos-8650040	132	2	25	25	NUM
bjos-8650040	132	3	m	m	NUM
bjos-8650040	132	4	40	40	NUM
bjos-8650040	132	5	larynx	larynx	NOUN
bjos-8650040	133	1	yes	yes	INTJ
bjos-8650040	134	1	yes	yes	INTJ
bjos-8650040	135	1	yes	yes	INTJ
bjos-8650040	136	1	1	1	NUM
bjos-8650040	136	2	26	26	NUM
bjos-8650040	136	3	m	m	NUM
bjos-8650040	136	4	62	62	NUM
bjos-8650040	136	5	larynx	larynx	NOUN
bjos-8650040	137	1	yes	yes	INTJ
bjos-8650040	138	1	yes	yes	INTJ
bjos-8650040	138	2	yes	yes	INTJ
bjos-8650040	138	3	1	1	NUM
bjos-8650040	138	4	27	27	NUM
bjos-8650040	138	5	f	f	NOUN
bjos-8650040	138	6	50	50	NUM
bjos-8650040	138	7	right	right	ADJ
bjos-8650040	138	8	tonsil	tonsil	NOUN
bjos-8650040	139	1	yes	yes	INTJ
bjos-8650040	140	1	yes	yes	INTJ
bjos-8650040	141	1	yes	yes	INTJ
bjos-8650040	142	1	1	1	NUM
bjos-8650040	142	2	28	28	NUM
bjos-8650040	142	3	m	m	NUM
bjos-8650040	142	4	68	68	NUM
bjos-8650040	142	5	left	left	ADJ
bjos-8650040	142	6	tonsil	tonsil	NOUN
bjos-8650040	143	1	yes	yes	INTJ
bjos-8650040	143	2	no	no	INTJ
bjos-8650040	144	1	no	no	DET
bjos-8650040	144	2	0	0	NUM
bjos-8650040	144	3	29	29	NUM
bjos-8650040	144	4	m	m	NUM
bjos-8650040	144	5	70	70	NUM
bjos-8650040	144	6	buccal	buccal	ADJ
bjos-8650040	144	7	mucosa	mucosa	NOUN
bjos-8650040	144	8	-	-	PUNCT
bjos-8650040	144	9	left	leave	VERB
bjos-8650040	144	10	yes	yes	INTJ
bjos-8650040	145	1	no	no	INTJ
bjos-8650040	145	2	yes	yes	INTJ
bjos-8650040	146	1	1	1	NUM
bjos-8650040	146	2	30	30	NUM
bjos-8650040	146	3	m	m	NUM
bjos-8650040	146	4	63	63	NUM
bjos-8650040	146	5	buccal	buccal	ADJ
bjos-8650040	146	6	mucosa	mucosa	NOUN
bjos-8650040	146	7	-	-	PUNCT
bjos-8650040	146	8	right	right	NOUN
bjos-8650040	147	1	yes	yes	INTJ
bjos-8650040	148	1	no	no	INTJ
bjos-8650040	149	1	yes	yes	INTJ
bjos-8650040	149	2	3	3	NUM
bjos-8650040	149	3	31	31	NUM
bjos-8650040	149	4	m	m	NUM
bjos-8650040	149	5	55	55	NUM
bjos-8650040	149	6	base	base	NOUN
bjos-8650040	149	7	of	of	ADP
bjos-8650040	149	8	tongue	tongue	NOUN
bjos-8650040	150	1	yes	yes	INTJ
bjos-8650040	151	1	yes	yes	INTJ
bjos-8650040	152	1	yes	yes	INTJ
bjos-8650040	153	1	1	1	NUM
bjos-8650040	153	2	32	32	NUM
bjos-8650040	153	3	m	m	NUM
bjos-8650040	153	4	54	54	NUM
bjos-8650040	153	5	buccal	buccal	ADJ
bjos-8650040	153	6	mucosa	mucosa	NOUN
bjos-8650040	153	7	-	-	PUNCT
bjos-8650040	153	8	left	leave	VERB
bjos-8650040	154	1	yes	yes	INTJ
bjos-8650040	155	1	no	no	INTJ
bjos-8650040	156	1	yes	yes	INTJ
bjos-8650040	157	1	3	3	NUM
bjos-8650040	157	2	33	33	NUM
bjos-8650040	157	3	f	f	NOUN
bjos-8650040	157	4	55	55	NUM
bjos-8650040	157	5	recurrent	recurrent	ADJ
bjos-8650040	157	6	adenoid	adenoid	ADJ
bjos-8650040	157	7	cystic	cystic	ADJ
bjos-8650040	157	8	carcinoma	carcinoma	NOUN
bjos-8650040	157	9	with	with	ADP
bjos-8650040	157	10	secondary	secondary	ADJ
bjos-8650040	157	11	metastasis	metastasis	NOUN
bjos-8650040	158	1	yes	yes	INTJ
bjos-8650040	159	1	yes	yes	INTJ
bjos-8650040	160	1	yes	yes	INTJ
bjos-8650040	161	1	1	1	NUM
bjos-8650040	162	1	34	34	NUM
bjos-8650040	162	2	m	m	NUM
bjos-8650040	162	3	62	62	NUM
bjos-8650040	162	4	base	base	NOUN
bjos-8650040	162	5	of	of	ADP
bjos-8650040	162	6	tongue	tongue	NOUN
bjos-8650040	163	1	yes	yes	INTJ
bjos-8650040	163	2	no	no	INTJ
bjos-8650040	164	1	no	no	DET
bjos-8650040	164	2	0	0	NUM
bjos-8650040	164	3	35	35	NUM
bjos-8650040	164	4	f	f	NOUN
bjos-8650040	164	5	48	48	NUM
bjos-8650040	164	6	tonsil	tonsil	NOUN
bjos-8650040	165	1	yes	yes	INTJ
bjos-8650040	166	1	no	no	INTJ
bjos-8650040	166	2	yes	yes	INTJ
bjos-8650040	167	1	1	1	NUM
bjos-8650040	167	2	36	36	NUM
bjos-8650040	167	3	m	m	NUM
bjos-8650040	167	4	27	27	NUM
bjos-8650040	167	5	buccal	buccal	ADJ
bjos-8650040	167	6	mucosa	mucosa	NOUN
bjos-8650040	168	1	yes	yes	INTJ
bjos-8650040	169	1	yes	yes	INTJ
bjos-8650040	170	1	yes	yes	INTJ
bjos-8650040	171	1	3	3	NUM
bjos-8650040	171	2	37	37	NUM
bjos-8650040	171	3	f	f	NOUN
bjos-8650040	171	4	55	55	NUM
bjos-8650040	171	5	tongue	tongue	NOUN
bjos-8650040	172	1	yes	yes	INTJ
bjos-8650040	173	1	yes	yes	INTJ
bjos-8650040	174	1	yes	yes	INTJ
bjos-8650040	174	2	1	1	NUM
bjos-8650040	174	3	38	38	NUM
bjos-8650040	174	4	m	m	NUM
bjos-8650040	174	5	71	71	NUM
bjos-8650040	175	1	tongue	tongue	NOUN
bjos-8650040	176	1	yes	yes	INTJ
bjos-8650040	177	1	yes	yes	INTJ
bjos-8650040	178	1	yes	yes	INTJ
bjos-8650040	179	1	1	1	NUM
bjos-8650040	179	2	39	39	NUM
bjos-8650040	179	3	f	f	NOUN
bjos-8650040	179	4	43	43	NUM
bjos-8650040	179	5	larynx	larynx	NOUN
bjos-8650040	180	1	yes	yes	INTJ
bjos-8650040	181	1	no	no	INTJ
bjos-8650040	182	1	yes	yes	INTJ
bjos-8650040	183	1	1	1	NUM
bjos-8650040	183	2	40	40	NUM
bjos-8650040	183	3	f	f	NOUN
bjos-8650040	183	4	45	45	NUM
bjos-8650040	183	5	tonsilleft	tonsilleft	NOUN
bjos-8650040	184	1	yes	yes	INTJ
bjos-8650040	185	1	no	no	INTJ
bjos-8650040	186	1	yes	yes	INTJ
bjos-8650040	186	2	2	2	NUM
bjos-8650040	186	3	41	41	NUM
bjos-8650040	186	4	m	m	NUM
bjos-8650040	186	5	42	42	NUM
bjos-8650040	186	6	floor	floor	NOUN
bjos-8650040	186	7	of	of	ADP
bjos-8650040	186	8	mouth	mouth	NOUN
bjos-8650040	187	1	yes	yes	INTJ
bjos-8650040	188	1	yes	yes	INTJ
bjos-8650040	189	1	yes	yes	INTJ
bjos-8650040	190	1	2	2	NUM
bjos-8650040	190	2	42	42	NUM
bjos-8650040	190	3	m	m	NUM
bjos-8650040	190	4	65	65	NUM
bjos-8650040	190	5	soft	soft	ADJ
bjos-8650040	190	6	palate	palate	NOUN
bjos-8650040	191	1	yes	yes	INTJ
bjos-8650040	192	1	no	no	INTJ
bjos-8650040	192	2	yes	yes	INTJ
bjos-8650040	192	3	2	2	NUM
bjos-8650040	192	4	43	43	NUM
bjos-8650040	192	5	m	m	NUM
bjos-8650040	192	6	40	40	NUM
bjos-8650040	192	7	base	base	NOUN
bjos-8650040	192	8	of	of	ADP
bjos-8650040	192	9	tongue	tongue	NOUN
bjos-8650040	193	1	yes	yes	INTJ
bjos-8650040	194	1	yes	yes	INTJ
bjos-8650040	195	1	yes	yes	INTJ
bjos-8650040	196	1	2	2	NUM
bjos-8650040	196	2	44	44	NUM
bjos-8650040	196	3	m	m	NUM
bjos-8650040	196	4	53	53	NUM
bjos-8650040	196	5	larynx	larynx	NOUN
bjos-8650040	197	1	yes	yes	INTJ
bjos-8650040	198	1	no	no	INTJ
bjos-8650040	198	2	yes	yes	INTJ
bjos-8650040	198	3	2	2	NUM
bjos-8650040	198	4	45	45	NUM
bjos-8650040	198	5	m	m	NUM
bjos-8650040	198	6	36	36	NUM
bjos-8650040	198	7	base	base	NOUN
bjos-8650040	198	8	of	of	ADP
bjos-8650040	198	9	tongue	tongue	NOUN
bjos-8650040	199	1	yes	yes	INTJ
bjos-8650040	200	1	no	no	INTJ
bjos-8650040	200	2	yes	yes	INTJ
bjos-8650040	200	3	4	4	NUM
bjos-8650040	200	4	mean	mean	NOUN
bjos-8650040	200	5	values	value	NOUN
bjos-8650040	200	6	of	of	ADP
bjos-8650040	200	7	cytokine	cytokine	ADJ
bjos-8650040	200	8	concentration	concentration	NOUN
bjos-8650040	200	9	in	in	ADP
bjos-8650040	200	10	serum	serum	NOUN
bjos-8650040	200	11	of	of	ADP
bjos-8650040	200	12	mucositis	mucositis	NOUN
bjos-8650040	200	13	patients	patient	NOUN
bjos-8650040	200	14	and	and	CCONJ
bjos-8650040	200	15	healthy	healthy	ADJ
bjos-8650040	200	16	controls	control	NOUN
bjos-8650040	200	17	.	.	PUNCT
bjos-8650040	201	1	cytokines	cytokine	VERB
bjos-8650040	202	1	mean±s.d	mean±s.d	PROPN
bjos-8650040	202	2	.	.	PUNCT
bjos-8650040	203	1	median	median	ADJ
bjos-8650040	203	2	percentage	percentage	NOUN
bjos-8650040	203	3	of	of	ADP
bjos-8650040	203	4	patients	patient	NOUN
bjos-8650040	203	5	showing	show	VERB
bjos-8650040	203	6	upregulation	upregulation	NOUN
bjos-8650040	203	7	in	in	ADP
bjos-8650040	203	8	mucositis	mucositis	PROPN
bjos-8650040	203	9	group	group	NOUN
bjos-8650040	203	10	as	as	SCONJ
bjos-8650040	203	11	compared	compare	VERB
bjos-8650040	203	12	to	to	ADP
bjos-8650040	203	13	control	control	NOUN
bjos-8650040	203	14	group	group	NOUN
bjos-8650040	203	15	p	p	NOUN
bjos-8650040	203	16	-	-	PUNCT
bjos-8650040	203	17	value	value	NOUN
bjos-8650040	203	18	riom	riom	NOUN
bjos-8650040	203	19	patients	patient	NOUN
bjos-8650040	203	20	(	(	PUNCT
bjos-8650040	203	21	group	group	NOUN
bjos-8650040	203	22	i	i	NOUN
bjos-8650040	203	23	)	)	PUNCT
bjos-8650040	203	24	control	control	NOUN
bjos-8650040	203	25	group	group	NOUN
bjos-8650040	203	26	(	(	PUNCT
bjos-8650040	203	27	group	group	NOUN
bjos-8650040	203	28	ii	ii	PROPN
bjos-8650040	203	29	)	)	PUNCT
bjos-8650040	203	30	riom	riom	PROPN
bjos-8650040	203	31	patients	patient	NOUN
bjos-8650040	203	32	(	(	PUNCT
bjos-8650040	203	33	group	group	NOUN
bjos-8650040	203	34	i	i	NOUN
bjos-8650040	203	35	)	)	PUNCT
bjos-8650040	203	36	control	control	NOUN
bjos-8650040	203	37	group	group	NOUN
bjos-8650040	203	38	(	(	PUNCT
bjos-8650040	203	39	group	group	NOUN
bjos-8650040	203	40	ii	ii	PROPN
bjos-8650040	203	41	)	)	PUNCT
bjos-8650040	203	42	nf	nf	PROPN
bjos-8650040	203	43	-	-	PUNCT
bjos-8650040	203	44	κβ	κβ	NOUN
bjos-8650040	203	45	(	(	PUNCT
bjos-8650040	203	46	ng	ng	PROPN
bjos-8650040	203	47	/	/	SYM
bjos-8650040	203	48	ml	ml	NOUN
bjos-8650040	203	49	)	)	PUNCT
bjos-8650040	203	50	262.65±169.91	262.65±169.91	NUM
bjos-8650040	203	51	25.66±9.502	25.66±9.502	NUM
bjos-8650040	203	52	240	240	NUM
bjos-8650040	203	53	28.00	28.00	NUM
bjos-8650040	203	54	100	100	NUM
bjos-8650040	203	55	%	%	NOUN
bjos-8650040	203	56	(	(	PUNCT
bjos-8650040	203	57	45/45	45/45	NUM
bjos-8650040	203	58	)	)	PUNCT
bjos-8650040	203	59	.001	.001	NUM
bjos-8650040	203	60	(	(	PUNCT
bjos-8650040	203	61	s	s	NOUN
bjos-8650040	203	62	)	)	PUNCT
bjos-8650040	203	63	il-1α(pg	il-1α(pg	NOUN
bjos-8650040	203	64	/	/	SYM
bjos-8650040	203	65	ml	ml	NOUN
bjos-8650040	203	66	)	)	PUNCT
bjos-8650040	203	67	38.919±69.99	38.919±69.99	PROPN
bjos-8650040	203	68	26.7907±10.5	26.7907±10.5	NUM
bjos-8650040	203	69	29	29	NUM
bjos-8650040	203	70	25.7	25.7	NUM
bjos-8650040	203	71	60	60	NUM
bjos-8650040	203	72	%	%	NOUN
bjos-8650040	203	73	(	(	PUNCT
bjos-8650040	203	74	27/45	27/45	NUM
bjos-8650040	203	75	)	)	PUNCT
bjos-8650040	203	76	.115(ns	.115(ns	NUM
bjos-8650040	203	77	)	)	PUNCT
bjos-8650040	203	78	il-6	il-6	NOUN
bjos-8650040	204	1	(	(	PUNCT
bjos-8650040	204	2	pg	pg	NOUN
bjos-8650040	204	3	/	/	SYM
bjos-8650040	204	4	ml	ml	VERB
bjos-8650040	204	5	)	)	PUNCT
bjos-8650040	204	6	112.56±309.7	112.56±309.7	NUM
bjos-8650040	204	7	4.880±2.95	4.880±2.95	NOUN
bjos-8650040	204	8	45.7	45.7	NUM
bjos-8650040	204	9	5.450	5.450	NUM
bjos-8650040	204	10	100%(45/45	100%(45/45	NOUN
bjos-8650040	204	11	)	)	PUNCT
bjos-8650040	204	12	.001(s	.001(	NOUN
bjos-8650040	204	13	)	)	PUNCT
bjos-8650040	204	14	il-8	il-8	PUNCT
bjos-8650040	204	15	(	(	PUNCT
bjos-8650040	204	16	pg	pg	NOUN
bjos-8650040	204	17	/	/	SYM
bjos-8650040	204	18	ml	ml	NOUN
bjos-8650040	204	19	)	)	PUNCT
bjos-8650040	204	20	53.38±137.88	53.38±137.88	PROPN
bjos-8650040	204	21	8.690±2.354	8.690±2.354	ADP
bjos-8650040	204	22	9.8	9.8	NUM
bjos-8650040	204	23	9.050	9.050	NUM
bjos-8650040	204	24	53.34%(24/45	53.34%(24/45	NUM
bjos-8650040	204	25	)	)	PUNCT
bjos-8650040	204	26	.952(ns	.952(ns	X
bjos-8650040	204	27	)	)	PUNCT
bjos-8650040	204	28	tnf	tnf	PROPN
bjos-8650040	204	29	-	-	PUNCT
bjos-8650040	204	30	α	α	PROPN
bjos-8650040	204	31	(	(	PUNCT
bjos-8650040	204	32	pg	pg	NOUN
bjos-8650040	204	33	/	/	SYM
bjos-8650040	204	34	ml	ml	VERB
bjos-8650040	204	35	)	)	PUNCT
bjos-8650040	204	36	372.28±472.39	372.28±472.39	NUM
bjos-8650040	204	37	12.00±7.0590	12.00±7.0590	NUM
bjos-8650040	204	38	256	256	NUM
bjos-8650040	204	39	9.100	9.100	NUM
bjos-8650040	204	40	100	100	NUM
bjos-8650040	204	41	%	%	NOUN
bjos-8650040	204	42	(	(	PUNCT
bjos-8650040	204	43	45/45	45/45	NUM
bjos-8650040	204	44	)	)	PUNCT
bjos-8650040	204	45	.001(s	.001(	NOUN
bjos-8650040	204	46	)	)	PUNCT
bjos-8650040	204	47	braz	braz	PROPN
bjos-8650040	204	48	j	j	PROPN
bjos-8650040	204	49	oral	oral	PROPN
bjos-8650040	204	50	sci	sci	PROPN
bjos-8650040	204	51	.	.	PUNCT
bjos-8650040	205	1	15(4):280	15(4):280	NUM
bjos-8650040	205	2	-	-	SYM
bjos-8650040	205	3	286	286	NUM
bjos-8650040	205	4	283	283	NUM
bjos-8650040	205	5	on	on	ADP
bjos-8650040	205	6	comparing	compare	VERB
bjos-8650040	205	7	the	the	DET
bjos-8650040	205	8	expression	expression	NOUN
bjos-8650040	205	9	level	level	NOUN
bjos-8650040	205	10	of	of	ADP
bjos-8650040	205	11	different	different	ADJ
bjos-8650040	205	12	proinflammatory	proinflammatory	ADJ
bjos-8650040	205	13	cytokines	cytokine	NOUN
bjos-8650040	205	14	of	of	ADP
bjos-8650040	205	15	the	the	DET
bjos-8650040	205	16	patients	patient	NOUN
bjos-8650040	205	17	receiving	receive	VERB
bjos-8650040	205	18	chemotherapy	chemotherapy	NOUN
bjos-8650040	205	19	along	along	ADP
bjos-8650040	205	20	with	with	ADP
bjos-8650040	205	21	the	the	DET
bjos-8650040	205	22	radiation	radiation	NOUN
bjos-8650040	205	23	therapy	therapy	NOUN
bjos-8650040	205	24	and	and	CCONJ
bjos-8650040	205	25	those	those	PRON
bjos-8650040	205	26	undergoing	undergo	VERB
bjos-8650040	205	27	just	just	ADV
bjos-8650040	205	28	the	the	DET
bjos-8650040	205	29	radiation	radiation	NOUN
bjos-8650040	205	30	therapy	therapy	NOUN
bjos-8650040	205	31	no	no	DET
bjos-8650040	205	32	significant	significant	ADJ
bjos-8650040	205	33	difference	difference	NOUN
bjos-8650040	205	34	(	(	PUNCT
bjos-8650040	205	35	p>0.05	p>0.05	NOUN
bjos-8650040	205	36	)	)	PUNCT
bjos-8650040	205	37	was	be	AUX
bjos-8650040	205	38	observed	observe	VERB
bjos-8650040	205	39	in	in	ADP
bjos-8650040	205	40	the	the	DET
bjos-8650040	205	41	expression	expression	NOUN
bjos-8650040	205	42	of	of	ADP
bjos-8650040	205	43	these	these	DET
bjos-8650040	205	44	cytokines	cytokine	NOUN
bjos-8650040	205	45	as	as	SCONJ
bjos-8650040	205	46	depicted	depict	VERB
bjos-8650040	205	47	in	in	ADP
bjos-8650040	205	48	figure	figure	NOUN
bjos-8650040	205	49	2	2	NUM
bjos-8650040	205	50	thus	thus	ADV
bjos-8650040	205	51	implying	imply	VERB
bjos-8650040	205	52	that	that	SCONJ
bjos-8650040	205	53	radiation	radiation	NOUN
bjos-8650040	205	54	and	and	CCONJ
bjos-8650040	205	55	chemotherapy	chemotherapy	NOUN
bjos-8650040	205	56	treatments	treatment	NOUN
bjos-8650040	205	57	whether	whether	SCONJ
bjos-8650040	205	58	given	give	VERB
bjos-8650040	205	59	alone	alone	ADJ
bjos-8650040	205	60	or	or	CCONJ
bjos-8650040	205	61	in	in	ADP
bjos-8650040	205	62	combination	combination	NOUN
bjos-8650040	205	63	as	as	ADP
bjos-8650040	205	64	a	a	DET
bjos-8650040	205	65	part	part	NOUN
bjos-8650040	205	66	of	of	ADP
bjos-8650040	205	67	treatment	treatment	NOUN
bjos-8650040	205	68	regimen	regiman	NOUN
bjos-8650040	205	69	for	for	ADP
bjos-8650040	205	70	head	head	NOUN
bjos-8650040	205	71	and	and	CCONJ
bjos-8650040	205	72	neck	neck	NOUN
bjos-8650040	205	73	cancer	cancer	NOUN
bjos-8650040	205	74	have	have	VERB
bjos-8650040	205	75	almost	almost	ADV
bjos-8650040	205	76	the	the	DET
bjos-8650040	205	77	same	same	ADJ
bjos-8650040	205	78	effect	effect	NOUN
bjos-8650040	205	79	on	on	ADP
bjos-8650040	205	80	the	the	DET
bjos-8650040	205	81	expression	expression	NOUN
bjos-8650040	205	82	level	level	NOUN
bjos-8650040	205	83	of	of	ADP
bjos-8650040	205	84	the	the	DET
bjos-8650040	205	85	studied	study	VERB
bjos-8650040	205	86	pro	pro	ADJ
bjos-8650040	205	87	-	-	ADJ
bjos-8650040	205	88	inflammatory	inflammatory	ADJ
bjos-8650040	205	89	cytokines	cytokine	NOUN
bjos-8650040	205	90	.	.	PUNCT
bjos-8650040	206	1	cytokine	cytokine	ADJ
bjos-8650040	206	2	expression	expression	NOUN
bjos-8650040	206	3	in	in	ADP
bjos-8650040	206	4	riom	riom	ADJ
bjos-8650040	206	5	patients	patient	NOUN
bjos-8650040	206	6	furthermore	furthermore	ADV
bjos-8650040	206	7	,	,	PUNCT
bjos-8650040	206	8	analyzing	analyze	VERB
bjos-8650040	206	9	the	the	DET
bjos-8650040	206	10	expression	expression	NOUN
bjos-8650040	206	11	of	of	ADP
bjos-8650040	206	12	different	different	ADJ
bjos-8650040	206	13	cytokines	cytokine	NOUN
bjos-8650040	206	14	(	(	PUNCT
bjos-8650040	206	15	tnf	tnf	PROPN
bjos-8650040	206	16	-	-	PUNCT
bjos-8650040	206	17	α	α	PROPN
bjos-8650040	206	18	,	,	PUNCT
bjos-8650040	206	19	nf	nf	NOUN
bjos-8650040	206	20	-	-	PUNCT
bjos-8650040	206	21	κβ	κβ	NOUN
bjos-8650040	206	22	,	,	PUNCT
bjos-8650040	206	23	il-8	il-8	NOUN
bjos-8650040	206	24	,	,	PUNCT
bjos-8650040	206	25	il-6	il-6	NUM
bjos-8650040	206	26	,	,	PUNCT
bjos-8650040	206	27	il	il	PROPN
bjos-8650040	206	28	-	-	PROPN
bjos-8650040	206	29	α	α	NOUN
bjos-8650040	206	30	)	)	PUNCT
bjos-8650040	206	31	with	with	ADP
bjos-8650040	206	32	respect	respect	NOUN
bjos-8650040	206	33	to	to	ADP
bjos-8650040	206	34	the	the	DET
bjos-8650040	206	35	different	different	ADJ
bjos-8650040	206	36	grades	grade	NOUN
bjos-8650040	206	37	of	of	ADP
bjos-8650040	206	38	mucositis	mucositis	PRON
bjos-8650040	206	39	we	we	PRON
bjos-8650040	206	40	have	have	AUX
bjos-8650040	206	41	found	find	VERB
bjos-8650040	206	42	that	that	SCONJ
bjos-8650040	206	43	the	the	DET
bjos-8650040	206	44	expression	expression	NOUN
bjos-8650040	206	45	level	level	NOUN
bjos-8650040	206	46	of	of	ADP
bjos-8650040	206	47	studied	study	VERB
bjos-8650040	206	48	cytokines	cytokine	NOUN
bjos-8650040	206	49	increases	increase	NOUN
bjos-8650040	206	50	with	with	ADP
bjos-8650040	206	51	the	the	DET
bjos-8650040	206	52	progression	progression	NOUN
bjos-8650040	206	53	of	of	ADP
bjos-8650040	206	54	the	the	DET
bjos-8650040	206	55	mucositis	mucositis	NOUN
bjos-8650040	206	56	(	(	PUNCT
bjos-8650040	206	57	grade	grade	NOUN
bjos-8650040	206	58	1	1	NUM
bjos-8650040	206	59	to	to	ADP
bjos-8650040	206	60	grade	grade	NOUN
bjos-8650040	206	61	4	4	NUM
bjos-8650040	206	62	)	)	PUNCT
bjos-8650040	206	63	as	as	SCONJ
bjos-8650040	206	64	depicted	depict	VERB
bjos-8650040	206	65	in	in	ADP
bjos-8650040	206	66	figure	figure	NOUN
bjos-8650040	206	67	3	3	NUM
bjos-8650040	206	68	.	.	PUNCT
bjos-8650040	206	69	fig	fig	NOUN
bjos-8650040	206	70	.	.	PUNCT
bjos-8650040	207	1	1	1	NUM
bjos-8650040	207	2	mean	mean	VERB
bjos-8650040	207	3	serum	serum	NOUN
bjos-8650040	207	4	concentrations	concentration	NOUN
bjos-8650040	207	5	of	of	ADP
bjos-8650040	207	6	pro	pro	ADJ
bjos-8650040	207	7	-	-	ADJ
bjos-8650040	207	8	inflammatory	inflammatory	ADJ
bjos-8650040	207	9	cytokines	cytokine	NOUN
bjos-8650040	207	10	in	in	ADP
bjos-8650040	207	11	control	control	NOUN
bjos-8650040	207	12	subjects	subject	NOUN
bjos-8650040	207	13	and	and	CCONJ
bjos-8650040	207	14	mucositis	mucositis	NOUN
bjos-8650040	207	15	patients	patient	NOUN
bjos-8650040	207	16	.	.	PUNCT
bjos-8650040	208	1	fig	fig	NOUN
bjos-8650040	208	2	.	.	PUNCT
bjos-8650040	209	1	2	2	NUM
bjos-8650040	209	2	graph	graph	NOUN
bjos-8650040	209	3	depicting	depict	VERB
bjos-8650040	209	4	the	the	DET
bjos-8650040	209	5	mean	mean	NOUN
bjos-8650040	209	6	of	of	ADP
bjos-8650040	209	7	expression	expression	NOUN
bjos-8650040	209	8	of	of	ADP
bjos-8650040	209	9	different	different	ADJ
bjos-8650040	209	10	pro	pro	ADJ
bjos-8650040	209	11	-	-	ADJ
bjos-8650040	209	12	inflammatory	inflammatory	ADJ
bjos-8650040	209	13	cytokines	cytokine	NOUN
bjos-8650040	209	14	for	for	ADP
bjos-8650040	209	15	patients	patient	NOUN
bjos-8650040	209	16	undergoing	undergo	VERB
bjos-8650040	209	17	radiation	radiation	NOUN
bjos-8650040	209	18	therapy	therapy	NOUN
bjos-8650040	209	19	along	along	ADP
bjos-8650040	209	20	with	with	ADP
bjos-8650040	209	21	chemotherapy	chemotherapy	NOUN
bjos-8650040	209	22	(	(	PUNCT
bjos-8650040	209	23	ct+rt	ct+rt	NOUN
bjos-8650040	209	24	)	)	PUNCT
bjos-8650040	209	25	and	and	CCONJ
bjos-8650040	209	26	those	those	PRON
bjos-8650040	209	27	undergoing	undergo	VERB
bjos-8650040	209	28	only	only	ADV
bjos-8650040	209	29	the	the	DET
bjos-8650040	209	30	radiation	radiation	NOUN
bjos-8650040	209	31	therapy	therapy	NOUN
bjos-8650040	209	32	(	(	PUNCT
bjos-8650040	209	33	rt	rt	PROPN
bjos-8650040	209	34	)	)	PUNCT
bjos-8650040	209	35	.	.	PUNCT
bjos-8650040	210	1	fig	fig	NOUN
bjos-8650040	210	2	.	.	PUNCT
bjos-8650040	211	1	3	3	NUM
bjos-8650040	211	2	comparison	comparison	NOUN
bjos-8650040	211	3	of	of	ADP
bjos-8650040	211	4	expression	expression	NOUN
bjos-8650040	211	5	of	of	ADP
bjos-8650040	211	6	different	different	ADJ
bjos-8650040	211	7	cytokines	cytokine	NOUN
bjos-8650040	211	8	-	-	PUNCT
bjos-8650040	211	9	nf	nf	NOUN
bjos-8650040	211	10	-	-	PUNCT
bjos-8650040	211	11	κβ	κβ	NOUN
bjos-8650040	211	12	,	,	PUNCT
bjos-8650040	211	13	il-1α	il-1α	NOUN
bjos-8650040	211	14	,	,	PUNCT
bjos-8650040	211	15	il-6	il-6	NUM
bjos-8650040	211	16	,	,	PUNCT
bjos-8650040	211	17	il-8	il-8	PUNCT
bjos-8650040	211	18	and	and	CCONJ
bjos-8650040	211	19	tnf	tnf	PROPN
bjos-8650040	211	20	-	-	PUNCT
bjos-8650040	211	21	α	α	PROPN
bjos-8650040	211	22	in	in	ADP
bjos-8650040	211	23	different	different	ADJ
bjos-8650040	211	24	grades	grade	NOUN
bjos-8650040	211	25	of	of	ADP
bjos-8650040	211	26	mucositis	mucositis	PROPN
bjos-8650040	211	27	.	.	PUNCT
bjos-8650040	212	1	discussion	discussion	NOUN
bjos-8650040	212	2	oral	oral	NOUN
bjos-8650040	212	3	mucositis	mucositis	PROPN
bjos-8650040	212	4	is	be	AUX
bjos-8650040	212	5	an	an	DET
bjos-8650040	212	6	undesirable	undesirable	ADJ
bjos-8650040	212	7	painful	painful	ADJ
bjos-8650040	212	8	outcome	outcome	NOUN
bjos-8650040	212	9	endured	endure	VERB
bjos-8650040	212	10	by	by	ADP
bjos-8650040	212	11	patients	patient	NOUN
bjos-8650040	212	12	receiving	receive	VERB
bjos-8650040	212	13	radiation	radiation	NOUN
bjos-8650040	212	14	and/or	and/or	CCONJ
bjos-8650040	212	15	chemotherapy	chemotherapy	NOUN
bjos-8650040	212	16	for	for	ADP
bjos-8650040	212	17	head	head	NOUN
bjos-8650040	212	18	and	and	CCONJ
bjos-8650040	212	19	neck	neck	NOUN
bjos-8650040	212	20	cancer	cancer	NOUN
bjos-8650040	212	21	treatment	treatment	NOUN
bjos-8650040	212	22	.	.	PUNCT
bjos-8650040	213	1	radiation	radiation	NOUN
bjos-8650040	213	2	and	and	CCONJ
bjos-8650040	213	3	chemotherapy	chemotherapy	NOUN
bjos-8650040	213	4	are	be	AUX
bjos-8650040	213	5	effective	effective	ADJ
bjos-8650040	213	6	activators	activator	NOUN
bjos-8650040	213	7	of	of	ADP
bjos-8650040	213	8	several	several	ADJ
bjos-8650040	213	9	pathways	pathway	NOUN
bjos-8650040	213	10	in	in	ADP
bjos-8650040	213	11	endothelia	endothelia	PROPN
bjos-8650040	213	12	,	,	PUNCT
bjos-8650040	213	13	fibroblasts	fibroblast	NOUN
bjos-8650040	213	14	and	and	CCONJ
bjos-8650040	213	15	epithelia	epithelium	NOUN
bjos-8650040	213	16	thus	thus	ADV
bjos-8650040	213	17	leading	lead	VERB
bjos-8650040	213	18	to	to	ADP
bjos-8650040	213	19	the	the	DET
bjos-8650040	213	20	production	production	NOUN
bjos-8650040	213	21	and	and	CCONJ
bjos-8650040	213	22	upregulation	upregulation	NOUN
bjos-8650040	213	23	of	of	ADP
bjos-8650040	213	24	certain	certain	ADJ
bjos-8650040	213	25	pro	pro	ADJ
bjos-8650040	213	26	inflammatory	inflammatory	ADJ
bjos-8650040	213	27	cytokines16,17	cytokines16,17	NOUN
bjos-8650040	213	28	which	which	PRON
bjos-8650040	213	29	have	have	AUX
bjos-8650040	213	30	been	be	AUX
bjos-8650040	213	31	reported	report	VERB
bjos-8650040	213	32	to	to	PART
bjos-8650040	213	33	play	play	VERB
bjos-8650040	213	34	an	an	DET
bjos-8650040	213	35	important	important	ADJ
bjos-8650040	213	36	role	role	NOUN
bjos-8650040	213	37	during	during	ADP
bjos-8650040	213	38	inflammation	inflammation	NOUN
bjos-8650040	213	39	and	and	CCONJ
bjos-8650040	213	40	tissue	tissue	NOUN
bjos-8650040	213	41	damage18	damage18	NOUN
bjos-8650040	213	42	.	.	PUNCT
bjos-8650040	214	1	the	the	DET
bjos-8650040	214	2	present	present	ADJ
bjos-8650040	214	3	study	study	NOUN
bjos-8650040	214	4	examined	examine	VERB
bjos-8650040	214	5	the	the	DET
bjos-8650040	214	6	expression	expression	NOUN
bjos-8650040	214	7	level	level	NOUN
bjos-8650040	214	8	of	of	ADP
bjos-8650040	214	9	nf	nf	NOUN
bjos-8650040	214	10	-	-	PUNCT
bjos-8650040	214	11	κβ	κβ	NOUN
bjos-8650040	214	12	and	and	CCONJ
bjos-8650040	214	13	its	its	PRON
bjos-8650040	214	14	associated	associated	ADJ
bjos-8650040	214	15	pro	pro	ADJ
bjos-8650040	214	16	-	-	ADJ
bjos-8650040	214	17	inflammatory	inflammatory	ADJ
bjos-8650040	214	18	cytokines	cytokine	NOUN
bjos-8650040	214	19	(	(	PUNCT
bjos-8650040	214	20	il-6	il-6	NUM
bjos-8650040	214	21	,	,	PUNCT
bjos-8650040	214	22	tnf	tnf	PROPN
bjos-8650040	214	23	-	-	PUNCT
bjos-8650040	214	24	α	α	PROPN
bjos-8650040	214	25	,	,	PUNCT
bjos-8650040	214	26	il-1α	il-1α	NOUN
bjos-8650040	214	27	and	and	CCONJ
bjos-8650040	214	28	il-8	il-8	NOUN
bjos-8650040	214	29	)	)	PUNCT
bjos-8650040	214	30	in	in	ADP
bjos-8650040	214	31	head	head	NOUN
bjos-8650040	214	32	and	and	CCONJ
bjos-8650040	214	33	neck	neck	NOUN
bjos-8650040	214	34	cancer	cancer	NOUN
bjos-8650040	214	35	patients	patient	NOUN
bjos-8650040	214	36	undergoing	undergo	VERB
bjos-8650040	214	37	radiation	radiation	NOUN
bjos-8650040	214	38	and/or	and/or	CCONJ
bjos-8650040	214	39	chemotherapy	chemotherapy	NOUN
bjos-8650040	214	40	as	as	ADP
bjos-8650040	214	41	a	a	DET
bjos-8650040	214	42	part	part	NOUN
bjos-8650040	214	43	of	of	ADP
bjos-8650040	214	44	their	their	PRON
bjos-8650040	214	45	treatment	treatment	NOUN
bjos-8650040	214	46	.	.	PUNCT
bjos-8650040	215	1	our	our	PRON
bjos-8650040	215	2	results	result	NOUN
bjos-8650040	215	3	showed	show	VERB
bjos-8650040	215	4	a	a	DET
bjos-8650040	215	5	significant	significant	ADJ
bjos-8650040	215	6	increase	increase	NOUN
bjos-8650040	215	7	in	in	ADP
bjos-8650040	215	8	the	the	DET
bjos-8650040	215	9	expression	expression	NOUN
bjos-8650040	215	10	of	of	ADP
bjos-8650040	215	11	nf	nf	NOUN
bjos-8650040	215	12	-	-	PUNCT
bjos-8650040	215	13	κβ	κβ	NOUN
bjos-8650040	215	14	,	,	PUNCT
bjos-8650040	215	15	il-6	il-6	NOUN
bjos-8650040	215	16	and	and	CCONJ
bjos-8650040	215	17	tnf	tnf	PROPN
bjos-8650040	215	18	-	-	PUNCT
bjos-8650040	215	19	α	α	PROPN
bjos-8650040	215	20	(	(	PUNCT
bjos-8650040	215	21	p	p	NOUN
bjos-8650040	215	22	value<0.05	value<0.05	NOUN
bjos-8650040	215	23	)	)	PUNCT
bjos-8650040	215	24	in	in	ADP
bjos-8650040	215	25	the	the	DET
bjos-8650040	215	26	serum	serum	NOUN
bjos-8650040	215	27	of	of	ADP
bjos-8650040	215	28	all	all	DET
bjos-8650040	215	29	the	the	DET
bjos-8650040	215	30	patients	patient	NOUN
bjos-8650040	215	31	enrolled	enrol	VERB
bjos-8650040	215	32	for	for	ADP
bjos-8650040	215	33	the	the	DET
bjos-8650040	215	34	study	study	NOUN
bjos-8650040	215	35	as	as	ADP
bjos-8650040	215	36	compared	compare	VERB
bjos-8650040	215	37	to	to	ADP
bjos-8650040	215	38	the	the	DET
bjos-8650040	215	39	control	control	NOUN
bjos-8650040	215	40	group	group	NOUN
bjos-8650040	215	41	.	.	PUNCT
bjos-8650040	216	1	however	however	ADV
bjos-8650040	216	2	,	,	PUNCT
bjos-8650040	216	3	nearly	nearly	ADV
bjos-8650040	216	4	60	60	NUM
bjos-8650040	216	5	%	%	NOUN
bjos-8650040	216	6	and	and	CCONJ
bjos-8650040	216	7	52.5	52.5	NUM
bjos-8650040	216	8	%	%	NOUN
bjos-8650040	216	9	of	of	ADP
bjos-8650040	216	10	the	the	DET
bjos-8650040	216	11	patients	patient	NOUN
bjos-8650040	216	12	showed	show	VERB
bjos-8650040	216	13	an	an	DET
bjos-8650040	216	14	increase	increase	NOUN
bjos-8650040	216	15	in	in	ADP
bjos-8650040	216	16	the	the	DET
bjos-8650040	216	17	expression	expression	NOUN
bjos-8650040	216	18	of	of	ADP
bjos-8650040	216	19	il-1α	il-1α	PROPN
bjos-8650040	216	20	and	and	CCONJ
bjos-8650040	216	21	il-8	il-8	NOUN
bjos-8650040	216	22	(	(	PUNCT
bjos-8650040	216	23	p	p	NOUN
bjos-8650040	216	24	value>0.05	value>0.05	PROPN
bjos-8650040	216	25	)	)	PUNCT
bjos-8650040	216	26	as	as	SCONJ
bjos-8650040	216	27	compared	compare	VERB
bjos-8650040	216	28	to	to	ADP
bjos-8650040	216	29	the	the	DET
bjos-8650040	216	30	control	control	NOUN
bjos-8650040	216	31	group	group	NOUN
bjos-8650040	216	32	(	(	PUNCT
bjos-8650040	216	33	healthy	healthy	ADJ
bjos-8650040	216	34	volunteers	volunteer	NOUN
bjos-8650040	216	35	)	)	PUNCT
bjos-8650040	216	36	.	.	PUNCT
bjos-8650040	217	1	a	a	DET
bjos-8650040	217	2	marginal	marginal	ADJ
bjos-8650040	217	3	increase	increase	NOUN
bjos-8650040	217	4	has	have	AUX
bjos-8650040	217	5	been	be	AUX
bjos-8650040	217	6	seen	see	VERB
bjos-8650040	217	7	in	in	ADP
bjos-8650040	217	8	the	the	DET
bjos-8650040	217	9	expression	expression	NOUN
bjos-8650040	217	10	of	of	ADP
bjos-8650040	217	11	nf	nf	NOUN
bjos-8650040	217	12	-	-	PUNCT
bjos-8650040	217	13	κβ	κβ	NOUN
bjos-8650040	217	14	due	due	ADP
bjos-8650040	217	15	to	to	ADP
bjos-8650040	217	16	the	the	DET
bjos-8650040	217	17	exposure	exposure	NOUN
bjos-8650040	217	18	of	of	ADP
bjos-8650040	217	19	the	the	DET
bjos-8650040	217	20	tissue	tissue	NOUN
bjos-8650040	217	21	to	to	ADP
bjos-8650040	217	22	chemotherapy	chemotherapy	NOUN
bjos-8650040	217	23	or	or	CCONJ
bjos-8650040	217	24	radiation	radiation	NOUN
bjos-8650040	217	25	therapy	therapy	NOUN
bjos-8650040	217	26	causing	cause	VERB
bjos-8650040	217	27	the	the	DET
bjos-8650040	217	28	production	production	NOUN
bjos-8650040	217	29	of	of	ADP
bjos-8650040	217	30	reactive	reactive	ADJ
bjos-8650040	217	31	oxygen	oxygen	NOUN
bjos-8650040	217	32	species	specie	NOUN
bjos-8650040	217	33	(	(	PUNCT
bjos-8650040	217	34	ros	ros	PROPN
bjos-8650040	217	35	)	)	PUNCT
bjos-8650040	217	36	that	that	PRON
bjos-8650040	217	37	ultimately	ultimately	ADV
bjos-8650040	217	38	results	result	VERB
bjos-8650040	217	39	in	in	ADP
bjos-8650040	217	40	tissue	tissue	NOUN
bjos-8650040	217	41	injury	injury	NOUN
bjos-8650040	217	42	and	and	CCONJ
bjos-8650040	217	43	cell	cell	NOUN
bjos-8650040	217	44	death4,11,14,16	death4,11,14,16	NOUN
bjos-8650040	217	45	.	.	PUNCT
bjos-8650040	218	1	previous	previous	ADJ
bjos-8650040	218	2	studies	study	NOUN
bjos-8650040	218	3	have	have	AUX
bjos-8650040	218	4	reported	report	VERB
bjos-8650040	218	5	the	the	DET
bjos-8650040	218	6	transcription	transcription	NOUN
bjos-8650040	218	7	factor	factor	NOUN
bjos-8650040	218	8	nf	nf	NOUN
bjos-8650040	218	9	-	-	PUNCT
bjos-8650040	218	10	κβ	κβ	NOUN
bjos-8650040	218	11	as	as	ADP
bjos-8650040	218	12	being	be	AUX
bjos-8650040	218	13	a	a	DET
bjos-8650040	218	14	regulator	regulator	NOUN
bjos-8650040	218	15	of	of	ADP
bjos-8650040	218	16	inflammation	inflammation	NOUN
bjos-8650040	218	17	signal	signal	NOUN
bjos-8650040	218	18	and	and	CCONJ
bjos-8650040	218	19	immunity	immunity	NOUN
bjos-8650040	218	20	as	as	ADV
bjos-8650040	218	21	well	well	ADV
bjos-8650040	218	22	as	as	ADP
bjos-8650040	218	23	also	also	ADV
bjos-8650040	218	24	being	be	AUX
bjos-8650040	218	25	involved	involve	VERB
bjos-8650040	218	26	in	in	ADP
bjos-8650040	218	27	the	the	DET
bjos-8650040	218	28	progression	progression	NOUN
bjos-8650040	218	29	of	of	ADP
bjos-8650040	218	30	mucositis4,11	mucositis4,11	PROPN
bjos-8650040	218	31	.	.	PUNCT
bjos-8650040	219	1	nf	nf	PROPN
bjos-8650040	219	2	-	-	PUNCT
bjos-8650040	219	3	κβ	κβ	NOUN
bjos-8650040	219	4	regulates	regulate	VERB
bjos-8650040	219	5	the	the	DET
bjos-8650040	219	6	expression	expression	NOUN
bjos-8650040	219	7	of	of	ADP
bjos-8650040	219	8	approximately	approximately	ADV
bjos-8650040	219	9	200	200	NUM
bjos-8650040	219	10	genes	gene	NOUN
bjos-8650040	219	11	many	many	ADJ
bjos-8650040	219	12	of	of	ADP
bjos-8650040	219	13	which	which	PRON
bjos-8650040	219	14	may	may	AUX
bjos-8650040	219	15	play	play	VERB
bjos-8650040	219	16	the	the	DET
bjos-8650040	219	17	role	role	NOUN
bjos-8650040	219	18	in	in	ADP
bjos-8650040	219	19	the	the	DET
bjos-8650040	219	20	pathogenesis	pathogenesis	NOUN
bjos-8650040	219	21	of	of	ADP
bjos-8650040	219	22	mucositis4,13,19	mucositis4,13,19	ADV
bjos-8650040	219	23	including	include	VERB
bjos-8650040	219	24	those	those	PRON
bjos-8650040	219	25	encoding	encode	VERB
bjos-8650040	219	26	cox-215,19	cox-215,19	NOUN
bjos-8650040	219	27	-	-	PUNCT
bjos-8650040	219	28	21	21	NUM
bjos-8650040	219	29	and	and	CCONJ
bjos-8650040	219	30	proinflammatory	proinflammatory	ADJ
bjos-8650040	219	31	cytokines	cytokine	NOUN
bjos-8650040	219	32	such	such	ADJ
bjos-8650040	219	33	as	as	ADP
bjos-8650040	219	34	tnf	tnf	PROPN
bjos-8650040	219	35	-	-	PUNCT
bjos-8650040	219	36	α	α	PROPN
bjos-8650040	219	37	,	,	PUNCT
bjos-8650040	219	38	il-6	il-6	NOUN
bjos-8650040	219	39	,	,	PUNCT
bjos-8650040	219	40	and	and	CCONJ
bjos-8650040	219	41	il-1β4,11,14,22	il-1β4,11,14,22	NOUN
bjos-8650040	219	42	.	.	PUNCT
bjos-8650040	220	1	cox-2	cox-2	VERB
bjos-8650040	220	2	intensifies	intensifie	NOUN
bjos-8650040	220	3	and	and	CCONJ
bjos-8650040	220	4	prolongs	prolong	VERB
bjos-8650040	220	5	mucositis	mucositis	NOUN
bjos-8650040	220	6	by	by	ADP
bjos-8650040	220	7	interacting	interact	VERB
bjos-8650040	220	8	with	with	ADP
bjos-8650040	220	9	a	a	DET
bjos-8650040	220	10	variety	variety	NOUN
bjos-8650040	220	11	of	of	ADP
bjos-8650040	220	12	apoptotic	apoptotic	ADJ
bjos-8650040	220	13	pathways	pathway	NOUN
bjos-8650040	220	14	and	and	CCONJ
bjos-8650040	220	15	by	by	ADP
bjos-8650040	220	16	providing	provide	VERB
bjos-8650040	220	17	positive	positive	ADJ
bjos-8650040	220	18	feedback	feedback	NOUN
bjos-8650040	220	19	to	to	ADP
bjos-8650040	220	20	nf	nf	NOUN
bjos-8650040	220	21	-	-	PUNCT
bjos-8650040	220	22	κβ	κβ	NOUN
bjos-8650040	220	23	.	.	PUNCT
bjos-8650040	221	1	the	the	DET
bjos-8650040	221	2	increase	increase	NOUN
bjos-8650040	221	3	in	in	ADP
bjos-8650040	221	4	the	the	DET
bjos-8650040	221	5	expression	expression	NOUN
bjos-8650040	221	6	of	of	ADP
bjos-8650040	221	7	cox-2	cox-2	NOUN
bjos-8650040	221	8	can	can	AUX
bjos-8650040	221	9	be	be	AUX
bjos-8650040	221	10	an	an	DET
bjos-8650040	221	11	braz	braz	PROPN
bjos-8650040	221	12	j	j	PROPN
bjos-8650040	221	13	oral	oral	PROPN
bjos-8650040	221	14	sci	sci	PROPN
bjos-8650040	221	15	.	.	PUNCT
bjos-8650040	222	1	15(4):280	15(4):280	NUM
bjos-8650040	222	2	-	-	PUNCT
bjos-8650040	222	3	286	286	NUM
bjos-8650040	222	4	initial	initial	ADJ
bjos-8650040	222	5	sign	sign	NOUN
bjos-8650040	222	6	of	of	ADP
bjos-8650040	222	7	the	the	DET
bjos-8650040	222	8	inflammatory	inflammatory	ADJ
bjos-8650040	222	9	cascade	cascade	NOUN
bjos-8650040	222	10	which	which	PRON
bjos-8650040	222	11	leads	lead	VERB
bjos-8650040	222	12	to	to	ADP
bjos-8650040	222	13	the	the	DET
bjos-8650040	222	14	production	production	NOUN
bjos-8650040	222	15	of	of	ADP
bjos-8650040	222	16	prostaglandins	prostaglandin	NOUN
bjos-8650040	222	17	and	and	CCONJ
bjos-8650040	222	18	further	further	ADJ
bjos-8650040	222	19	tissue	tissue	NOUN
bjos-8650040	222	20	damage4,11,15,19	damage4,11,15,19	NOUN
bjos-8650040	222	21	.	.	PUNCT
bjos-8650040	223	1	further	far	ADV
bjos-8650040	223	2	,	,	PUNCT
bjos-8650040	223	3	upregulation	upregulation	NOUN
bjos-8650040	223	4	in	in	ADP
bjos-8650040	223	5	the	the	DET
bjos-8650040	223	6	expression	expression	NOUN
bjos-8650040	223	7	of	of	ADP
bjos-8650040	223	8	proinflammatory	proinflammatory	ADJ
bjos-8650040	223	9	cytokines	cytokine	NOUN
bjos-8650040	223	10	by	by	ADP
bjos-8650040	223	11	the	the	DET
bjos-8650040	223	12	action	action	NOUN
bjos-8650040	223	13	of	of	ADP
bjos-8650040	223	14	nf	nf	NOUN
bjos-8650040	223	15	-	-	PUNCT
bjos-8650040	223	16	κβ	κβ	NOUN
bjos-8650040	223	17	triggers	trigger	VERB
bjos-8650040	223	18	the	the	DET
bjos-8650040	223	19	initiation	initiation	NOUN
bjos-8650040	223	20	of	of	ADP
bjos-8650040	223	21	various	various	ADJ
bjos-8650040	223	22	pathways	pathway	NOUN
bjos-8650040	223	23	that	that	PRON
bjos-8650040	223	24	damage	damage	VERB
bjos-8650040	223	25	epithelial	epithelial	ADJ
bjos-8650040	223	26	cells	cell	NOUN
bjos-8650040	223	27	and	and	CCONJ
bjos-8650040	223	28	surrounding	surround	VERB
bjos-8650040	223	29	fibroblasts	fibroblast	NOUN
bjos-8650040	223	30	.	.	PUNCT
bjos-8650040	224	1	the	the	DET
bjos-8650040	224	2	feedback	feedback	NOUN
bjos-8650040	224	3	loop	loop	NOUN
bjos-8650040	224	4	formed	form	VERB
bjos-8650040	224	5	between	between	ADP
bjos-8650040	224	6	various	various	ADJ
bjos-8650040	224	7	proinflammatory	proinflammatory	ADJ
bjos-8650040	224	8	cytokines	cytokine	NOUN
bjos-8650040	224	9	such	such	ADJ
bjos-8650040	224	10	as	as	ADP
bjos-8650040	224	11	tnf	tnf	PROPN
bjos-8650040	224	12	-	-	PUNCT
bjos-8650040	224	13	α	α	PROPN
bjos-8650040	224	14	and	and	CCONJ
bjos-8650040	224	15	nf	nf	NOUN
bjos-8650040	224	16	-	-	PUNCT
bjos-8650040	224	17	κβ	κβ	NOUN
bjos-8650040	224	18	promotes	promote	VERB
bjos-8650040	224	19	the	the	DET
bjos-8650040	224	20	cycle	cycle	NOUN
bjos-8650040	224	21	of	of	ADP
bjos-8650040	224	22	inflammation	inflammation	NOUN
bjos-8650040	224	23	,	,	PUNCT
bjos-8650040	224	24	pain	pain	NOUN
bjos-8650040	224	25	,	,	PUNCT
bjos-8650040	224	26	and	and	CCONJ
bjos-8650040	224	27	functional	functional	ADJ
bjos-8650040	224	28	impairment11,13,14,17,23,24	impairment11,13,14,17,23,24	PROPN
bjos-8650040	224	29	.	.	PUNCT
bjos-8650040	225	1	the	the	DET
bjos-8650040	225	2	presence	presence	NOUN
bjos-8650040	225	3	of	of	ADP
bjos-8650040	225	4	tnf	tnf	PROPN
bjos-8650040	225	5	-	-	PUNCT
bjos-8650040	225	6	α	α	PROPN
bjos-8650040	225	7	has	have	AUX
bjos-8650040	225	8	been	be	AUX
bjos-8650040	225	9	reported	report	VERB
bjos-8650040	225	10	by	by	ADP
bjos-8650040	225	11	previous	previous	ADJ
bjos-8650040	225	12	studies	study	NOUN
bjos-8650040	225	13	related	relate	VERB
bjos-8650040	225	14	to	to	ADP
bjos-8650040	225	15	the	the	DET
bjos-8650040	225	16	stimulation	stimulation	NOUN
bjos-8650040	225	17	of	of	ADP
bjos-8650040	225	18	early	early	ADJ
bjos-8650040	225	19	damage	damage	NOUN
bjos-8650040	225	20	to	to	ADP
bjos-8650040	225	21	connective	connective	ADJ
bjos-8650040	225	22	tissue	tissue	NOUN
bjos-8650040	225	23	and	and	CCONJ
bjos-8650040	225	24	endothelium	endothelium	NOUN
bjos-8650040	225	25	thus	thus	ADV
bjos-8650040	225	26	initiating	initiate	VERB
bjos-8650040	225	27	mesenchymal	mesenchymal	ADJ
bjos-8650040	225	28	-	-	ADJ
bjos-8650040	225	29	epithelial	epithelial	ADJ
bjos-8650040	225	30	signaling	signaling	NOUN
bjos-8650040	225	31	and	and	CCONJ
bjos-8650040	225	32	reducing	reduce	VERB
bjos-8650040	225	33	epithelial	epithelial	ADJ
bjos-8650040	225	34	oxygenation	oxygenation	NOUN
bjos-8650040	225	35	ultimately	ultimately	ADV
bjos-8650040	225	36	resulting	result	VERB
bjos-8650040	225	37	in	in	ADP
bjos-8650040	225	38	epithelial	epithelial	ADJ
bjos-8650040	225	39	basal	basal	NOUN
bjos-8650040	225	40	cell	cell	NOUN
bjos-8650040	225	41	death	death	NOUN
bjos-8650040	225	42	and	and	CCONJ
bjos-8650040	225	43	injury11,15	injury11,15	PROPN
bjos-8650040	225	44	.	.	PUNCT
bjos-8650040	226	1	several	several	ADJ
bjos-8650040	226	2	studies	study	NOUN
bjos-8650040	226	3	have	have	AUX
bjos-8650040	226	4	also	also	ADV
bjos-8650040	226	5	reported	report	VERB
bjos-8650040	226	6	the	the	DET
bjos-8650040	226	7	increase	increase	NOUN
bjos-8650040	226	8	in	in	ADP
bjos-8650040	226	9	the	the	DET
bjos-8650040	226	10	expression	expression	NOUN
bjos-8650040	226	11	of	of	ADP
bjos-8650040	226	12	il-6	il-6	NOUN
bjos-8650040	226	13	and	and	CCONJ
bjos-8650040	226	14	il-8	il-8	NOUN
bjos-8650040	226	15	as	as	ADP
bjos-8650040	226	16	a	a	DET
bjos-8650040	226	17	downstream	downstream	ADJ
bjos-8650040	226	18	product	product	NOUN
bjos-8650040	226	19	of	of	ADP
bjos-8650040	226	20	nf	nf	NOUN
bjos-8650040	226	21	-	-	PUNCT
bjos-8650040	226	22	κβ	κβ	NOUN
bjos-8650040	226	23	activation	activation	NOUN
bjos-8650040	226	24	.	.	PUNCT
bjos-8650040	227	1	the	the	DET
bjos-8650040	227	2	upregulation	upregulation	NOUN
bjos-8650040	227	3	of	of	ADP
bjos-8650040	227	4	these	these	DET
bjos-8650040	227	5	proinflammatory	proinflammatory	ADJ
bjos-8650040	227	6	cytokines	cytokine	NOUN
bjos-8650040	227	7	has	have	AUX
bjos-8650040	227	8	been	be	AUX
bjos-8650040	227	9	known	know	VERB
bjos-8650040	227	10	to	to	PART
bjos-8650040	227	11	mediate	mediate	VERB
bjos-8650040	227	12	neutrophil	neutrophil	ADJ
bjos-8650040	227	13	extravasation	extravasation	NOUN
bjos-8650040	227	14	and	and	CCONJ
bjos-8650040	227	15	tissue	tissue	NOUN
bjos-8650040	227	16	infiltration	infiltration	NOUN
bjos-8650040	227	17	during	during	ADP
bjos-8650040	227	18	inflammation	inflammation	NOUN
bjos-8650040	227	19	thereby	thereby	ADV
bjos-8650040	227	20	playing	play	VERB
bjos-8650040	227	21	an	an	DET
bjos-8650040	227	22	important	important	ADJ
bjos-8650040	227	23	role	role	NOUN
bjos-8650040	227	24	in	in	ADP
bjos-8650040	227	25	the	the	DET
bjos-8650040	227	26	migration	migration	NOUN
bjos-8650040	227	27	of	of	ADP
bjos-8650040	227	28	leukocytes	leukocyte	NOUN
bjos-8650040	227	29	into	into	ADP
bjos-8650040	227	30	the	the	DET
bjos-8650040	227	31	site	site	NOUN
bjos-8650040	227	32	of	of	ADP
bjos-8650040	227	33	inflammation15,25	inflammation15,25	PROPN
bjos-8650040	227	34	-	-	PUNCT
bjos-8650040	227	35	27	27	NUM
bjos-8650040	227	36	.	.	PUNCT
bjos-8650040	228	1	the	the	DET
bjos-8650040	228	2	amplification	amplification	NOUN
bjos-8650040	228	3	of	of	ADP
bjos-8650040	228	4	these	these	DET
bjos-8650040	228	5	biological	biological	ADJ
bjos-8650040	228	6	events	event	NOUN
bjos-8650040	228	7	via	via	ADP
bjos-8650040	228	8	positive	positive	ADJ
bjos-8650040	228	9	feedback	feedback	NOUN
bjos-8650040	228	10	loops	loop	NOUN
bjos-8650040	228	11	as	as	ADV
bjos-8650040	228	12	well	well	ADV
bjos-8650040	228	13	as	as	ADP
bjos-8650040	228	14	stimulation	stimulation	NOUN
bjos-8650040	228	15	by	by	ADP
bjos-8650040	228	16	bacterial	bacterial	ADJ
bjos-8650040	228	17	cell	cell	NOUN
bjos-8650040	228	18	wall	wall	NOUN
bjos-8650040	228	19	products	product	NOUN
bjos-8650040	228	20	results	result	VERB
bjos-8650040	228	21	in	in	ADP
bjos-8650040	228	22	the	the	DET
bjos-8650040	228	23	widespread	widespread	ADJ
bjos-8650040	228	24	tissue	tissue	NOUN
bjos-8650040	228	25	damage	damage	NOUN
bjos-8650040	228	26	as	as	SCONJ
bjos-8650040	228	27	seen	see	VERB
bjos-8650040	228	28	in	in	ADP
bjos-8650040	228	29	the	the	DET
bjos-8650040	228	30	clinical	clinical	ADJ
bjos-8650040	228	31	setting	setting	NOUN
bjos-8650040	228	32	as	as	ADP
bjos-8650040	228	33	ulceration	ulceration	NOUN
bjos-8650040	228	34	.	.	PUNCT
bjos-8650040	229	1	this	this	DET
bjos-8650040	229	2	ulcerative	ulcerative	ADJ
bjos-8650040	229	3	phase	phase	NOUN
bjos-8650040	229	4	is	be	AUX
bjos-8650040	229	5	primarily	primarily	ADV
bjos-8650040	229	6	responsible	responsible	ADJ
bjos-8650040	229	7	for	for	ADP
bjos-8650040	229	8	the	the	DET
bjos-8650040	229	9	main	main	ADJ
bjos-8650040	229	10	clinical	clinical	ADJ
bjos-8650040	229	11	symptoms	symptom	NOUN
bjos-8650040	229	12	of	of	ADP
bjos-8650040	229	13	mucositis	mucositis	PROPN
bjos-8650040	229	14	(	(	PUNCT
bjos-8650040	229	15	pain	pain	NOUN
bjos-8650040	229	16	,	,	PUNCT
bjos-8650040	229	17	inflammation	inflammation	NOUN
bjos-8650040	229	18	,	,	PUNCT
bjos-8650040	229	19	and	and	CCONJ
bjos-8650040	229	20	loss	loss	NOUN
bjos-8650040	229	21	of	of	ADP
bjos-8650040	229	22	function)11,17,28	function)11,17,28	NOUN
bjos-8650040	229	23	.	.	PUNCT
bjos-8650040	230	1	a	a	DET
bjos-8650040	230	2	study	study	NOUN
bjos-8650040	230	3	by	by	ADP
bjos-8650040	230	4	ong	ong	PROPN
bjos-8650040	230	5	et	et	PROPN
bjos-8650040	230	6	al	al	PROPN
bjos-8650040	230	7	.	.	PROPN
bjos-8650040	230	8	,	,	PUNCT
bjos-8650040	230	9	in	in	ADP
bjos-8650040	230	10	2010	2010	NUM
bjos-8650040	230	11	partially	partially	ADV
bjos-8650040	230	12	related	relate	VERB
bjos-8650040	230	13	to	to	ADP
bjos-8650040	230	14	our	our	PRON
bjos-8650040	230	15	study	study	NOUN
bjos-8650040	230	16	was	be	AUX
bjos-8650040	230	17	done	do	VERB
bjos-8650040	230	18	to	to	PART
bjos-8650040	230	19	characterize	characterize	VERB
bjos-8650040	230	20	the	the	DET
bjos-8650040	230	21	expression	expression	NOUN
bjos-8650040	230	22	of	of	ADP
bjos-8650040	230	23	pro	pro	ADJ
bjos-8650040	230	24	-	-	ADJ
bjos-8650040	230	25	inflammatory	inflammatory	ADJ
bjos-8650040	230	26	cytokines	cytokine	NOUN
bjos-8650040	230	27	in	in	ADP
bjos-8650040	230	28	the	the	DET
bjos-8650040	230	29	gastrointestinal	gastrointestinal	ADJ
bjos-8650040	230	30	tract	tract	NOUN
bjos-8650040	230	31	using	use	VERB
bjos-8650040	230	32	a	a	DET
bjos-8650040	230	33	rat	rat	NOUN
bjos-8650040	230	34	model	model	NOUN
bjos-8650040	230	35	of	of	ADP
bjos-8650040	230	36	fractionated	fractionated	ADJ
bjos-8650040	230	37	radiotherapy	radiotherapy	NOUN
bjos-8650040	230	38	-	-	PUNCT
bjos-8650040	230	39	induced	induce	VERB
bjos-8650040	230	40	toxicity	toxicity	NOUN
bjos-8650040	230	41	.	.	PUNCT
bjos-8650040	231	1	ong	ong	PROPN
bjos-8650040	231	2	found	find	VERB
bjos-8650040	231	3	that	that	SCONJ
bjos-8650040	231	4	a	a	DET
bjos-8650040	231	5	significant	significant	ADJ
bjos-8650040	231	6	upregulation	upregulation	NOUN
bjos-8650040	231	7	of	of	ADP
bjos-8650040	231	8	il-1β	il-1β	PROPN
bjos-8650040	231	9	,	,	PUNCT
bjos-8650040	231	10	il-6	il-6	NUM
bjos-8650040	231	11	and	and	CCONJ
bjos-8650040	231	12	tnf	tnf	PROPN
bjos-8650040	231	13	mrna	mrna	PROPN
bjos-8650040	231	14	levels	level	NOUN
bjos-8650040	231	15	in	in	ADP
bjos-8650040	231	16	the	the	DET
bjos-8650040	231	17	jejunum	jejunum	NOUN
bjos-8650040	231	18	and	and	CCONJ
bjos-8650040	231	19	colon	colon	NOUN
bjos-8650040	231	20	thus	thus	ADV
bjos-8650040	231	21	concluding	conclude	VERB
bjos-8650040	231	22	the	the	DET
bjos-8650040	231	23	role	role	NOUN
bjos-8650040	231	24	of	of	ADP
bjos-8650040	231	25	pro	pro	ADJ
bjos-8650040	231	26	-	-	ADJ
bjos-8650040	231	27	inflammatory	inflammatory	ADJ
bjos-8650040	231	28	cytokines	cytokine	NOUN
bjos-8650040	231	29	in	in	ADP
bjos-8650040	231	30	radiotherapy	radiotherapy	NOUN
bjos-8650040	231	31	-	-	PUNCT
bjos-8650040	231	32	induced	induce	VERB
bjos-8650040	231	33	gastrointestinal	gastrointestinal	ADJ
bjos-8650040	231	34	mucositis22	mucositis22	NOUN
bjos-8650040	231	35	.	.	PUNCT
bjos-8650040	232	1	another	another	DET
bjos-8650040	232	2	study29	study29	NOUN
bjos-8650040	232	3	implicated	implicate	VERB
bjos-8650040	232	4	the	the	DET
bjos-8650040	232	5	role	role	NOUN
bjos-8650040	232	6	of	of	ADP
bjos-8650040	232	7	nf	nf	NOUN
bjos-8650040	232	8	-	-	PUNCT
bjos-8650040	232	9	κβ	κβ	NOUN
bjos-8650040	232	10	,	,	PUNCT
bjos-8650040	232	11	proinflammatory	proinflammatory	ADJ
bjos-8650040	232	12	cytokines	cytokine	NOUN
bjos-8650040	232	13	,	,	PUNCT
bjos-8650040	232	14	cox	cox	PROPN
bjos-8650040	232	15	and	and	CCONJ
bjos-8650040	232	16	mmps	mmp	NOUN
bjos-8650040	232	17	in	in	ADP
bjos-8650040	232	18	the	the	DET
bjos-8650040	232	19	pathogenesis	pathogenesis	NOUN
bjos-8650040	232	20	of	of	ADP
bjos-8650040	232	21	mucositis	mucositis	NOUN
bjos-8650040	232	22	as	as	SCONJ
bjos-8650040	232	23	these	these	DET
bjos-8650040	232	24	factors	factor	NOUN
bjos-8650040	232	25	were	be	AUX
bjos-8650040	232	26	being	be	AUX
bjos-8650040	232	27	expressed	express	VERB
bjos-8650040	232	28	at	at	ADP
bjos-8650040	232	29	elevated	elevated	ADJ
bjos-8650040	232	30	levels	level	NOUN
bjos-8650040	232	31	in	in	ADP
bjos-8650040	232	32	both	both	CCONJ
bjos-8650040	232	33	serum	serum	NOUN
bjos-8650040	232	34	and	and	CCONJ
bjos-8650040	232	35	tissue	tissue	NOUN
bjos-8650040	232	36	following	follow	VERB
bjos-8650040	232	37	radiotherapy	radiotherapy	NOUN
bjos-8650040	232	38	and/or	and/or	CCONJ
bjos-8650040	232	39	chemotherapy29	chemotherapy29	NOUN
bjos-8650040	232	40	.	.	PUNCT
bjos-8650040	233	1	our	our	PRON
bjos-8650040	233	2	findings	finding	NOUN
bjos-8650040	233	3	have	have	AUX
bjos-8650040	233	4	also	also	ADV
bjos-8650040	233	5	been	be	AUX
bjos-8650040	233	6	supported	support	VERB
bjos-8650040	233	7	by	by	ADP
bjos-8650040	233	8	studies	study	NOUN
bjos-8650040	233	9	done	do	VERB
bjos-8650040	233	10	on	on	ADP
bjos-8650040	233	11	an	an	DET
bjos-8650040	233	12	animal	animal	NOUN
bjos-8650040	233	13	model	model	NOUN
bjos-8650040	233	14	by	by	ADP
bjos-8650040	233	15	logan	logan	PROPN
bjos-8650040	233	16	et	et	PROPN
bjos-8650040	233	17	al	al	PROPN
bjos-8650040	233	18	that	that	PRON
bjos-8650040	233	19	reported	report	VERB
bjos-8650040	233	20	the	the	DET
bjos-8650040	233	21	changes	change	NOUN
bjos-8650040	233	22	in	in	ADP
bjos-8650040	233	23	the	the	DET
bjos-8650040	233	24	expression	expression	NOUN
bjos-8650040	233	25	of	of	ADP
bjos-8650040	233	26	nf	nf	NOUN
bjos-8650040	233	27	-	-	PUNCT
bjos-8650040	233	28	κβ	κβ	NOUN
bjos-8650040	233	29	,	,	PUNCT
bjos-8650040	233	30	tnf	tnf	PROPN
bjos-8650040	233	31	,	,	PUNCT
bjos-8650040	233	32	il-1β	il-1β	PROPN
bjos-8650040	233	33	and	and	CCONJ
bjos-8650040	233	34	il-6	il-6	NOUN
bjos-8650040	233	35	in	in	ADP
bjos-8650040	233	36	the	the	DET
bjos-8650040	233	37	mucosa	mucosa	NOUN
bjos-8650040	233	38	and	and	CCONJ
bjos-8650040	233	39	serum	serum	NOUN
bjos-8650040	233	40	following	follow	VERB
bjos-8650040	233	41	chemotherapy	chemotherapy	NOUN
bjos-8650040	233	42	orated	orate	VERB
bjos-8650040	233	43	a	a	DET
bjos-8650040	233	44	statistically	statistically	ADV
bjos-8650040	233	45	increased	increase	VERB
bjos-8650040	233	46	oral	oral	ADJ
bjos-8650040	233	47	mucosal	mucosal	NOUN
bjos-8650040	233	48	stain17,30	stain17,30	NOUN
bjos-8650040	233	49	.	.	PUNCT
bjos-8650040	234	1	another	another	DET
bjos-8650040	234	2	study	study	NOUN
bjos-8650040	234	3	done	do	VERB
bjos-8650040	234	4	by	by	ADP
bjos-8650040	234	5	logan	logan	PROPN
bjos-8650040	234	6	et	et	PROPN
bjos-8650040	234	7	al	al	PROPN
bjos-8650040	234	8	.	.	PROPN
bjos-8650040	234	9	,	,	PUNCT
bjos-8650040	234	10	on	on	ADP
bjos-8650040	234	11	a	a	DET
bjos-8650040	234	12	human	human	ADJ
bjos-8650040	234	13	biopsy	biopsy	NOUN
bjos-8650040	234	14	demonstrated	demonstrate	VERB
bjos-8650040	234	15	the	the	DET
bjos-8650040	234	16	increased	increase	VERB
bjos-8650040	234	17	level	level	NOUN
bjos-8650040	234	18	of	of	ADP
bjos-8650040	234	19	nf	nf	NOUN
bjos-8650040	234	20	-	-	PUNCT
bjos-8650040	234	21	κβ	κβ	NOUN
bjos-8650040	234	22	and	and	CCONJ
bjos-8650040	234	23	cox-2	cox-2	ADV
bjos-8650040	234	24	in	in	ADP
bjos-8650040	234	25	patients	patient	NOUN
bjos-8650040	234	26	with	with	ADP
bjos-8650040	234	27	chemotherapy	chemotherapy	NOUN
bjos-8650040	234	28	as	as	ADV
bjos-8650040	234	29	well	well	ADV
bjos-8650040	234	30	as	as	ADP
bjos-8650040	234	31	radiotherapy17	radiotherapy17	NOUN
bjos-8650040	234	32	.	.	PUNCT
bjos-8650040	235	1	however	however	ADV
bjos-8650040	235	2	,	,	PUNCT
bjos-8650040	235	3	ikebe	ikebe	NOUN
bjos-8650040	235	4	et	et	PROPN
bjos-8650040	235	5	al	al	PROPN
bjos-8650040	235	6	.	.	PROPN
bjos-8650040	235	7	,	,	PUNCT
bjos-8650040	235	8	observed	observe	VERB
bjos-8650040	235	9	the	the	DET
bjos-8650040	235	10	expression	expression	NOUN
bjos-8650040	235	11	of	of	ADP
bjos-8650040	235	12	nf	nf	NOUN
bjos-8650040	235	13	-	-	PUNCT
bjos-8650040	235	14	κβ	κβ	NOUN
bjos-8650040	235	15	to	to	PART
bjos-8650040	235	16	be	be	AUX
bjos-8650040	235	17	reduced	reduce	VERB
bjos-8650040	235	18	after	after	ADP
bjos-8650040	235	19	chemo	chemo	NOUN
bjos-8650040	235	20	radiotherapy	radiotherapy	NOUN
bjos-8650040	235	21	and	and	CCONJ
bjos-8650040	235	22	concluded	conclude	VERB
bjos-8650040	235	23	that	that	SCONJ
bjos-8650040	235	24	the	the	DET
bjos-8650040	235	25	vulnerability	vulnerability	NOUN
bjos-8650040	235	26	of	of	ADP
bjos-8650040	235	27	oral	oral	ADJ
bjos-8650040	235	28	mucosa	mucosa	NOUN
bjos-8650040	235	29	undergoing	undergo	VERB
bjos-8650040	235	30	chemo	chemo	NOUN
bjos-8650040	235	31	radiation	radiation	NOUN
bjos-8650040	235	32	may	may	AUX
bjos-8650040	235	33	be	be	AUX
bjos-8650040	235	34	associated	associate	VERB
bjos-8650040	235	35	with	with	ADP
bjos-8650040	235	36	reduced	reduce	VERB
bjos-8650040	235	37	nf	nf	NOUN
bjos-8650040	235	38	-	-	PUNCT
bjos-8650040	235	39	κβ	κβ	NOUN
bjos-8650040	235	40	expression	expression	NOUN
bjos-8650040	235	41	and	and	CCONJ
bjos-8650040	235	42	impaired	impaired	ADJ
bjos-8650040	235	43	growth	growth	NOUN
bjos-8650040	235	44	activity31	activity31	NOUN
bjos-8650040	235	45	.	.	PUNCT
bjos-8650040	236	1	the	the	DET
bjos-8650040	236	2	role	role	NOUN
bjos-8650040	236	3	of	of	ADP
bjos-8650040	236	4	systemic	systemic	ADJ
bjos-8650040	236	5	inflammation	inflammation	NOUN
bjos-8650040	236	6	in	in	ADP
bjos-8650040	236	7	the	the	DET
bjos-8650040	236	8	development	development	NOUN
bjos-8650040	236	9	of	of	ADP
bjos-8650040	236	10	mucositis	mucositis	NOUN
bjos-8650040	236	11	was	be	AUX
bjos-8650040	236	12	further	far	ADV
bjos-8650040	236	13	supported	support	VERB
bjos-8650040	236	14	by	by	ADP
bjos-8650040	236	15	studies	study	NOUN
bjos-8650040	236	16	showing	show	VERB
bjos-8650040	236	17	that	that	SCONJ
bjos-8650040	236	18	the	the	DET
bjos-8650040	236	19	therapy	therapy	NOUN
bjos-8650040	236	20	targeted	target	VERB
bjos-8650040	236	21	to	to	PART
bjos-8650040	236	22	alter	alter	VERB
bjos-8650040	236	23	cytokine	cytokine	ADJ
bjos-8650040	236	24	expression	expression	NOUN
bjos-8650040	236	25	is	be	AUX
bjos-8650040	236	26	able	able	ADJ
bjos-8650040	236	27	to	to	PART
bjos-8650040	236	28	modify	modify	VERB
bjos-8650040	236	29	the	the	DET
bjos-8650040	236	30	course	course	NOUN
bjos-8650040	236	31	of	of	ADP
bjos-8650040	236	32	mucositis32	mucositis32	NOUN
bjos-8650040	236	33	.	.	PUNCT
bjos-8650040	237	1	animal33	animal33	ADV
bjos-8650040	237	2	and	and	CCONJ
bjos-8650040	237	3	human	human	ADJ
bjos-8650040	237	4	studies34	studies34	NOUN
bjos-8650040	237	5	have	have	AUX
bjos-8650040	237	6	demonstrated	demonstrate	VERB
bjos-8650040	237	7	a	a	DET
bjos-8650040	237	8	decrease	decrease	NOUN
bjos-8650040	237	9	in	in	ADP
bjos-8650040	237	10	the	the	DET
bjos-8650040	237	11	occurrence	occurrence	NOUN
bjos-8650040	237	12	or	or	CCONJ
bjos-8650040	237	13	severity	severity	NOUN
bjos-8650040	237	14	of	of	ADP
bjos-8650040	237	15	mucositis	mucositis	NOUN
bjos-8650040	237	16	following	follow	VERB
bjos-8650040	237	17	the	the	DET
bjos-8650040	237	18	administration	administration	NOUN
bjos-8650040	237	19	of	of	ADP
bjos-8650040	237	20	tnf	tnf	PROPN
bjos-8650040	237	21	inhibitors	inhibitor	NOUN
bjos-8650040	237	22	.	.	PUNCT
bjos-8650040	238	1	the	the	DET
bjos-8650040	238	2	cytokines	cytokine	NOUN
bjos-8650040	238	3	are	be	AUX
bjos-8650040	238	4	reported	report	VERB
bjos-8650040	238	5	to	to	PART
bjos-8650040	238	6	be	be	AUX
bjos-8650040	238	7	unregulated	unregulate	VERB
bjos-8650040	238	8	when	when	SCONJ
bjos-8650040	238	9	individually	individually	ADV
bjos-8650040	238	10	subjected	subject	VERB
bjos-8650040	238	11	to	to	ADP
bjos-8650040	238	12	radiation	radiation	NOUN
bjos-8650040	238	13	treatment11,15,19,20,22,35	treatment11,15,19,20,22,35	PRON
bjos-8650040	238	14	and	and	CCONJ
bjos-8650040	238	15	chemotherapy24,30,36	chemotherapy24,30,36	PROPN
bjos-8650040	238	16	-	-	PUNCT
bjos-8650040	238	17	41	41	NUM
bjos-8650040	238	18	.	.	PUNCT
bjos-8650040	239	1	however	however	ADV
bjos-8650040	239	2	,	,	PUNCT
bjos-8650040	239	3	no	no	DET
bjos-8650040	239	4	such	such	ADJ
bjos-8650040	239	5	studies	study	NOUN
bjos-8650040	239	6	have	have	AUX
bjos-8650040	239	7	been	be	AUX
bjos-8650040	239	8	made	make	VERB
bjos-8650040	239	9	on	on	ADP
bjos-8650040	239	10	patients	patient	NOUN
bjos-8650040	239	11	undergoing	undergo	VERB
bjos-8650040	239	12	chemotherapy	chemotherapy	NOUN
bjos-8650040	239	13	and	and	CCONJ
bjos-8650040	239	14	radiation	radiation	NOUN
bjos-8650040	239	15	therapy	therapy	NOUN
bjos-8650040	239	16	simultaneously	simultaneously	ADV
bjos-8650040	239	17	.	.	PUNCT
bjos-8650040	240	1	we	we	PRON
bjos-8650040	240	2	evaluated	evaluate	VERB
bjos-8650040	240	3	the	the	DET
bjos-8650040	240	4	level	level	NOUN
bjos-8650040	240	5	of	of	ADP
bjos-8650040	240	6	cytokines	cytokine	NOUN
bjos-8650040	240	7	(	(	PUNCT
bjos-8650040	240	8	tnf	tnf	PROPN
bjos-8650040	240	9	-	-	PUNCT
bjos-8650040	240	10	α	α	PROPN
bjos-8650040	240	11	,	,	PUNCT
bjos-8650040	240	12	nfκβ	nfκβ	ADJ
bjos-8650040	240	13	,	,	PUNCT
bjos-8650040	240	14	il-8	il-8	NOUN
bjos-8650040	240	15	,	,	PUNCT
bjos-8650040	240	16	il-6	il-6	NUM
bjos-8650040	240	17	,	,	PUNCT
bjos-8650040	240	18	il	il	PROPN
bjos-8650040	240	19	-	-	PROPN
bjos-8650040	240	20	α	α	NOUN
bjos-8650040	240	21	)	)	PUNCT
bjos-8650040	240	22	in	in	ADP
bjos-8650040	240	23	patients	patient	NOUN
bjos-8650040	240	24	receiving	receive	VERB
bjos-8650040	240	25	radiation	radiation	NOUN
bjos-8650040	240	26	treatment	treatment	NOUN
bjos-8650040	240	27	and	and	CCONJ
bjos-8650040	240	28	those	those	PRON
bjos-8650040	240	29	receiving	receive	VERB
bjos-8650040	240	30	chemotherapy	chemotherapy	NOUN
bjos-8650040	240	31	along	along	ADP
bjos-8650040	240	32	with	with	ADP
bjos-8650040	240	33	the	the	DET
bjos-8650040	240	34	radiation	radiation	NOUN
bjos-8650040	240	35	treatment	treatment	NOUN
bjos-8650040	240	36	.	.	PUNCT
bjos-8650040	241	1	this	this	DET
bjos-8650040	241	2	study	study	NOUN
bjos-8650040	241	3	for	for	ADP
bjos-8650040	241	4	the	the	DET
bjos-8650040	241	5	first	first	ADJ
bjos-8650040	241	6	time	time	NOUN
bjos-8650040	241	7	reveals	reveal	VERB
bjos-8650040	241	8	that	that	SCONJ
bjos-8650040	241	9	there	there	PRON
bjos-8650040	241	10	is	be	VERB
bjos-8650040	241	11	no	no	DET
bjos-8650040	241	12	significant	significant	ADJ
bjos-8650040	241	13	variation	variation	NOUN
bjos-8650040	241	14	in	in	ADP
bjos-8650040	241	15	the	the	DET
bjos-8650040	241	16	levels	level	NOUN
bjos-8650040	241	17	of	of	ADP
bjos-8650040	241	18	cytokines	cytokine	NOUN
bjos-8650040	241	19	in	in	ADP
bjos-8650040	241	20	the	the	DET
bjos-8650040	241	21	patients	patient	NOUN
bjos-8650040	241	22	undergoing	undergo	VERB
bjos-8650040	241	23	radiation	radiation	NOUN
bjos-8650040	241	24	as	as	ADV
bjos-8650040	241	25	well	well	ADV
bjos-8650040	241	26	as	as	ADP
bjos-8650040	241	27	chemotherapy	chemotherapy	NOUN
bjos-8650040	241	28	and	and	CCONJ
bjos-8650040	241	29	those	those	PRON
bjos-8650040	241	30	undergoing	undergo	VERB
bjos-8650040	241	31	just	just	ADV
bjos-8650040	241	32	the	the	DET
bjos-8650040	241	33	radiation	radiation	NOUN
bjos-8650040	241	34	treatment	treatment	NOUN
bjos-8650040	241	35	.	.	PUNCT
bjos-8650040	242	1	this	this	DET
bjos-8650040	242	2	finding	finding	NOUN
bjos-8650040	242	3	demonstrated	demonstrate	VERB
bjos-8650040	242	4	that	that	SCONJ
bjos-8650040	242	5	the	the	DET
bjos-8650040	242	6	severity	severity	NOUN
bjos-8650040	242	7	of	of	ADP
bjos-8650040	242	8	mucositis	mucositis	PROPN
bjos-8650040	242	9	does	do	AUX
bjos-8650040	242	10	not	not	PART
bjos-8650040	242	11	depend	depend	VERB
bjos-8650040	242	12	on	on	ADP
bjos-8650040	242	13	the	the	DET
bjos-8650040	242	14	type	type	NOUN
bjos-8650040	242	15	of	of	ADP
bjos-8650040	242	16	treatment	treatment	NOUN
bjos-8650040	242	17	(	(	PUNCT
bjos-8650040	242	18	radiation	radiation	NOUN
bjos-8650040	242	19	and/or	and/or	CCONJ
bjos-8650040	242	20	chemotherapy	chemotherapy	NOUN
bjos-8650040	242	21	)	)	PUNCT
bjos-8650040	242	22	being	be	AUX
bjos-8650040	242	23	administered	administer	VERB
bjos-8650040	242	24	to	to	ADP
bjos-8650040	242	25	the	the	DET
bjos-8650040	242	26	patient	patient	NOUN
bjos-8650040	242	27	and	and	CCONJ
bjos-8650040	242	28	that	that	SCONJ
bjos-8650040	242	29	both	both	DET
bjos-8650040	242	30	the	the	DET
bjos-8650040	242	31	treatments	treatment	NOUN
bjos-8650040	242	32	have	have	VERB
bjos-8650040	242	33	more	more	ADJ
bjos-8650040	242	34	or	or	CCONJ
bjos-8650040	242	35	less	less	ADV
bjos-8650040	242	36	the	the	DET
bjos-8650040	242	37	same	same	ADJ
bjos-8650040	242	38	effect	effect	NOUN
bjos-8650040	242	39	on	on	ADP
bjos-8650040	242	40	the	the	DET
bjos-8650040	242	41	level	level	NOUN
bjos-8650040	242	42	of	of	ADP
bjos-8650040	242	43	these	these	DET
bjos-8650040	242	44	cytokines	cytokine	NOUN
bjos-8650040	242	45	.	.	PUNCT
bjos-8650040	243	1	we	we	PRON
bjos-8650040	243	2	further	far	ADV
bjos-8650040	243	3	correlate	correlate	VERB
bjos-8650040	243	4	our	our	PRON
bjos-8650040	243	5	study	study	NOUN
bjos-8650040	243	6	to	to	ADP
bjos-8650040	243	7	the	the	DET
bjos-8650040	243	8	clinic	clinic	NOUN
bjos-8650040	243	9	-	-	ADJ
bjos-8650040	243	10	pathological	pathological	ADJ
bjos-8650040	243	11	parameters	parameter	NOUN
bjos-8650040	243	12	(	(	PUNCT
bjos-8650040	243	13	grading	grade	VERB
bjos-8650040	243	14	of	of	ADP
bjos-8650040	243	15	mucositis	mucositis	NOUN
bjos-8650040	243	16	)	)	PUNCT
bjos-8650040	243	17	.	.	PUNCT
bjos-8650040	244	1	interestingly	interestingly	ADV
bjos-8650040	244	2	we	we	PRON
bjos-8650040	244	3	found	find	VERB
bjos-8650040	244	4	that	that	SCONJ
bjos-8650040	244	5	advanced	advanced	ADJ
bjos-8650040	244	6	stage	stage	NOUN
bjos-8650040	244	7	(	(	PUNCT
bjos-8650040	244	8	grade	grade	NOUN
bjos-8650040	244	9	4	4	NUM
bjos-8650040	244	10	)	)	PUNCT
bjos-8650040	244	11	mucositis	mucositis	NOUN
bjos-8650040	244	12	demonstrated	demonstrate	VERB
bjos-8650040	244	13	the	the	DET
bjos-8650040	244	14	increase	increase	NOUN
bjos-8650040	244	15	in	in	ADP
bjos-8650040	244	16	the	the	DET
bjos-8650040	244	17	expression	expression	NOUN
bjos-8650040	244	18	of	of	ADP
bjos-8650040	244	19	cytokines	cytokine	NOUN
bjos-8650040	244	20	(	(	PUNCT
bjos-8650040	244	21	tnf	tnf	PROPN
bjos-8650040	244	22	-	-	PUNCT
bjos-8650040	244	23	α	α	PROPN
bjos-8650040	244	24	,	,	PUNCT
bjos-8650040	244	25	nf	nf	NOUN
bjos-8650040	244	26	-	-	PUNCT
bjos-8650040	244	27	κβ	κβ	NOUN
bjos-8650040	244	28	,	,	PUNCT
bjos-8650040	244	29	il-8	il-8	NOUN
bjos-8650040	244	30	,	,	PUNCT
bjos-8650040	244	31	il-6	il-6	NUM
bjos-8650040	244	32	,	,	PUNCT
bjos-8650040	244	33	il	il	PROPN
bjos-8650040	244	34	-	-	PROPN
bjos-8650040	244	35	α	α	NOUN
bjos-8650040	244	36	)	)	PUNCT
bjos-8650040	244	37	as	as	SCONJ
bjos-8650040	244	38	compared	compare	VERB
bjos-8650040	244	39	to	to	ADP
bjos-8650040	244	40	early	early	ADJ
bjos-8650040	244	41	stage	stage	NOUN
bjos-8650040	244	42	(	(	PUNCT
bjos-8650040	244	43	grade	grade	NOUN
bjos-8650040	244	44	o	o	PROPN
bjos-8650040	244	45	&	&	CCONJ
bjos-8650040	244	46	1	1	NUM
bjos-8650040	244	47	)	)	PUNCT
bjos-8650040	244	48	of	of	ADP
bjos-8650040	244	49	mucositis	mucositis	PROPN
bjos-8650040	244	50	as	as	ADV
bjos-8650040	244	51	well	well	ADV
bjos-8650040	244	52	as	as	ADP
bjos-8650040	244	53	healthy	healthy	ADJ
bjos-8650040	244	54	control	control	NOUN
bjos-8650040	244	55	.	.	PUNCT
bjos-8650040	245	1	this	this	DET
bjos-8650040	245	2	finding	finding	NOUN
bjos-8650040	245	3	was	be	AUX
bjos-8650040	245	4	supported	support	VERB
bjos-8650040	245	5	by	by	ADP
bjos-8650040	245	6	ong	ong	INTJ
bjos-8650040	245	7	et	et	PROPN
bjos-8650040	245	8	al	al	PROPN
bjos-8650040	245	9	.	.	PROPN
bjos-8650040	245	10	,	,	PUNCT
bjos-8650040	245	11	who	who	PRON
bjos-8650040	245	12	also	also	ADV
bjos-8650040	245	13	reported	report	VERB
bjos-8650040	245	14	the	the	DET
bjos-8650040	245	15	importance	importance	NOUN
bjos-8650040	245	16	of	of	ADP
bjos-8650040	245	17	these	these	DET
bjos-8650040	245	18	proinflammatory	proinflammatory	ADJ
bjos-8650040	245	19	cytokines	cytokine	NOUN
bjos-8650040	245	20	in	in	ADP
bjos-8650040	245	21	the	the	DET
bjos-8650040	245	22	development	development	NOUN
bjos-8650040	245	23	and	and	CCONJ
bjos-8650040	245	24	severity	severity	NOUN
bjos-8650040	245	25	of	of	ADP
bjos-8650040	245	26	radiotherapy	radiotherapy	NOUN
bjos-8650040	245	27	induced	induce	VERB
bjos-8650040	245	28	gastrointestinal	gastrointestinal	ADJ
bjos-8650040	245	29	mucositis	mucositis	NOUN
bjos-8650040	245	30	in	in	ADP
bjos-8650040	245	31	rats22	rats22	NOUN
bjos-8650040	245	32	.	.	PUNCT
bjos-8650040	246	1	it	it	PRON
bjos-8650040	246	2	is	be	AUX
bjos-8650040	246	3	therefore	therefore	ADV
bjos-8650040	246	4	very	very	ADV
bjos-8650040	246	5	clear	clear	ADJ
bjos-8650040	246	6	to	to	PART
bjos-8650040	246	7	understand	understand	VERB
bjos-8650040	246	8	that	that	DET
bjos-8650040	246	9	inflammatory	inflammatory	ADJ
bjos-8650040	246	10	cytokines	cytokine	NOUN
bjos-8650040	246	11	(	(	PUNCT
bjos-8650040	246	12	tnf	tnf	PROPN
bjos-8650040	246	13	-	-	PUNCT
bjos-8650040	246	14	α	α	PROPN
bjos-8650040	246	15	,	,	PUNCT
bjos-8650040	246	16	nf	nf	NOUN
bjos-8650040	246	17	-	-	PUNCT
bjos-8650040	246	18	κβ	κβ	NOUN
bjos-8650040	246	19	,	,	PUNCT
bjos-8650040	246	20	il-8	il-8	NOUN
bjos-8650040	246	21	,	,	PUNCT
bjos-8650040	246	22	il-6	il-6	NUM
bjos-8650040	246	23	,	,	PUNCT
bjos-8650040	246	24	il	il	PROPN
bjos-8650040	246	25	-	-	PROPN
bjos-8650040	246	26	α	α	NOUN
bjos-8650040	246	27	)	)	PUNCT
bjos-8650040	246	28	play	play	VERB
bjos-8650040	246	29	a	a	DET
bjos-8650040	246	30	vital	vital	ADJ
bjos-8650040	246	31	role	role	NOUN
bjos-8650040	246	32	in	in	ADP
bjos-8650040	246	33	the	the	DET
bjos-8650040	246	34	progression	progression	NOUN
bjos-8650040	246	35	of	of	ADP
bjos-8650040	246	36	radiation	radiation	NOUN
bjos-8650040	246	37	induced	induce	VERB
bjos-8650040	246	38	oral	oral	ADJ
bjos-8650040	246	39	mucositis	mucositis	NOUN
bjos-8650040	246	40	.	.	PUNCT
bjos-8650040	247	1	conclusion	conclusion	NOUN
bjos-8650040	247	2	on	on	ADP
bjos-8650040	247	3	the	the	DET
bjos-8650040	247	4	basis	basis	NOUN
bjos-8650040	247	5	of	of	ADP
bjos-8650040	247	6	above	above	ADP
bjos-8650040	247	7	findings	finding	NOUN
bjos-8650040	247	8	,	,	PUNCT
bjos-8650040	247	9	we	we	PRON
bjos-8650040	247	10	are	be	AUX
bjos-8650040	247	11	able	able	ADJ
bjos-8650040	247	12	to	to	PART
bjos-8650040	247	13	conclude	conclude	VERB
bjos-8650040	247	14	that	that	PRON
bjos-8650040	247	15	nf	nf	NOUN
bjos-8650040	247	16	-	-	PUNCT
bjos-8650040	247	17	κβ	κβ	NOUN
bjos-8650040	247	18	and	and	CCONJ
bjos-8650040	247	19	its	its	PRON
bjos-8650040	247	20	associated	associated	ADJ
bjos-8650040	247	21	cytokines	cytokine	NOUN
bjos-8650040	247	22	(	(	PUNCT
bjos-8650040	247	23	tnf	tnf	PROPN
bjos-8650040	247	24	-	-	PUNCT
bjos-8650040	247	25	α	α	PROPN
bjos-8650040	247	26	,	,	PUNCT
bjos-8650040	247	27	il-8	il-8	NOUN
bjos-8650040	247	28	,	,	PUNCT
bjos-8650040	247	29	il-6	il-6	NUM
bjos-8650040	247	30	,	,	PUNCT
bjos-8650040	247	31	il	il	PROPN
bjos-8650040	247	32	-	-	PROPN
bjos-8650040	247	33	α	α	NOUN
bjos-8650040	247	34	)	)	PUNCT
bjos-8650040	247	35	are	be	AUX
bjos-8650040	247	36	involved	involve	VERB
bjos-8650040	247	37	in	in	ADP
bjos-8650040	247	38	the	the	DET
bjos-8650040	247	39	pathogenesis	pathogenesis	NOUN
bjos-8650040	247	40	of	of	ADP
bjos-8650040	247	41	radiation	radiation	NOUN
bjos-8650040	247	42	induced	induce	VERB
bjos-8650040	247	43	oral	oral	ADJ
bjos-8650040	247	44	mucositis	mucositis	NOUN
bjos-8650040	247	45	.	.	PUNCT
bjos-8650040	248	1	we	we	PRON
bjos-8650040	248	2	further	far	ADV
bjos-8650040	248	3	provide	provide	VERB
bjos-8650040	248	4	evidence	evidence	NOUN
bjos-8650040	248	5	for	for	ADP
bjos-8650040	248	6	the	the	DET
bjos-8650040	248	7	association	association	NOUN
bjos-8650040	248	8	of	of	ADP
bjos-8650040	248	9	these	these	DET
bjos-8650040	248	10	pro	pro	ADJ
bjos-8650040	248	11	-	-	ADJ
bjos-8650040	248	12	inflammatory	inflammatory	ADJ
bjos-8650040	248	13	cytokines	cytokine	NOUN
bjos-8650040	248	14	with	with	ADP
bjos-8650040	248	15	the	the	DET
bjos-8650040	248	16	progression	progression	NOUN
bjos-8650040	248	17	of	of	ADP
bjos-8650040	248	18	this	this	DET
bjos-8650040	248	19	disease	disease	NOUN
bjos-8650040	248	20	into	into	ADP
bjos-8650040	248	21	more	more	ADV
bjos-8650040	248	22	advanced	advanced	ADJ
bjos-8650040	248	23	stages	stage	NOUN
bjos-8650040	248	24	.	.	PUNCT
bjos-8650040	249	1	continued	continue	VERB
bjos-8650040	249	2	research	research	NOUN
bjos-8650040	249	3	will	will	AUX
bjos-8650040	249	4	undoubtedly	undoubtedly	ADV
bjos-8650040	249	5	provide	provide	VERB
bjos-8650040	249	6	a	a	DET
bjos-8650040	249	7	better	well	ADJ
bjos-8650040	249	8	understanding	understanding	NOUN
bjos-8650040	249	9	of	of	ADP
bjos-8650040	249	10	the	the	DET
bjos-8650040	249	11	dynamics	dynamic	NOUN
bjos-8650040	249	12	leading	lead	VERB
bjos-8650040	249	13	to	to	ADP
bjos-8650040	249	14	mucosal	mucosal	NOUN
bjos-8650040	249	15	injury	injury	NOUN
bjos-8650040	249	16	and	and	CCONJ
bjos-8650040	249	17	to	to	ADP
bjos-8650040	249	18	more	more	ADV
bjos-8650040	249	19	effective	effective	ADJ
bjos-8650040	249	20	measures	measure	NOUN
bjos-8650040	249	21	for	for	ADP
bjos-8650040	249	22	prevention	prevention	NOUN
bjos-8650040	249	23	and	and	CCONJ
bjos-8650040	249	24	treatment	treatment	NOUN
bjos-8650040	249	25	.	.	PUNCT
bjos-8650040	250	1	refinement	refinement	NOUN
bjos-8650040	250	2	of	of	ADP
bjos-8650040	250	3	the	the	DET
bjos-8650040	250	4	five	five	NUM
bjos-8650040	250	5	-	-	PUNCT
bjos-8650040	250	6	stage	stage	NOUN
bjos-8650040	250	7	model	model	NOUN
bjos-8650040	250	8	of	of	ADP
bjos-8650040	250	9	mucositis	mucositis	NOUN
bjos-8650040	250	10	pathogenesis	pathogenesis	NOUN
bjos-8650040	250	11	may	may	AUX
bjos-8650040	250	12	aid	aid	VERB
bjos-8650040	250	13	in	in	ADP
bjos-8650040	250	14	the	the	DET
bjos-8650040	250	15	rational	rational	ADJ
bjos-8650040	250	16	use	use	NOUN
bjos-8650040	250	17	of	of	ADP
bjos-8650040	250	18	therapies	therapy	NOUN
bjos-8650040	250	19	to	to	PART
bjos-8650040	250	20	maximize	maximize	VERB
bjos-8650040	250	21	their	their	PRON
bjos-8650040	250	22	efficacy	efficacy	NOUN
bjos-8650040	250	23	.	.	PUNCT
bjos-8650040	251	1	further	further	ADJ
bjos-8650040	251	2	studies	study	NOUN
bjos-8650040	251	3	are	be	AUX
bjos-8650040	251	4	necessary	necessary	ADJ
bjos-8650040	251	5	to	to	PART
bjos-8650040	251	6	elucidate	elucidate	VERB
bjos-8650040	251	7	the	the	DET
bjos-8650040	251	8	exact	exact	ADJ
bjos-8650040	251	9	role	role	NOUN
bjos-8650040	251	10	of	of	ADP
bjos-8650040	251	11	these	these	DET
bjos-8650040	251	12	cytokines	cytokine	NOUN
bjos-8650040	251	13	as	as	ADP
bjos-8650040	251	14	biomarkers	biomarker	NOUN
bjos-8650040	251	15	for	for	ADP
bjos-8650040	251	16	this	this	DET
bjos-8650040	251	17	disease	disease	NOUN
bjos-8650040	251	18	.	.	PUNCT
bjos-8650040	252	1	acknowledgement	acknowledgement	NOUN
bjos-8650040	252	2	this	this	DET
bjos-8650040	252	3	work	work	NOUN
bjos-8650040	252	4	has	have	AUX
bjos-8650040	252	5	been	be	AUX
bjos-8650040	252	6	supported	support	VERB
bjos-8650040	252	7	by	by	ADP
bjos-8650040	252	8	grants	grant	NOUN
bjos-8650040	252	9	from	from	ADP
bjos-8650040	252	10	university	university	NOUN
bjos-8650040	252	11	grants	grant	NOUN
bjos-8650040	252	12	commission	commission	PROPN
bjos-8650040	252	13	(	(	PUNCT
bjos-8650040	252	14	ugc	ugc	PROPN
bjos-8650040	252	15	)	)	PUNCT
bjos-8650040	252	16	,	,	PUNCT
bjos-8650040	252	17	bahadur	bahadur	PROPN
bjos-8650040	252	18	shah	shah	PROPN
bjos-8650040	252	19	zafar	zafar	PROPN
bjos-8650040	252	20	marg	marg	PROPN
bjos-8650040	252	21	,	,	PUNCT
bjos-8650040	252	22	delhi-110	delhi-110	VERB
bjos-8650040	252	23	002	002	NUM
bjos-8650040	252	24	,	,	PUNCT
bjos-8650040	252	25	india	india	PROPN
bjos-8650040	252	26	.	.	PUNCT
bjos-8650040	253	1	conflict	conflict	NOUN
bjos-8650040	253	2	of	of	ADP
bjos-8650040	253	3	interest	interest	NOUN
bjos-8650040	253	4	none	none	NOUN
bjos-8650040	253	5	declared	declare	VERB
bjos-8650040	253	6	.	.	PUNCT
bjos-8650040	254	1	references	reference	NOUN
bjos-8650040	254	2	1	1	NUM
bjos-8650040	254	3	.	.	PUNCT
bjos-8650040	255	1	rizvi	rizvi	PROPN
bjos-8650040	255	2	mm	mm	PROPN
bjos-8650040	255	3	,	,	PUNCT
bjos-8650040	255	4	alam	alam	PROPN
bjos-8650040	255	5	ms	ms	PROPN
bjos-8650040	255	6	,	,	PUNCT
bjos-8650040	255	7	ali	ali	PROPN
bjos-8650040	255	8	a	a	PROPN
bjos-8650040	255	9	,	,	PUNCT
bjos-8650040	255	10	mehdi	mehdi	NOUN
bjos-8650040	255	11	sj	sj	PROPN
bjos-8650040	255	12	,	,	PUNCT
bjos-8650040	255	13	batra	batra	PROPN
bjos-8650040	255	14	s	s	PROPN
bjos-8650040	255	15	,	,	PUNCT
bjos-8650040	255	16	mandal	mandal	PROPN
bjos-8650040	255	17	ak	ak	PROPN
bjos-8650040	255	18	.	.	PROPN
bjos-8650040	255	19	aberrant	aberrant	ADJ
bjos-8650040	255	20	promoter	promoter	NOUN
bjos-8650040	255	21	methylation	methylation	NOUN
bjos-8650040	255	22	and	and	CCONJ
bjos-8650040	255	23	inactivation	inactivation	NOUN
bjos-8650040	255	24	of	of	ADP
bjos-8650040	255	25	pten	pten	ADJ
bjos-8650040	255	26	gene	gene	NOUN
bjos-8650040	255	27	in	in	ADP
bjos-8650040	255	28	cervical	cervical	ADJ
bjos-8650040	255	29	carcinoma	carcinoma	NOUN
bjos-8650040	255	30	from	from	ADP
bjos-8650040	255	31	indian	indian	ADJ
bjos-8650040	255	32	population	population	NOUN
bjos-8650040	255	33	.	.	PUNCT
bjos-8650040	256	1	j	j	PROPN
bjos-8650040	256	2	cancer	cancer	NOUN
bjos-8650040	256	3	res	re	VERB
bjos-8650040	256	4	clin	clin	PROPN
bjos-8650040	256	5	oncol	oncol	PROPN
bjos-8650040	256	6	.	.	PUNCT
bjos-8650040	257	1	2011	2011	NUM
bjos-8650040	257	2	aug;137(8):1255	aug;137(8):1255	PROPN
bjos-8650040	257	3	-	-	PUNCT
bjos-8650040	257	4	62	62	NUM
bjos-8650040	257	5	.	.	PUNCT
bjos-8650040	258	1	doi	doi	NOUN
bjos-8650040	258	2	:	:	PUNCT
bjos-8650040	258	3	10.1007	10.1007	NUM
bjos-8650040	258	4	/	/	SYM
bjos-8650040	258	5	s00432	s00432	NOUN
bjos-8650040	258	6	-	-	PUNCT
bjos-8650040	258	7	011	011	NUM
bjos-8650040	258	8	-	-	PUNCT
bjos-8650040	258	9	0994	0994	NUM
bjos-8650040	258	10	-	-	PUNCT
bjos-8650040	258	11	0	0	NUM
bjos-8650040	258	12	.	.	NOUN
bjos-8650040	259	1	2	2	NUM
bjos-8650040	259	2	.	.	X
bjos-8650040	260	1	rizvi	rizvi	PROPN
bjos-8650040	260	2	mm	mm	PROPN
bjos-8650040	260	3	,	,	PUNCT
bjos-8650040	260	4	ali	ali	PROPN
bjos-8650040	260	5	a	a	PROPN
bjos-8650040	260	6	,	,	PUNCT
bjos-8650040	260	7	mehdi	mehdi	NOUN
bjos-8650040	260	8	sj	sj	PROPN
bjos-8650040	260	9	,	,	PUNCT
bjos-8650040	260	10	saluja	saluja	PROPN
bjos-8650040	260	11	ss	ss	PROPN
bjos-8650040	260	12	,	,	PUNCT
bjos-8650040	260	13	mishra	mishra	PROPN
bjos-8650040	260	14	pk	pk	PROPN
bjos-8650040	260	15	.	.	PROPN
bjos-8650040	260	16	association	association	NOUN
bjos-8650040	260	17	of	of	ADP
bjos-8650040	260	18	284cytokine	284cytokine	ADJ
bjos-8650040	260	19	expression	expression	NOUN
bjos-8650040	260	20	in	in	ADP
bjos-8650040	260	21	riom	riom	ADJ
bjos-8650040	260	22	patients	patient	NOUN
bjos-8650040	260	23	braz	braz	PROPN
bjos-8650040	260	24	j	j	PROPN
bjos-8650040	260	25	oral	oral	PROPN
bjos-8650040	260	26	sci	sci	PROPN
bjos-8650040	260	27	.	.	PUNCT
bjos-8650040	261	1	15(4):280	15(4):280	NUM
bjos-8650040	261	2	-	-	SYM
bjos-8650040	261	3	286	286	NUM
bjos-8650040	261	4	285	285	NUM
bjos-8650040	261	5	cytokine	cytokine	NOUN
bjos-8650040	261	6	expression	expression	NOUN
bjos-8650040	261	7	in	in	ADP
bjos-8650040	261	8	riom	riom	ADJ
bjos-8650040	261	9	patients	patient	NOUN
bjos-8650040	261	10	epigenetic	epigenetic	ADJ
bjos-8650040	261	11	alteration	alteration	NOUN
bjos-8650040	261	12	in	in	ADP
bjos-8650040	261	13	pten	pten	ADJ
bjos-8650040	261	14	gene	gene	NOUN
bjos-8650040	261	15	with	with	ADP
bjos-8650040	261	16	colorectal	colorectal	ADJ
bjos-8650040	261	17	cancer	cancer	NOUN
bjos-8650040	261	18	progression	progression	NOUN
bjos-8650040	261	19	among	among	ADP
bjos-8650040	261	20	indian	indian	ADJ
bjos-8650040	261	21	population	population	NOUN
bjos-8650040	261	22	.	.	PUNCT
bjos-8650040	262	1	int	int	PROPN
bjos-8650040	262	2	j	j	PROPN
bjos-8650040	262	3	colorectal	colorectal	ADJ
bjos-8650040	262	4	dis	dis	PROPN
bjos-8650040	262	5	.	.	PUNCT
bjos-8650040	263	1	2013	2013	NUM
bjos-8650040	263	2	feb;28(2):283	feb;28(2):283	NOUN
bjos-8650040	263	3	-	-	PUNCT
bjos-8650040	263	4	4	4	NUM
bjos-8650040	263	5	.	.	PUNCT
bjos-8650040	263	6	doi	doi	NOUN
bjos-8650040	263	7	:	:	PUNCT
bjos-8650040	263	8	10.1007	10.1007	NUM
bjos-8650040	263	9	/	/	SYM
bjos-8650040	263	10	s00384	s00384	PROPN
bjos-8650040	263	11	-	-	PUNCT
bjos-8650040	263	12	012	012	NUM
bjos-8650040	263	13	-	-	PUNCT
bjos-8650040	263	14	1482	1482	NUM
bjos-8650040	263	15	-	-	PUNCT
bjos-8650040	263	16	y.	y.	NOUN
bjos-8650040	263	17	3	3	NUM
bjos-8650040	263	18	.	.	PUNCT
bjos-8650040	264	1	dirix	dirix	PROPN
bjos-8650040	264	2	p	p	NOUN
bjos-8650040	264	3	,	,	PUNCT
bjos-8650040	264	4	nuyts	nuyts	PROPN
bjos-8650040	264	5	s	s	PROPN
bjos-8650040	264	6	,	,	PUNCT
bjos-8650040	264	7	van	van	PROPN
bjos-8650040	264	8	den	den	PROPN
bjos-8650040	264	9	bogaert	bogaert	PROPN
bjos-8650040	264	10	w.	w.	PROPN
bjos-8650040	264	11	radiation	radiation	NOUN
bjos-8650040	264	12	-	-	PUNCT
bjos-8650040	264	13	induced	induce	VERB
bjos-8650040	264	14	xerostomia	xerostomia	NOUN
bjos-8650040	264	15	in	in	ADP
bjos-8650040	264	16	patients	patient	NOUN
bjos-8650040	264	17	with	with	ADP
bjos-8650040	264	18	head	head	NOUN
bjos-8650040	264	19	and	and	CCONJ
bjos-8650040	264	20	neck	neck	NOUN
bjos-8650040	264	21	cancer	cancer	NOUN
bjos-8650040	264	22	:	:	PUNCT
bjos-8650040	264	23	a	a	DET
bjos-8650040	264	24	literature	literature	NOUN
bjos-8650040	264	25	review	review	NOUN
bjos-8650040	264	26	.	.	PUNCT
bjos-8650040	265	1	cancer	cancer	NOUN
bjos-8650040	265	2	.	.	PUNCT
bjos-8650040	266	1	2006	2006	NUM
bjos-8650040	266	2	dec;107(1):2525	dec;107(1):2525	PROPN
bjos-8650040	266	3	-	-	PUNCT
bjos-8650040	266	4	34	34	NUM
bjos-8650040	266	5	.	.	NOUN
bjos-8650040	266	6	4	4	X
bjos-8650040	266	7	.	.	X
bjos-8650040	267	1	sonis	sonis	PROPN
bjos-8650040	267	2	st	st	PROPN
bjos-8650040	267	3	,	,	PUNCT
bjos-8650040	267	4	elting	elte	VERB
bjos-8650040	267	5	ls	ls	PROPN
bjos-8650040	267	6	,	,	PUNCT
bjos-8650040	267	7	keefe	keefe	PROPN
bjos-8650040	267	8	d	d	PROPN
bjos-8650040	267	9	,	,	PUNCT
bjos-8650040	267	10	peterson	peterson	PROPN
bjos-8650040	267	11	de	de	PROPN
bjos-8650040	267	12	,	,	PUNCT
bjos-8650040	267	13	schubert	schubert	PROPN
bjos-8650040	267	14	m	m	PROPN
bjos-8650040	267	15	,	,	PUNCT
bjos-8650040	267	16	hauer	hauer	PROPN
bjos-8650040	267	17	-	-	PROPN
bjos-8650040	267	18	jensen	jensen	PROPN
bjos-8650040	267	19	m	m	PROPN
bjos-8650040	267	20	,	,	PUNCT
bjos-8650040	267	21	et	et	PROPN
bjos-8650040	267	22	al	al	PROPN
bjos-8650040	267	23	.	.	PROPN
bjos-8650040	267	24	,	,	PUNCT
bjos-8650040	267	25	perspectives	perspective	NOUN
bjos-8650040	267	26	on	on	ADP
bjos-8650040	267	27	cancer	cancer	NOUN
bjos-8650040	267	28	therapy	therapy	NOUN
bjos-8650040	267	29	-	-	PUNCT
bjos-8650040	267	30	induced	induce	VERB
bjos-8650040	267	31	mucosal	mucosal	NOUN
bjos-8650040	267	32	injury	injury	NOUN
bjos-8650040	267	33	:	:	PUNCT
bjos-8650040	267	34	pathogen¬esis	pathogen¬esis	NOUN
bjos-8650040	267	35	,	,	PUNCT
bjos-8650040	267	36	measurement	measurement	NOUN
bjos-8650040	267	37	,	,	PUNCT
bjos-8650040	267	38	epidemiology	epidemiology	NOUN
bjos-8650040	267	39	,	,	PUNCT
bjos-8650040	267	40	and	and	CCONJ
bjos-8650040	267	41	consequences	consequence	NOUN
bjos-8650040	267	42	for	for	ADP
bjos-8650040	267	43	patients	patient	NOUN
bjos-8650040	267	44	.	.	PUNCT
bjos-8650040	268	1	cancer	cancer	NOUN
bjos-8650040	268	2	.	.	PUNCT
bjos-8650040	269	1	2004	2004	NUM
bjos-8650040	269	2	may;100(9	may;100(9	PROPN
bjos-8650040	269	3	suppl):1995	suppl):1995	NOUN
bjos-8650040	269	4	-	-	PUNCT
bjos-8650040	269	5	2025	2025	NUM
bjos-8650040	269	6	.	.	PUNCT
bjos-8650040	270	1	5	5	X
bjos-8650040	270	2	.	.	X
bjos-8650040	270	3	peterson	peterson	PROPN
bjos-8650040	270	4	de	de	PROPN
bjos-8650040	270	5	,	,	PUNCT
bjos-8650040	270	6	bensadoun	bensadoun	PROPN
bjos-8650040	270	7	rj	rj	PROPN
bjos-8650040	270	8	,	,	PUNCT
bjos-8650040	270	9	roila	roila	NOUN
bjos-8650040	270	10	f	f	NOUN
bjos-8650040	270	11	;	;	PUNCT
bjos-8650040	270	12	esmo	esmo	NOUN
bjos-8650040	270	13	guidelines	guideline	NOUN
bjos-8650040	270	14	working	working	NOUN
bjos-8650040	270	15	group	group	NOUN
bjos-8650040	270	16	.	.	PUNCT
bjos-8650040	271	1	management	management	NOUN
bjos-8650040	271	2	of	of	ADP
bjos-8650040	271	3	oral	oral	ADJ
bjos-8650040	271	4	and	and	CCONJ
bjos-8650040	271	5	gastrointestinal	gastrointestinal	ADJ
bjos-8650040	271	6	mucositis	mucositis	NOUN
bjos-8650040	271	7	:	:	PUNCT
bjos-8650040	271	8	esmo	esmo	VERB
bjos-8650040	271	9	clinical	clinical	ADJ
bjos-8650040	271	10	practice	practice	NOUN
bjos-8650040	271	11	guidelines	guideline	NOUN
bjos-8650040	271	12	.	.	PUNCT
bjos-8650040	272	1	ann	ann	PROPN
bjos-8650040	272	2	oncol	oncol	PROPN
bjos-8650040	272	3	.	.	PUNCT
bjos-8650040	273	1	2011	2011	NUM
bjos-8650040	273	2	sep;22	sep;22	VERB
bjos-8650040	273	3	suppl	suppl	ADJ
bjos-8650040	273	4	6	6	NUM
bjos-8650040	273	5	:	:	PUNCT
bjos-8650040	273	6	vi78	vi78	PROPN
bjos-8650040	273	7	-	-	PUNCT
bjos-8650040	273	8	84	84	NUM
bjos-8650040	273	9	.	.	PUNCT
bjos-8650040	274	1	doi	doi	NOUN
bjos-8650040	274	2	:	:	PUNCT
bjos-8650040	274	3	10.1093	10.1093	NUM
bjos-8650040	274	4	/	/	SYM
bjos-8650040	274	5	annonc	annonc	PROPN
bjos-8650040	274	6	/	/	SYM
bjos-8650040	274	7	mdr391	mdr391	PROPN
bjos-8650040	274	8	.	.	PUNCT
bjos-8650040	275	1	erratum	erratum	PROPN
bjos-8650040	275	2	in	in	ADP
bjos-8650040	275	3	:	:	PUNCT
bjos-8650040	275	4	ann	ann	PROPN
bjos-8650040	275	5	oncol	oncol	PROPN
bjos-8650040	275	6	.	.	PUNCT
bjos-8650040	276	1	2012	2012	NUM
bjos-8650040	276	2	mar;23(3):810	mar;23(3):810	NOUN
bjos-8650040	276	3	.	.	PUNCT
bjos-8650040	277	1	6	6	NUM
bjos-8650040	277	2	.	.	X
bjos-8650040	277	3	peterson	peterson	PROPN
bjos-8650040	277	4	de	de	PROPN
bjos-8650040	277	5	.	.	PROPN
bjos-8650040	277	6	new	new	ADJ
bjos-8650040	277	7	strategies	strategy	NOUN
bjos-8650040	277	8	for	for	ADP
bjos-8650040	277	9	management	management	NOUN
bjos-8650040	277	10	of	of	ADP
bjos-8650040	277	11	oral	oral	ADJ
bjos-8650040	277	12	mucositis	mucositis	NOUN
bjos-8650040	277	13	in	in	ADP
bjos-8650040	277	14	cancer	cancer	NOUN
bjos-8650040	277	15	patients	patient	NOUN
bjos-8650040	277	16	.	.	PUNCT
bjos-8650040	278	1	j	j	PROPN
bjos-8650040	278	2	support	support	PROPN
bjos-8650040	278	3	oncol	oncol	ADJ
bjos-8650040	278	4	.	.	PUNCT
bjos-8650040	279	1	2006	2006	NUM
bjos-8650040	279	2	feb;4(2	feb;4(2	NOUN
bjos-8650040	279	3	suppl	suppl	NOUN
bjos-8650040	280	1	1):9	1):9	NUM
bjos-8650040	280	2	-	-	SYM
bjos-8650040	280	3	13	13	NUM
bjos-8650040	280	4	.	.	PUNCT
bjos-8650040	281	1	7	7	X
bjos-8650040	281	2	.	.	X
bjos-8650040	281	3	pico	pico	PROPN
bjos-8650040	281	4	jl	jl	PROPN
bjos-8650040	281	5	,	,	PUNCT
bjos-8650040	281	6	avila	avila	PROPN
bjos-8650040	281	7	-	-	PUNCT
bjos-8650040	281	8	garavito	garavito	PROPN
bjos-8650040	281	9	a	a	PROPN
bjos-8650040	281	10	,	,	PUNCT
bjos-8650040	281	11	naccache	naccache	PROPN
bjos-8650040	281	12	p.	p.	PROPN
bjos-8650040	282	1	mucositis	mucositis	NOUN
bjos-8650040	282	2	:	:	PUNCT
bjos-8650040	282	3	its	its	PRON
bjos-8650040	282	4	occurrence	occurrence	NOUN
bjos-8650040	282	5	,	,	PUNCT
bjos-8650040	282	6	consequences	consequence	NOUN
bjos-8650040	282	7	,	,	PUNCT
bjos-8650040	282	8	and	and	CCONJ
bjos-8650040	282	9	treatment	treatment	NOUN
bjos-8650040	282	10	in	in	ADP
bjos-8650040	282	11	the	the	DET
bjos-8650040	282	12	oncology	oncology	NOUN
bjos-8650040	282	13	setting	setting	NOUN
bjos-8650040	282	14	.	.	PUNCT
bjos-8650040	283	1	oncologist	oncologist	NOUN
bjos-8650040	283	2	.	.	PUNCT
bjos-8650040	284	1	1998;3(6):446	1998;3(6):446	NUM
bjos-8650040	284	2	-	-	SYM
bjos-8650040	284	3	51	51	NUM
bjos-8650040	284	4	.	.	NOUN
bjos-8650040	284	5	8	8	NUM
bjos-8650040	284	6	.	.	X
bjos-8650040	284	7	trotti	trotti	VERB
bjos-8650040	284	8	a	a	DET
bjos-8650040	284	9	,	,	PUNCT
bjos-8650040	284	10	bellm	bellm	ADJ
bjos-8650040	284	11	la	la	PROPN
bjos-8650040	284	12	,	,	PUNCT
bjos-8650040	284	13	epstein	epstein	PROPN
bjos-8650040	284	14	jb	jb	PROPN
bjos-8650040	284	15	,	,	PUNCT
bjos-8650040	284	16	frame	frame	PROPN
bjos-8650040	284	17	d	d	NOUN
bjos-8650040	284	18	,	,	PUNCT
bjos-8650040	284	19	fuchs	fuchs	PROPN
bjos-8650040	284	20	hj	hj	PROPN
bjos-8650040	284	21	,	,	PUNCT
bjos-8650040	284	22	gwede	gwede	PROPN
bjos-8650040	284	23	ck	ck	PROPN
bjos-8650040	284	24	,	,	PUNCT
bjos-8650040	284	25	et	et	PROPN
bjos-8650040	284	26	al	al	PROPN
bjos-8650040	284	27	.	.	PROPN
bjos-8650040	284	28	,	,	PUNCT
bjos-8650040	284	29	mucositis	mucositis	NOUN
bjos-8650040	284	30	incidence	incidence	NOUN
bjos-8650040	284	31	,	,	PUNCT
bjos-8650040	284	32	severity	severity	NOUN
bjos-8650040	284	33	and	and	CCONJ
bjos-8650040	284	34	associated	associate	VERB
bjos-8650040	284	35	outcomes	outcome	NOUN
bjos-8650040	284	36	in	in	ADP
bjos-8650040	284	37	patients	patient	NOUN
bjos-8650040	284	38	with	with	ADP
bjos-8650040	284	39	head	head	NOUN
bjos-8650040	284	40	and	and	CCONJ
bjos-8650040	284	41	neck	neck	NOUN
bjos-8650040	284	42	cancer	cancer	NOUN
bjos-8650040	284	43	receiving	receive	VERB
bjos-8650040	284	44	radiotherapy	radiotherapy	NOUN
bjos-8650040	284	45	with	with	ADP
bjos-8650040	284	46	or	or	CCONJ
bjos-8650040	284	47	without	without	ADP
bjos-8650040	284	48	chemotherapy	chemotherapy	NOUN
bjos-8650040	284	49	:	:	PUNCT
bjos-8650040	284	50	a	a	DET
bjos-8650040	284	51	systematic	systematic	ADJ
bjos-8650040	284	52	literature	literature	PROPN
bjos-8650040	284	53	review	review	NOUN
bjos-8650040	284	54	.	.	PUNCT
bjos-8650040	285	1	radiother	radiother	PROPN
bjos-8650040	285	2	oncol	oncol	PROPN
bjos-8650040	285	3	.	.	PUNCT
bjos-8650040	286	1	2003	2003	NUM
bjos-8650040	286	2	mar;66(3):253	mar;66(3):253	NUM
bjos-8650040	286	3	-	-	PUNCT
bjos-8650040	286	4	62	62	NUM
bjos-8650040	286	5	.	.	PUNCT
bjos-8650040	287	1	9	9	X
bjos-8650040	287	2	.	.	X
bjos-8650040	287	3	silverman	silverman	PROPN
bjos-8650040	287	4	s	s	PART
bjos-8650040	287	5	jr	jr	PROPN
bjos-8650040	287	6	.	.	PUNCT
bjos-8650040	287	7	diagnosis	diagnosis	NOUN
bjos-8650040	287	8	and	and	CCONJ
bjos-8650040	287	9	management	management	NOUN
bjos-8650040	287	10	of	of	ADP
bjos-8650040	287	11	oral	oral	ADJ
bjos-8650040	287	12	mucositis	mucositis	NOUN
bjos-8650040	287	13	.	.	PUNCT
bjos-8650040	288	1	j	j	PROPN
bjos-8650040	288	2	support	support	PROPN
bjos-8650040	288	3	oncol	oncol	PROPN
bjos-8650040	288	4	.	.	PUNCT
bjos-8650040	289	1	2007	2007	NUM
bjos-8650040	289	2	feb;5(2	feb;5(2	ADP
bjos-8650040	289	3	suppl	suppl	PROPN
bjos-8650040	289	4	1):13	1):13	PROPN
bjos-8650040	289	5	-	-	SYM
bjos-8650040	289	6	21	21	NUM
bjos-8650040	289	7	.	.	PUNCT
bjos-8650040	290	1	10	10	NUM
bjos-8650040	290	2	.	.	PUNCT
bjos-8650040	290	3	rubenstein	rubenstein	PROPN
bjos-8650040	290	4	eb	eb	PROPN
bjos-8650040	290	5	,	,	PUNCT
bjos-8650040	290	6	peterson	peterson	PROPN
bjos-8650040	290	7	de	de	PROPN
bjos-8650040	290	8	,	,	PUNCT
bjos-8650040	290	9	schubert	schubert	PROPN
bjos-8650040	290	10	m	m	PROPN
bjos-8650040	290	11	,	,	PUNCT
bjos-8650040	290	12	keefe	keefe	PROPN
bjos-8650040	290	13	d	d	PROPN
bjos-8650040	290	14	,	,	PUNCT
bjos-8650040	290	15	mcguire	mcguire	PROPN
bjos-8650040	290	16	d	d	PROPN
bjos-8650040	290	17	,	,	PUNCT
bjos-8650040	290	18	epstein	epstein	PROPN
bjos-8650040	290	19	j	j	PROPN
bjos-8650040	290	20	,	,	PUNCT
bjos-8650040	290	21	elting	elte	VERB
bjos-8650040	290	22	ls	ls	PROPN
bjos-8650040	290	23	,	,	PUNCT
bjos-8650040	290	24	fox	fox	PROPN
bjos-8650040	290	25	pc	pc	NOUN
bjos-8650040	290	26	,	,	PUNCT
bjos-8650040	290	27	cooksley	cooksley	NOUN
bjos-8650040	290	28	c	c	PROPN
bjos-8650040	290	29	,	,	PUNCT
bjos-8650040	290	30	sonis	sonis	PROPN
bjos-8650040	290	31	st	st	PROPN
bjos-8650040	290	32	;	;	PUNCT
bjos-8650040	290	33	mucositis	mucositis	NOUN
bjos-8650040	290	34	study	study	NOUN
bjos-8650040	290	35	section	section	NOUN
bjos-8650040	290	36	of	of	ADP
bjos-8650040	290	37	the	the	DET
bjos-8650040	290	38	multinational	multinational	ADJ
bjos-8650040	290	39	association	association	NOUN
bjos-8650040	290	40	for	for	ADP
bjos-8650040	290	41	supportive	supportive	ADJ
bjos-8650040	290	42	care	care	NOUN
bjos-8650040	290	43	in	in	ADP
bjos-8650040	290	44	cancer	cancer	NOUN
bjos-8650040	290	45	;	;	PUNCT
bjos-8650040	290	46	international	international	ADJ
bjos-8650040	290	47	society	society	NOUN
bjos-8650040	290	48	for	for	ADP
bjos-8650040	290	49	oral	oral	ADJ
bjos-8650040	290	50	oncology	oncology	NOUN
bjos-8650040	290	51	.	.	PUNCT
bjos-8650040	291	1	clinical	clinical	ADJ
bjos-8650040	291	2	practice	practice	NOUN
bjos-8650040	291	3	guidelines	guideline	NOUN
bjos-8650040	291	4	for	for	ADP
bjos-8650040	291	5	the	the	DET
bjos-8650040	291	6	prevention	prevention	NOUN
bjos-8650040	291	7	and	and	CCONJ
bjos-8650040	291	8	treatment	treatment	NOUN
bjos-8650040	291	9	of	of	ADP
bjos-8650040	291	10	cancer	cancer	NOUN
bjos-8650040	291	11	therapy	therapy	NOUN
bjos-8650040	291	12	-	-	PUNCT
bjos-8650040	291	13	induced	induce	VERB
bjos-8650040	291	14	oral	oral	ADJ
bjos-8650040	291	15	and	and	CCONJ
bjos-8650040	291	16	gastrointestinal	gastrointestinal	ADJ
bjos-8650040	291	17	mucositis	mucositis	PROPN
bjos-8650040	291	18	.	.	PUNCT
bjos-8650040	292	1	cancer	cancer	NOUN
bjos-8650040	292	2	.	.	PUNCT
bjos-8650040	293	1	2004	2004	NUM
bjos-8650040	293	2	may	may	AUX
bjos-8650040	293	3	1;100(9	1;100(9	NUM
bjos-8650040	293	4	suppl):2026	suppl):2026	PROPN
bjos-8650040	293	5	-	-	PUNCT
bjos-8650040	293	6	46	46	NUM
bjos-8650040	293	7	.	.	PUNCT
bjos-8650040	293	8	11	11	NUM
bjos-8650040	293	9	.	.	PUNCT
bjos-8650040	294	1	sonis	sonis	PROPN
bjos-8650040	294	2	st	st	PROPN
bjos-8650040	294	3	,	,	PUNCT
bjos-8650040	294	4	o’donnell	o’donnell	PROPN
bjos-8650040	294	5	ke	ke	NOUN
bjos-8650040	294	6	,	,	PUNCT
bjos-8650040	294	7	popat	popat	NOUN
bjos-8650040	294	8	r	r	NOUN
bjos-8650040	294	9	,	,	PUNCT
bjos-8650040	294	10	bragdon	bragdon	ADJ
bjos-8650040	294	11	c	c	NOUN
bjos-8650040	294	12	,	,	PUNCT
bjos-8650040	294	13	phelan	phelan	PROPN
bjos-8650040	294	14	s	s	PART
bjos-8650040	294	15	,	,	PUNCT
bjos-8650040	294	16	cocks	cock	NOUN
bjos-8650040	294	17	d	d	NOUN
bjos-8650040	294	18	,	,	PUNCT
bjos-8650040	294	19	et	et	PROPN
bjos-8650040	294	20	al	al	PROPN
bjos-8650040	294	21	.	.	PUNCT
bjos-8650040	295	1	the	the	DET
bjos-8650040	295	2	relationship	relationship	NOUN
bjos-8650040	295	3	between	between	ADP
bjos-8650040	295	4	mucosal	mucosal	NOUN
bjos-8650040	295	5	cyclooxygenase-2	cyclooxygenase-2	NUM
bjos-8650040	295	6	(	(	PUNCT
bjos-8650040	295	7	cox-2	cox-2	NOUN
bjos-8650040	295	8	)	)	PUNCT
bjos-8650040	295	9	expression	expression	NOUN
bjos-8650040	295	10	and	and	CCONJ
bjos-8650040	295	11	experimental	experimental	ADJ
bjos-8650040	295	12	radiation	radiation	NOUN
bjos-8650040	295	13	-	-	PUNCT
bjos-8650040	295	14	induced	induce	VERB
bjos-8650040	295	15	mucositis	mucositis	NOUN
bjos-8650040	295	16	.	.	PUNCT
bjos-8650040	296	1	oral	oral	ADJ
bjos-8650040	296	2	oncol	oncol	ADJ
bjos-8650040	296	3	.	.	PUNCT
bjos-8650040	297	1	2004	2004	NUM
bjos-8650040	297	2	feb;40(2):170	feb;40(2):170	PROPN
bjos-8650040	297	3	-	-	PUNCT
bjos-8650040	297	4	6	6	NUM
bjos-8650040	297	5	.	.	NOUN
bjos-8650040	297	6	12	12	NUM
bjos-8650040	297	7	.	.	PUNCT
bjos-8650040	298	1	dorr	dorr	PROPN
bjos-8650040	298	2	w	w	PROPN
bjos-8650040	298	3	,	,	PUNCT
bjos-8650040	298	4	hamilton	hamilton	PROPN
bjos-8650040	298	5	cs	cs	PROPN
bjos-8650040	298	6	,	,	PUNCT
bjos-8650040	298	7	boyd	boyd	PROPN
bjos-8650040	298	8	t	t	PROPN
bjos-8650040	298	9	,	,	PUNCT
bjos-8650040	298	10	reed	reed	PROPN
bjos-8650040	298	11	b	b	PROPN
bjos-8650040	298	12	,	,	PUNCT
bjos-8650040	298	13	denham	denham	PROPN
bjos-8650040	298	14	jw	jw	PROPN
bjos-8650040	298	15	.	.	PUNCT
bjos-8650040	298	16	radiation	radiation	NOUN
bjos-8650040	298	17	-	-	PUNCT
bjos-8650040	298	18	induced	induce	VERB
bjos-8650040	298	19	changes	change	NOUN
bjos-8650040	298	20	in	in	ADP
bjos-8650040	298	21	cellularity	cellularity	NOUN
bjos-8650040	298	22	and	and	CCONJ
bjos-8650040	298	23	proliferation	proliferation	NOUN
bjos-8650040	298	24	in	in	ADP
bjos-8650040	298	25	human	human	ADJ
bjos-8650040	298	26	oral	oral	ADJ
bjos-8650040	298	27	mucosa	mucosa	NOUN
bjos-8650040	298	28	.	.	PUNCT
bjos-8650040	299	1	int	int	PROPN
bjos-8650040	299	2	j	j	PROPN
bjos-8650040	299	3	radiat	radiat	PROPN
bjos-8650040	299	4	oncol	oncol	ADJ
bjos-8650040	299	5	biol	biol	PROPN
bjos-8650040	299	6	phys	phy	NOUN
bjos-8650040	299	7	.	.	PUNCT
bjos-8650040	300	1	2002	2002	NUM
bjos-8650040	301	1	mar;52(4):911	mar;52(4):911	NOUN
bjos-8650040	301	2	-	-	SYM
bjos-8650040	301	3	7	7	NUM
bjos-8650040	301	4	.	.	NOUN
bjos-8650040	301	5	13	13	NUM
bjos-8650040	301	6	.	.	PUNCT
bjos-8650040	302	1	sonis	sonis	PROPN
bjos-8650040	302	2	st	st	PROPN
bjos-8650040	302	3	.	.	PROPN
bjos-8650040	303	1	the	the	DET
bjos-8650040	303	2	biologic	biologic	ADJ
bjos-8650040	303	3	role	role	NOUN
bjos-8650040	303	4	for	for	ADP
bjos-8650040	303	5	nuclear	nuclear	ADJ
bjos-8650040	303	6	factor	factor	NOUN
bjos-8650040	303	7	-	-	PUNCT
bjos-8650040	303	8	kappab	kappab	NOUN
bjos-8650040	303	9	in	in	ADP
bjos-8650040	303	10	disease	disease	NOUN
bjos-8650040	303	11	and	and	CCONJ
bjos-8650040	303	12	its	its	PRON
bjos-8650040	303	13	potential	potential	ADJ
bjos-8650040	303	14	involvement	involvement	NOUN
bjos-8650040	303	15	in	in	ADP
bjos-8650040	303	16	mucosal	mucosal	NOUN
bjos-8650040	303	17	injury	injury	NOUN
bjos-8650040	303	18	associated	associate	VERB
bjos-8650040	303	19	with	with	ADP
bjos-8650040	303	20	anti	anti	ADJ
bjos-8650040	303	21	-	-	ADJ
bjos-8650040	303	22	neoplastic	neoplastic	ADJ
bjos-8650040	303	23	therapy	therapy	NOUN
bjos-8650040	303	24	.	.	PUNCT
bjos-8650040	304	1	crit	crit	PROPN
bjos-8650040	304	2	rev	rev	PROPN
bjos-8650040	304	3	oral	oral	ADJ
bjos-8650040	304	4	biol	biol	PROPN
bjos-8650040	304	5	med	me	VERB
bjos-8650040	304	6	.	.	PUNCT
bjos-8650040	305	1	2002;13(5):380	2002;13(5):380	NUM
bjos-8650040	305	2	-	-	SYM
bjos-8650040	305	3	9	9	NUM
bjos-8650040	305	4	.	.	NOUN
bjos-8650040	305	5	14	14	NUM
bjos-8650040	305	6	.	.	PUNCT
bjos-8650040	306	1	sonis	sonis	PROPN
bjos-8650040	306	2	st	st	PROPN
bjos-8650040	306	3	.	.	PROPN
bjos-8650040	306	4	pathobiology	pathobiology	NOUN
bjos-8650040	306	5	of	of	ADP
bjos-8650040	306	6	oral	oral	ADJ
bjos-8650040	306	7	mucositis	mucositis	NOUN
bjos-8650040	306	8	:	:	PUNCT
bjos-8650040	306	9	novel	novel	ADJ
bjos-8650040	306	10	insights	insight	NOUN
bjos-8650040	306	11	and	and	CCONJ
bjos-8650040	306	12	opportunities	opportunity	NOUN
bjos-8650040	306	13	.	.	PUNCT
bjos-8650040	307	1	j	j	PROPN
bjos-8650040	307	2	support	support	PROPN
bjos-8650040	307	3	oncol	oncol	PROPN
bjos-8650040	307	4	.	.	PUNCT
bjos-8650040	308	1	2007	2007	NUM
bjos-8650040	308	2	oct;5(9	oct;5(9	X
bjos-8650040	308	3	suppl	suppl	PROPN
bjos-8650040	308	4	4):3	4):3	PROPN
bjos-8650040	308	5	-	-	PROPN
bjos-8650040	308	6	11	11	NUM
bjos-8650040	308	7	.	.	PUNCT
bjos-8650040	309	1	15	15	NUM
bjos-8650040	309	2	.	.	PUNCT
bjos-8650040	310	1	yeoh	yeoh	PROPN
bjos-8650040	310	2	asj	asj	PROPN
bjos-8650040	310	3	,	,	PUNCT
bjos-8650040	310	4	bowen	bowen	PROPN
bjos-8650040	310	5	jm	jm	PROPN
bjos-8650040	310	6	,	,	PUNCT
bjos-8650040	310	7	gibson	gibson	PROPN
bjos-8650040	310	8	rj	rj	PROPN
bjos-8650040	310	9	,	,	PUNCT
bjos-8650040	310	10	keefe	keefe	PROPN
bjos-8650040	310	11	dm	dm	PROPN
bjos-8650040	310	12	.	.	PUNCT
bjos-8650040	310	13	nuclear	nuclear	ADJ
bjos-8650040	310	14	factor	factor	NOUN
bjos-8650040	310	15	κb	κb	PROPN
bjos-8650040	310	16	(	(	PUNCT
bjos-8650040	310	17	nfκb	nfκb	PROPN
bjos-8650040	310	18	)	)	PUNCT
bjos-8650040	310	19	and	and	CCONJ
bjos-8650040	310	20	cyclooxygenase-2	cyclooxygenase-2	NUM
bjos-8650040	310	21	(	(	PUNCT
bjos-8650040	310	22	cox-2	cox-2	NOUN
bjos-8650040	310	23	)	)	PUNCT
bjos-8650040	310	24	expression	expression	NOUN
bjos-8650040	310	25	in	in	ADP
bjos-8650040	310	26	the	the	DET
bjos-8650040	310	27	irradiated	irradiate	VERB
bjos-8650040	310	28	colorectum	colorectum	NOUN
bjos-8650040	310	29	is	be	AUX
bjos-8650040	310	30	associated	associate	VERB
bjos-8650040	310	31	with	with	ADP
bjos-8650040	310	32	subsequent	subsequent	ADJ
bjos-8650040	310	33	histopathological	histopathological	ADJ
bjos-8650040	310	34	changes	change	NOUN
bjos-8650040	310	35	.	.	PUNCT
bjos-8650040	311	1	int	int	NOUN
bjos-8650040	311	2	.	.	PUNCT
bjos-8650040	312	1	j.	j.	PROPN
bjos-8650040	312	2	radiation	radiation	PROPN
bjos-8650040	312	3	oncology	oncology	NOUN
bjos-8650040	312	4	biol	biol	PROPN
bjos-8650040	312	5	.	.	PUNCT
bjos-8650040	313	1	phys	phy	NOUN
bjos-8650040	313	2	.	.	PUNCT
bjos-8650040	314	1	2005	2005	NUM
bjos-8650040	314	2	dec;63(5):1295	dec;63(5):1295	PROPN
bjos-8650040	314	3	-	-	PUNCT
bjos-8650040	314	4	303	303	NUM
bjos-8650040	314	5	.	.	PUNCT
bjos-8650040	315	1	16	16	NUM
bjos-8650040	315	2	.	.	PUNCT
bjos-8650040	316	1	satheesh	satheesh	PROPN
bjos-8650040	316	2	kumar	kumar	PROPN
bjos-8650040	316	3	ps	ps	PROPN
bjos-8650040	316	4	.	.	PROPN
bjos-8650040	316	5	radiation	radiation	NOUN
bjos-8650040	316	6	mucositis	mucositis	PROPN
bjos-8650040	316	7	.	.	PUNCT
bjos-8650040	317	1	in	in	ADP
bjos-8650040	317	2	:	:	PUNCT
bjos-8650040	317	3	racz	racz	NOUN
bjos-8650040	317	4	gb	gb	ADP
bjos-8650040	317	5	,	,	PUNCT
bjos-8650040	317	6	noe	noe	PROPN
bjos-8650040	317	7	ce	ce	PROPN
bjos-8650040	317	8	,	,	PUNCT
bjos-8650040	317	9	editors	editor	NOUN
bjos-8650040	317	10	.	.	PUNCT
bjos-8650040	318	1	pain	pain	NOUN
bjos-8650040	318	2	management	management	NOUN
bjos-8650040	318	3	current	current	ADJ
bjos-8650040	318	4	issues	issue	NOUN
bjos-8650040	318	5	and	and	CCONJ
bjos-8650040	318	6	opinions	opinion	NOUN
bjos-8650040	318	7	.	.	PUNCT
bjos-8650040	319	1	intech	intech	PROPN
bjos-8650040	319	2	.	.	PUNCT
bjos-8650040	320	1	chapter	chapter	NOUN
bjos-8650040	320	2	22	22	NUM
bjos-8650040	320	3	.	.	PUNCT
bjos-8650040	321	1	isbn	isbn	NOUN
bjos-8650040	321	2	:	:	PUNCT
bjos-8650040	321	3	2012.978	2012.978	NUM
bjos-8650040	321	4	-	-	SYM
bjos-8650040	321	5	953	953	NUM
bjos-8650040	321	6	-	-	PUNCT
bjos-8650040	321	7	307	307	NUM
bjos-8650040	321	8	-	-	PUNCT
bjos-8650040	321	9	813	813	NUM
bjos-8650040	321	10	-	-	SYM
bjos-8650040	321	11	7	7	NUM
bjos-8650040	321	12	.	.	PUNCT
bjos-8650040	321	13	available	available	ADJ
bjos-8650040	321	14	from	from	ADP
bjos-8650040	321	15	:	:	PUNCT
bjos-8650040	321	16	https://www.intechopen	https://www.intechopen	PROPN
bjos-8650040	321	17	.	.	PUNCT
bjos-8650040	321	18	com	com	NOUN
bjos-8650040	321	19	/	/	SYM
bjos-8650040	321	20	books	book	NOUN
bjos-8650040	321	21	/	/	SYM
bjos-8650040	321	22	pain	pain	NOUN
bjos-8650040	321	23	-	-	PUNCT
bjos-8650040	321	24	management	management	NOUN
bjos-8650040	321	25	-	-	PUNCT
bjos-8650040	321	26	current	current	ADJ
bjos-8650040	321	27	-	-	PUNCT
bjos-8650040	321	28	issues	issue	NOUN
bjos-8650040	321	29	-	-	PUNCT
bjos-8650040	321	30	and	and	CCONJ
bjos-8650040	321	31	-	-	PUNCT
bjos-8650040	321	32	opinions	opinion	NOUN
bjos-8650040	321	33	/	/	SYM
bjos-8650040	321	34	radiationmucositis	radiationmucositis	NOUN
bjos-8650040	321	35	.	.	PUNCT
bjos-8650040	322	1	17	17	NUM
bjos-8650040	322	2	.	.	PUNCT
bjos-8650040	322	3	logan	logan	PROPN
bjos-8650040	322	4	rm	rm	PROPN
bjos-8650040	322	5	,	,	PUNCT
bjos-8650040	322	6	gibson	gibson	PROPN
bjos-8650040	322	7	rj	rj	PROPN
bjos-8650040	322	8	,	,	PUNCT
bjos-8650040	322	9	sonis	sonis	PROPN
bjos-8650040	322	10	st	st	PROPN
bjos-8650040	322	11	,	,	PUNCT
bjos-8650040	322	12	keefe	keefe	PROPN
bjos-8650040	322	13	dm	dm	PROPN
bjos-8650040	322	14	.	.	PUNCT
bjos-8650040	322	15	nuclear	nuclear	ADJ
bjos-8650040	322	16	factor	factor	NOUN
bjos-8650040	322	17	-	-	PUNCT
bjos-8650040	322	18	κappab	κappab	NOUN
bjos-8650040	322	19	(	(	PUNCT
bjos-8650040	322	20	nfkappab	nfkappab	NOUN
bjos-8650040	322	21	)	)	PUNCT
bjos-8650040	322	22	and	and	CCONJ
bjos-8650040	322	23	cyclooxygenase-2	cyclooxygenase-2	NUM
bjos-8650040	322	24	(	(	PUNCT
bjos-8650040	322	25	cox-2	cox-2	NOUN
bjos-8650040	322	26	)	)	PUNCT
bjos-8650040	322	27	expression	expression	NOUN
bjos-8650040	322	28	in	in	ADP
bjos-8650040	322	29	the	the	DET
bjos-8650040	322	30	oral	oral	ADJ
bjos-8650040	322	31	mucosa	mucosa	NOUN
bjos-8650040	322	32	following	follow	VERB
bjos-8650040	322	33	cancer	cancer	NOUN
bjos-8650040	322	34	chemotherapy	chemotherapy	NOUN
bjos-8650040	322	35	.	.	PUNCT
bjos-8650040	323	1	oral	oral	ADJ
bjos-8650040	323	2	oncol	oncol	ADJ
bjos-8650040	323	3	.	.	PUNCT
bjos-8650040	324	1	2007	2007	NUM
bjos-8650040	324	2	apr;43(4):395	apr;43(4):395	NUM
bjos-8650040	324	3	-	-	SYM
bjos-8650040	324	4	401	401	NUM
bjos-8650040	324	5	.	.	PUNCT
bjos-8650040	325	1	18	18	NUM
bjos-8650040	325	2	.	.	PUNCT
bjos-8650040	326	1	sultani	sultani	PROPN
bjos-8650040	326	2	m	m	PROPN
bjos-8650040	326	3	,	,	PUNCT
bjos-8650040	326	4	stringer	stringer	PROPN
bjos-8650040	326	5	am	am	PROPN
bjos-8650040	326	6	,	,	PUNCT
bjos-8650040	326	7	bowen	bowen	PROPN
bjos-8650040	326	8	jm	jm	PROPN
bjos-8650040	326	9	,	,	PUNCT
bjos-8650040	326	10	gibson	gibson	PROPN
bjos-8650040	326	11	rj	rj	PROPN
bjos-8650040	326	12	.	.	PUNCT
bjos-8650040	327	1	anti	anti	ADJ
bjos-8650040	327	2	-	-	ADJ
bjos-8650040	327	3	inflammatory	inflammatory	ADJ
bjos-8650040	327	4	cytokines	cytokine	NOUN
bjos-8650040	327	5	:	:	PUNCT
bjos-8650040	327	6	important	important	ADJ
bjos-8650040	327	7	immunoregulatory	immunoregulatory	ADJ
bjos-8650040	327	8	factors	factor	NOUN
bjos-8650040	327	9	contributing	contribute	VERB
bjos-8650040	327	10	to	to	ADP
bjos-8650040	327	11	chemotherapy	chemotherapy	NOUN
bjos-8650040	327	12	-	-	PUNCT
bjos-8650040	327	13	induced	induce	VERB
bjos-8650040	327	14	gastrointestinal	gastrointestinal	ADJ
bjos-8650040	327	15	mucositis	mucositis	NOUN
bjos-8650040	327	16	.	.	PUNCT
bjos-8650040	328	1	chemother	chemother	PROPN
bjos-8650040	328	2	res	re	NOUN
bjos-8650040	328	3	pract	pract	PROPN
bjos-8650040	328	4	.	.	PUNCT
bjos-8650040	329	1	2012;2012:490804	2012;2012:490804	NUM
bjos-8650040	329	2	.	.	PUNCT
bjos-8650040	330	1	doi	doi	NOUN
bjos-8650040	330	2	:	:	PUNCT
bjos-8650040	330	3	10.1155/2012/490804	10.1155/2012/490804	NUM
bjos-8650040	330	4	.	.	PUNCT
bjos-8650040	331	1	19	19	NUM
bjos-8650040	331	2	.	.	PUNCT
bjos-8650040	331	3	yeoh	yeoh	PROPN
bjos-8650040	331	4	a	a	PRON
bjos-8650040	331	5	,	,	PUNCT
bjos-8650040	331	6	gibson	gibson	PROPN
bjos-8650040	331	7	r	r	PROPN
bjos-8650040	331	8	,	,	PUNCT
bjos-8650040	331	9	yeoh	yeoh	PROPN
bjos-8650040	331	10	e	e	PROPN
bjos-8650040	331	11	,	,	PUNCT
bjos-8650040	331	12	bowen	bowen	PROPN
bjos-8650040	331	13	j	j	PROPN
bjos-8650040	331	14	,	,	PUNCT
bjos-8650040	331	15	stringer	stringer	PROPN
bjos-8650040	331	16	a	a	PRON
bjos-8650040	331	17	,	,	PUNCT
bjos-8650040	331	18	giam	giam	PROPN
bjos-8650040	331	19	k	k	PROPN
bjos-8650040	331	20	,	,	PUNCT
bjos-8650040	331	21	et	et	PROPN
bjos-8650040	331	22	al	al	PROPN
bjos-8650040	331	23	.	.	PUNCT
bjos-8650040	332	1	radiation	radiation	NOUN
bjos-8650040	332	2	therapy	therapy	NOUN
bjos-8650040	332	3	-	-	PUNCT
bjos-8650040	332	4	induced	induce	VERB
bjos-8650040	332	5	mucositis	mucositis	NOUN
bjos-8650040	332	6	:	:	PUNCT
bjos-8650040	332	7	relationships	relationship	NOUN
bjos-8650040	332	8	between	between	ADP
bjos-8650040	332	9	fractionated	fractionated	ADJ
bjos-8650040	332	10	radiation	radiation	NOUN
bjos-8650040	332	11	,	,	PUNCT
bjos-8650040	332	12	nf	nf	NOUN
bjos-8650040	332	13	-	-	PUNCT
bjos-8650040	332	14	κb	κb	NOUN
bjos-8650040	332	15	,	,	PUNCT
bjos-8650040	332	16	cox-1	cox-1	X
bjos-8650040	332	17	,	,	PUNCT
bjos-8650040	332	18	and	and	CCONJ
bjos-8650040	332	19	cox-2	cox-2	NOUN
bjos-8650040	332	20	.	.	PUNCT
bjos-8650040	333	1	cancer	cancer	NOUN
bjos-8650040	333	2	treat	treat	NOUN
bjos-8650040	333	3	rev	rev	VERB
bjos-8650040	333	4	.	.	PROPN
bjos-8650040	333	5	2006	2006	NUM
bjos-8650040	333	6	dec;32(8):645	dec;32(8):645	PROPN
bjos-8650040	333	7	-	-	SYM
bjos-8650040	333	8	51	51	NUM
bjos-8650040	333	9	.	.	NOUN
bjos-8650040	333	10	20	20	NUM
bjos-8650040	333	11	.	.	PUNCT
bjos-8650040	334	1	brach	brach	PROPN
bjos-8650040	334	2	ma	ma	PROPN
bjos-8650040	334	3	,	,	PUNCT
bjos-8650040	334	4	hass	hass	VERB
bjos-8650040	334	5	r	r	PROPN
bjos-8650040	334	6	,	,	PUNCT
bjos-8650040	334	7	sherman	sherman	NOUN
bjos-8650040	334	8	ml	ml	PROPN
bjos-8650040	334	9	,	,	PUNCT
bjos-8650040	334	10	gunji	gunji	PROPN
bjos-8650040	334	11	h	h	PROPN
bjos-8650040	334	12	,	,	PUNCT
bjos-8650040	334	13	weichselbaum	weichselbaum	PROPN
bjos-8650040	334	14	r	r	PROPN
bjos-8650040	334	15	,	,	PUNCT
bjos-8650040	334	16	kufe	kufe	PROPN
bjos-8650040	334	17	d.	d.	PROPN
bjos-8650040	334	18	ionizing	ionize	VERB
bjos-8650040	334	19	radiation	radiation	NOUN
bjos-8650040	334	20	induces	induce	VERB
bjos-8650040	334	21	expression	expression	NOUN
bjos-8650040	334	22	and	and	CCONJ
bjos-8650040	334	23	binding	bind	VERB
bjos-8650040	334	24	activity	activity	NOUN
bjos-8650040	334	25	of	of	ADP
bjos-8650040	334	26	the	the	DET
bjos-8650040	334	27	nuclear	nuclear	ADJ
bjos-8650040	334	28	factor	factor	NOUN
bjos-8650040	334	29	,	,	PUNCT
bjos-8650040	335	1	kappa	kappa	PROPN
bjos-8650040	335	2	b.	b.	PROPN
bjos-8650040	336	1	j	j	PROPN
bjos-8650040	336	2	clin	clin	PROPN
bjos-8650040	336	3	invest	invest	PROPN
bjos-8650040	336	4	.	.	PUNCT
bjos-8650040	337	1	1991	1991	NUM
bjos-8650040	337	2	aug;88(2):691	aug;88(2):691	NOUN
bjos-8650040	337	3	-	-	PUNCT
bjos-8650040	337	4	5	5	NUM
bjos-8650040	337	5	.	.	NUM
bjos-8650040	337	6	21	21	NUM
bjos-8650040	337	7	.	.	PUNCT
bjos-8650040	338	1	lee	lee	PROPN
bjos-8650040	338	2	sj	sj	PROPN
bjos-8650040	338	3	,	,	PUNCT
bjos-8650040	338	4	dimtchev	dimtchev	NOUN
bjos-8650040	338	5	a	a	PRON
bjos-8650040	338	6	,	,	PUNCT
bjos-8650040	338	7	lavin	lavin	PROPN
bjos-8650040	338	8	mf	mf	NOUN
bjos-8650040	338	9	,	,	PUNCT
bjos-8650040	338	10	dritschilo	dritschilo	VERB
bjos-8650040	338	11	a	a	DET
bjos-8650040	338	12	,	,	PUNCT
bjos-8650040	338	13	jung	jung	PROPN
bjos-8650040	338	14	m.	m.	NOUN
bjos-8650040	338	15	a	a	DET
bjos-8650040	338	16	novel	novel	ADJ
bjos-8650040	338	17	ionizing	ionize	VERB
bjos-8650040	338	18	radiation	radiation	NOUN
bjos-8650040	338	19	-	-	PUNCT
bjos-8650040	338	20	induced	induce	VERB
bjos-8650040	338	21	signaling	signal	VERB
bjos-8650040	338	22	pathway	pathway	NOUN
bjos-8650040	338	23	that	that	PRON
bjos-8650040	338	24	activates	activate	VERB
bjos-8650040	338	25	the	the	DET
bjos-8650040	338	26	transcription	transcription	NOUN
bjos-8650040	338	27	factor	factor	NOUN
bjos-8650040	338	28	nf	nf	NOUN
bjos-8650040	338	29	-	-	PUNCT
bjos-8650040	338	30	kappab	kappab	NOUN
bjos-8650040	338	31	.	.	PUNCT
bjos-8650040	339	1	oncogene	oncogene	NOUN
bjos-8650040	339	2	.	.	PUNCT
bjos-8650040	340	1	1998	1998	NUM
bjos-8650040	340	2	oct;17(14):1821	oct;17(14):1821	NOUN
bjos-8650040	340	3	-	-	PUNCT
bjos-8650040	340	4	6	6	NUM
bjos-8650040	340	5	.	.	NOUN
bjos-8650040	341	1	22	22	NUM
bjos-8650040	341	2	.	.	PUNCT
bjos-8650040	342	1	ong	ong	INTJ
bjos-8650040	342	2	zy	zy	PROPN
bjos-8650040	342	3	,	,	PUNCT
bjos-8650040	342	4	gibson	gibson	PROPN
bjos-8650040	342	5	j	j	PROPN
bjos-8650040	342	6	,	,	PUNCT
bjos-8650040	342	7	bowen	bowen	PROPN
bjos-8650040	342	8	jm	jm	PROPN
bjos-8650040	342	9	,	,	PUNCT
bjos-8650040	342	10	stringer	stringer	PROPN
bjos-8650040	342	11	am	am	PROPN
bjos-8650040	342	12	,	,	PUNCT
bjos-8650040	342	13	darbyjm	darbyjm	ADJ
bjos-8650040	342	14	,	,	PUNCT
bjos-8650040	342	15	logan	logan	PROPN
bjos-8650040	342	16	rm	rm	PROPN
bjos-8650040	342	17	,	,	PUNCT
bjos-8650040	342	18	et	et	PROPN
bjos-8650040	342	19	al	al	PROPN
bjos-8650040	342	20	.	.	PUNCT
bjos-8650040	343	1	pro	pro	ADJ
bjos-8650040	343	2	-	-	ADJ
bjos-8650040	343	3	inflammatory	inflammatory	ADJ
bjos-8650040	343	4	cytokines	cytokine	NOUN
bjos-8650040	343	5	play	play	VERB
bjos-8650040	343	6	a	a	DET
bjos-8650040	343	7	key	key	ADJ
bjos-8650040	343	8	role	role	NOUN
bjos-8650040	343	9	in	in	ADP
bjos-8650040	343	10	the	the	DET
bjos-8650040	343	11	development	development	NOUN
bjos-8650040	343	12	of	of	ADP
bjos-8650040	343	13	radiotherapy	radiotherapy	NOUN
bjos-8650040	343	14	-	-	PUNCT
bjos-8650040	343	15	induced	induce	VERB
bjos-8650040	343	16	gastrointestinal	gastrointestinal	ADJ
bjos-8650040	343	17	mucositis	mucositis	PROPN
bjos-8650040	343	18	.	.	PUNCT
bjos-8650040	344	1	radiat	radiat	PROPN
bjos-8650040	344	2	oncol	oncol	PROPN
bjos-8650040	344	3	.	.	PUNCT
bjos-8650040	345	1	2010	2010	NUM
bjos-8650040	345	2	mar;5:22	mar;5:22	NOUN
bjos-8650040	345	3	.	.	PUNCT
bjos-8650040	345	4	doi	doi	NOUN
bjos-8650040	345	5	:	:	PUNCT
bjos-8650040	345	6	10.1186/1748	10.1186/1748	NUM
bjos-8650040	345	7	-	-	PUNCT
bjos-8650040	345	8	717x-5	717x-5	NUM
bjos-8650040	345	9	-	-	PUNCT
bjos-8650040	345	10	22	22	NUM
bjos-8650040	345	11	.	.	PUNCT
bjos-8650040	346	1	23	23	NUM
bjos-8650040	346	2	.	.	PUNCT
bjos-8650040	347	1	sonis	sonis	PROPN
bjos-8650040	347	2	st	st	PROPN
bjos-8650040	347	3	.	.	PROPN
bjos-8650040	347	4	mucositis	mucositis	PROPN
bjos-8650040	347	5	as	as	ADP
bjos-8650040	347	6	a	a	DET
bjos-8650040	347	7	biological	biological	ADJ
bjos-8650040	347	8	process	process	NOUN
bjos-8650040	347	9	:	:	PUNCT
bjos-8650040	347	10	a	a	DET
bjos-8650040	347	11	new	new	ADJ
bjos-8650040	347	12	hypothesis	hypothesis	NOUN
bjos-8650040	347	13	for	for	ADP
bjos-8650040	347	14	the	the	DET
bjos-8650040	347	15	development	development	NOUN
bjos-8650040	347	16	of	of	ADP
bjos-8650040	347	17	chemotherapy	chemotherapy	NOUN
bjos-8650040	347	18	-	-	PUNCT
bjos-8650040	347	19	induced	induce	VERB
bjos-8650040	347	20	stomatotoxicity	stomatotoxicity	NOUN
bjos-8650040	347	21	.	.	PUNCT
bjos-8650040	348	1	oral	oral	ADJ
bjos-8650040	348	2	oncol	oncol	ADJ
bjos-8650040	348	3	.	.	PUNCT
bjos-8650040	349	1	1998	1998	NUM
bjos-8650040	349	2	jan;34(1):39	jan;34(1):39	PROPN
bjos-8650040	349	3	-	-	PUNCT
bjos-8650040	349	4	43	43	NUM
bjos-8650040	349	5	.	.	PUNCT
bjos-8650040	350	1	24	24	NUM
bjos-8650040	350	2	.	.	PUNCT
bjos-8650040	350	3	logan	logan	PROPN
bjos-8650040	350	4	rm	rm	PROPN
bjos-8650040	350	5	,	,	PUNCT
bjos-8650040	350	6	stringer	stringer	PROPN
bjos-8650040	350	7	am	am	PROPN
bjos-8650040	350	8	,	,	PUNCT
bjos-8650040	350	9	bowen	bowen	PROPN
bjos-8650040	350	10	jm	jm	PROPN
bjos-8650040	350	11	,	,	PUNCT
bjos-8650040	350	12	gibson	gibson	PROPN
bjos-8650040	350	13	rj	rj	PROPN
bjos-8650040	350	14	,	,	PUNCT
bjos-8650040	350	15	sonis	sonis	PROPN
bjos-8650040	350	16	st	st	PROPN
bjos-8650040	350	17	,	,	PUNCT
bjos-8650040	350	18	keefe	keefe	PROPN
bjos-8650040	350	19	dm	dm	PROPN
bjos-8650040	350	20	.	.	PROPN
bjos-8650040	350	21	serum	serum	PROPN
bjos-8650040	350	22	levels	level	NOUN
bjos-8650040	350	23	of	of	ADP
bjos-8650040	350	24	nfkappab	nfkappab	NOUN
bjos-8650040	350	25	and	and	CCONJ
bjos-8650040	350	26	pro	pro	ADJ
bjos-8650040	350	27	-	-	ADJ
bjos-8650040	350	28	inflammatory	inflammatory	ADJ
bjos-8650040	350	29	cytokines	cytokine	NOUN
bjos-8650040	350	30	following	follow	VERB
bjos-8650040	350	31	administration	administration	NOUN
bjos-8650040	350	32	of	of	ADP
bjos-8650040	350	33	mucotoxic	mucotoxic	ADJ
bjos-8650040	350	34	drugs	drug	NOUN
bjos-8650040	350	35	.	.	PUNCT
bjos-8650040	351	1	cancer	cancer	NOUN
bjos-8650040	351	2	biol	biol	PROPN
bjos-8650040	351	3	ther	ther	ADV
bjos-8650040	351	4	.	.	PUNCT
bjos-8650040	352	1	2008	2008	NUM
bjos-8650040	353	1	jul;7(7):113945	jul;7(7):113945	ADJ
bjos-8650040	353	2	.	.	PUNCT
bjos-8650040	354	1	25	25	NUM
bjos-8650040	354	2	.	.	PUNCT
bjos-8650040	355	1	kelly	kelly	PROPN
bjos-8650040	355	2	cp	cp	PROPN
bjos-8650040	355	3	,	,	PUNCT
bjos-8650040	355	4	keates	keates	PROPN
bjos-8650040	355	5	s	s	PART
bjos-8650040	355	6	,	,	PUNCT
bjos-8650040	355	7	siegenberg	siegenberg	PROPN
bjos-8650040	355	8	d	d	PROPN
bjos-8650040	355	9	,	,	PUNCT
bjos-8650040	355	10	linevsky	linevsky	PROPN
bjos-8650040	355	11	jk	jk	PROPN
bjos-8650040	355	12	,	,	PUNCT
bjos-8650040	355	13	pothoulakis	pothoulakis	PROPN
bjos-8650040	355	14	c	c	PROPN
bjos-8650040	355	15	,	,	PUNCT
bjos-8650040	355	16	brady	brady	PROPN
bjos-8650040	355	17	hr	hr	PROPN
bjos-8650040	355	18	.	.	PUNCT
bjos-8650040	355	19	il-8	il-8	PROPN
bjos-8650040	355	20	secretion	secretion	NOUN
bjos-8650040	355	21	and	and	CCONJ
bjos-8650040	355	22	neutrophil	neutrophil	ADJ
bjos-8650040	355	23	activation	activation	NOUN
bjos-8650040	355	24	by	by	ADP
bjos-8650040	355	25	ht-29	ht-29	PUNCT
bjos-8650040	355	26	colonic	colonic	ADJ
bjos-8650040	355	27	epithelial	epithelial	ADJ
bjos-8650040	355	28	cells	cell	NOUN
bjos-8650040	355	29	.	.	PUNCT
bjos-8650040	356	1	am	be	AUX
bjos-8650040	356	2	j	j	PROPN
bjos-8650040	356	3	physiol	physiol	PROPN
bjos-8650040	356	4	.	.	PUNCT
bjos-8650040	357	1	1994	1994	NUM
bjos-8650040	358	1	dec;267(6	dec;267(6	PROPN
bjos-8650040	358	2	pt	pt	NOUN
bjos-8650040	358	3	1):991	1):991	NUM
bjos-8650040	358	4	-	-	PUNCT
bjos-8650040	358	5	7	7	NUM
bjos-8650040	358	6	.	.	NOUN
bjos-8650040	358	7	26	26	NUM
bjos-8650040	358	8	.	.	PUNCT
bjos-8650040	359	1	campbell	campbell	PROPN
bjos-8650040	359	2	bj	bj	PROPN
bjos-8650040	359	3	,	,	PUNCT
bjos-8650040	359	4	yu	yu	PROPN
bjos-8650040	359	5	lg	lg	PROPN
bjos-8650040	359	6	,	,	PUNCT
bjos-8650040	359	7	rhodes	rhodes	PROPN
bjos-8650040	359	8	jm	jm	PROPN
bjos-8650040	359	9	.	.	PROPN
bjos-8650040	359	10	altered	altered	ADJ
bjos-8650040	359	11	glycosylation	glycosylation	NOUN
bjos-8650040	359	12	in	in	ADP
bjos-8650040	359	13	inflammatory	inflammatory	ADJ
bjos-8650040	359	14	bowel	bowel	NOUN
bjos-8650040	359	15	disease	disease	NOUN
bjos-8650040	359	16	:	:	PUNCT
bjos-8650040	359	17	a	a	DET
bjos-8650040	359	18	possible	possible	ADJ
bjos-8650040	359	19	role	role	NOUN
bjos-8650040	359	20	in	in	ADP
bjos-8650040	359	21	cancer	cancer	NOUN
bjos-8650040	359	22	development	development	NOUN
bjos-8650040	359	23	.	.	PUNCT
bjos-8650040	360	1	glycoconj	glycoconj	NOUN
bjos-8650040	360	2	.	.	PUNCT
bjos-8650040	361	1	2001	2001	NUM
bjos-8650040	361	2	nov	nov	PROPN
bjos-8650040	361	3	-	-	PUNCT
bjos-8650040	361	4	dec;18(11	dec;18(11	PROPN
bjos-8650040	361	5	-	-	PUNCT
bjos-8650040	361	6	12):851	12):851	NUM
bjos-8650040	361	7	-	-	PUNCT
bjos-8650040	361	8	8	8	NUM
bjos-8650040	361	9	.	.	NOUN
bjos-8650040	361	10	27	27	NUM
bjos-8650040	361	11	.	.	PUNCT
bjos-8650040	362	1	ikeda	ikeda	PROPN
bjos-8650040	362	2	y	y	PROPN
bjos-8650040	362	3	,	,	PUNCT
bjos-8650040	362	4	ito	ito	PROPN
bjos-8650040	362	5	m	m	PROPN
bjos-8650040	362	6	,	,	PUNCT
bjos-8650040	362	7	matsuu	matsuu	PROPN
bjos-8650040	362	8	m	m	PROPN
bjos-8650040	362	9	,	,	PUNCT
bjos-8650040	362	10	shichijo	shichijo	PROPN
bjos-8650040	362	11	k	k	PROPN
bjos-8650040	362	12	,	,	PUNCT
bjos-8650040	362	13	fukuda	fukuda	PROPN
bjos-8650040	362	14	e	e	PROPN
bjos-8650040	362	15	,	,	PUNCT
bjos-8650040	362	16	nakayama	nakayama	PROPN
bjos-8650040	362	17	t	t	PROPN
bjos-8650040	362	18	et	et	PROPN
bjos-8650040	362	19	al	al	PROPN
bjos-8650040	362	20	.	.	PROPN
bjos-8650040	362	21	,	,	PUNCT
bjos-8650040	362	22	expression	expression	NOUN
bjos-8650040	362	23	of	of	ADP
bjos-8650040	362	24	icam-1	icam-1	NUM
bjos-8650040	362	25	and	and	CCONJ
bjos-8650040	362	26	acute	acute	ADJ
bjos-8650040	362	27	inflammatory	inflammatory	ADJ
bjos-8650040	362	28	cell	cell	NOUN
bjos-8650040	362	29	infiltration	infiltration	NOUN
bjos-8650040	362	30	in	in	ADP
bjos-8650040	362	31	the	the	DET
bjos-8650040	362	32	early	early	ADJ
bjos-8650040	362	33	phase	phase	NOUN
bjos-8650040	362	34	of	of	ADP
bjos-8650040	362	35	radiation	radiation	NOUN
bjos-8650040	362	36	colitis	colitis	NOUN
bjos-8650040	362	37	in	in	ADP
bjos-8650040	362	38	rats	rat	NOUN
bjos-8650040	362	39	.	.	PUNCT
bjos-8650040	363	1	j	j	PROPN
bjos-8650040	363	2	radiat	radiat	PROPN
bjos-8650040	363	3	res	re	NOUN
bjos-8650040	363	4	.	.	PUNCT
bjos-8650040	363	5	2000	2000	NUM
bjos-8650040	363	6	sep;41(3):279	sep;41(3):279	PROPN
bjos-8650040	363	7	-	-	PUNCT
bjos-8650040	363	8	91	91	NUM
bjos-8650040	363	9	.	.	PUNCT
bjos-8650040	364	1	28	28	NUM
bjos-8650040	364	2	.	.	PUNCT
bjos-8650040	365	1	duncan	duncan	PROPN
bjos-8650040	365	2	m	m	PROPN
bjos-8650040	365	3	,	,	PUNCT
bjos-8650040	365	4	grant	grant	PROPN
bjos-8650040	365	5	g.	g.	PROPN
bjos-8650040	365	6	oral	oral	ADJ
bjos-8650040	365	7	and	and	CCONJ
bjos-8650040	365	8	intestinal	intestinal	ADJ
bjos-8650040	365	9	mu¬cositis	mu¬cositis	PROPN
bjos-8650040	365	10	—	—	PUNCT
bjos-8650040	365	11	causes	cause	NOUN
bjos-8650040	365	12	and	and	CCONJ
bjos-8650040	365	13	possible	possible	ADJ
bjos-8650040	365	14	treatments	treatment	NOUN
bjos-8650040	365	15	.	.	PUNCT
bjos-8650040	366	1	aliment	aliment	NOUN
bjos-8650040	366	2	pharmacol	pharmacol	VERB
bjos-8650040	366	3	ther	ther	ADV
bjos-8650040	366	4	.	.	PUNCT
bjos-8650040	367	1	2003	2003	NUM
bjos-8650040	367	2	nov;18(9):853	nov;18(9):853	NOUN
bjos-8650040	367	3	-	-	SYM
bjos-8650040	367	4	74	74	NUM
bjos-8650040	367	5	.	.	PUNCT
bjos-8650040	368	1	29	29	NUM
bjos-8650040	368	2	.	.	PUNCT
bjos-8650040	369	1	scully	scully	PROPN
bjos-8650040	369	2	c	c	PROPN
bjos-8650040	369	3	,	,	PUNCT
bjos-8650040	369	4	sonis	sonis	NOUN
bjos-8650040	369	5	s	s	X
bjos-8650040	369	6	,	,	PUNCT
bjos-8650040	369	7	diz	diz	PROPN
bjos-8650040	369	8	pd	pd	PROPN
bjos-8650040	369	9	.	.	PROPN
bjos-8650040	370	1	oral	oral	PROPN
bjos-8650040	370	2	mucositis	mucositis	PROPN
bjos-8650040	370	3	.	.	PUNCT
bjos-8650040	371	1	oral	oral	ADJ
bjos-8650040	371	2	dis	dis	PROPN
bjos-8650040	371	3	.	.	PUNCT
bjos-8650040	371	4	2006	2006	NUM
bjos-8650040	372	1	may;12(3):22941	may;12(3):22941	PROPN
bjos-8650040	372	2	.	.	PROPN
bjos-8650040	372	3	30	30	NUM
bjos-8650040	372	4	.	.	PUNCT
bjos-8650040	373	1	logan	logan	PROPN
bjos-8650040	373	2	rm	rm	PROPN
bjos-8650040	373	3	,	,	PUNCT
bjos-8650040	373	4	gibson	gibson	PROPN
bjos-8650040	373	5	rj	rj	PROPN
bjos-8650040	373	6	,	,	PUNCT
bjos-8650040	373	7	bowen	bowen	PROPN
bjos-8650040	373	8	jm	jm	PROPN
bjos-8650040	373	9	,	,	PUNCT
bjos-8650040	373	10	stringer	stringer	PROPN
bjos-8650040	373	11	am	am	PROPN
bjos-8650040	373	12	,	,	PUNCT
bjos-8650040	373	13	sonis	sonis	PROPN
bjos-8650040	373	14	st	st	PROPN
bjos-8650040	373	15	,	,	PUNCT
bjos-8650040	373	16	keefe	keefe	PROPN
bjos-8650040	373	17	dm	dm	PROPN
bjos-8650040	373	18	.	.	PUNCT
bjos-8650040	373	19	characterisation	characterisation	NOUN
bjos-8650040	373	20	of	of	ADP
bjos-8650040	373	21	mucosal	mucosal	ADJ
bjos-8650040	373	22	changes	change	NOUN
bjos-8650040	373	23	in	in	ADP
bjos-8650040	373	24	the	the	DET
bjos-8650040	373	25	alimentary	alimentary	ADJ
bjos-8650040	373	26	tract	tract	NOUN
bjos-8650040	373	27	following	follow	VERB
bjos-8650040	373	28	administration	administration	NOUN
bjos-8650040	373	29	of	of	ADP
bjos-8650040	373	30	irinotecan	irinotecan	PROPN
bjos-8650040	373	31	:	:	PUNCT
bjos-8650040	373	32	implications	implication	NOUN
bjos-8650040	373	33	for	for	ADP
bjos-8650040	373	34	the	the	DET
bjos-8650040	373	35	pathobiology	pathobiology	NOUN
bjos-8650040	373	36	of	of	ADP
bjos-8650040	373	37	mucositis	mucositis	PROPN
bjos-8650040	373	38	.	.	PUNCT
bjos-8650040	374	1	cancer	cancer	NOUN
bjos-8650040	374	2	chemother	chemother	PROPN
bjos-8650040	374	3	pharmacol	pharmacol	PROPN
bjos-8650040	374	4	.	.	PUNCT
bjos-8650040	374	5	2008	2008	NUM
bjos-8650040	375	1	jun;62(1):33	jun;62(1):33	PROPN
bjos-8650040	375	2	-	-	PUNCT
bjos-8650040	375	3	41	41	NUM
bjos-8650040	375	4	.	.	PUNCT
bjos-8650040	376	1	31	31	NUM
bjos-8650040	376	2	.	.	PUNCT
bjos-8650040	377	1	ikebe	ikebe	PROPN
bjos-8650040	377	2	t	t	PROPN
bjos-8650040	377	3	,	,	PUNCT
bjos-8650040	377	4	yamasakia	yamasakia	PROPN
bjos-8650040	377	5	k	k	PROPN
bjos-8650040	377	6	,	,	PUNCT
bjos-8650040	377	7	takamunea	takamunea	PROPN
bjos-8650040	377	8	y	y	NOUN
bjos-8650040	377	9	,	,	PUNCT
bjos-8650040	377	10	nakayamaa	nakayamaa	NOUN
bjos-8650040	377	11	h	h	NOUN
bjos-8650040	377	12	,	,	PUNCT
bjos-8650040	377	13	shinohara	shinohara	PROPN
bjos-8650040	377	14	m.	m.	NOUN
bjos-8650040	377	15	reduced	reduce	VERB
bjos-8650040	377	16	expression	expression	NOUN
bjos-8650040	377	17	of	of	ADP
bjos-8650040	377	18	nuclear	nuclear	ADJ
bjos-8650040	377	19	factor	factor	NOUN
bjos-8650040	377	20	kb	kb	PROPN
bjos-8650040	377	21	in	in	ADP
bjos-8650040	377	22	oral	oral	ADJ
bjos-8650040	377	23	mucosa	mucosa	NOUN
bjos-8650040	377	24	undergoing	undergo	VERB
bjos-8650040	377	25	preoperative	preoperative	NOUN
bjos-8650040	377	26	chemoradiotherapy	chemoradiotherapy	PROPN
bjos-8650040	377	27	.	.	PUNCT
bjos-8650040	378	1	oral	oral	ADJ
bjos-8650040	378	2	science	science	PROPN
bjos-8650040	378	3	international	international	PROPN
bjos-8650040	378	4	.	.	PUNCT
bjos-8650040	379	1	2012	2012	NUM
bjos-8650040	379	2	nov;992):33	nov;992):33	PROPN
bjos-8650040	379	3	-	-	PUNCT
bjos-8650040	379	4	7	7	PROPN
bjos-8650040	379	5	.	.	PUNCT
bjos-8650040	379	6	doi:10.1016	doi:10.1016	PROPN
bjos-8650040	379	7	/	/	SYM
bjos-8650040	379	8	s1348	s1348	ADJ
bjos-8650040	379	9	-	-	PUNCT
bjos-8650040	379	10	8643(12)00008	8643(12)00008	NUM
bjos-8650040	379	11	-	-	PUNCT
bjos-8650040	379	12	0	0	NUM
bjos-8650040	379	13	.	.	PUNCT
bjos-8650040	380	1	32	32	NUM
bjos-8650040	380	2	.	.	PUNCT
bjos-8650040	381	1	khaw	khaw	PROPN
bjos-8650040	381	2	a	a	PROPN
bjos-8650040	381	3	,	,	PUNCT
bjos-8650040	381	4	logan	logan	PROPN
bjos-8650040	381	5	r	r	PROPN
bjos-8650040	381	6	,	,	PUNCT
bjos-8650040	381	7	keefe	keefe	PROPN
bjos-8650040	381	8	d	d	PROPN
bjos-8650040	381	9	,	,	PUNCT
bjos-8650040	381	10	bartold	bartold	ADJ
bjos-8650040	381	11	m.	m.	NOUN
bjos-8650040	381	12	radiation	radiation	NOUN
bjos-8650040	381	13	-	-	PUNCT
bjos-8650040	381	14	induced	induce	VERB
bjos-8650040	381	15	oral	oral	ADJ
bjos-8650040	381	16	mucositis	mucositis	NOUN
bjos-8650040	381	17	and	and	CCONJ
bjos-8650040	381	18	periodontitis	periodontitis	NOUN
bjos-8650040	381	19	–	–	PUNCT
bjos-8650040	381	20	proposal	proposal	NOUN
bjos-8650040	381	21	for	for	ADP
bjos-8650040	381	22	an	an	DET
bjos-8650040	381	23	inter	inter	NOUN
bjos-8650040	381	24	-	-	NOUN
bjos-8650040	381	25	relationship	relationship	NOUN
bjos-8650040	381	26	.	.	PUNCT
bjos-8650040	381	27	2014	2014	NUM
bjos-8650040	381	28	apr;20(3):e7	apr;20(3):e7	NOUN
bjos-8650040	381	29	-	-	PUNCT
bjos-8650040	381	30	18	18	NUM
bjos-8650040	381	31	.	.	PUNCT
bjos-8650040	382	1	doi	doi	NOUN
bjos-8650040	382	2	:	:	PUNCT
bjos-8650040	382	3	10.1111	10.1111	NUM
bjos-8650040	382	4	/	/	SYM
bjos-8650040	382	5	odi.12199	odi.12199	NOUN
bjos-8650040	382	6	.	.	PUNCT
bjos-8650040	383	1	33	33	NUM
bjos-8650040	383	2	.	.	PUNCT
bjos-8650040	384	1	lima	lima	PROPN
bjos-8650040	384	2	v	v	PROPN
bjos-8650040	384	3	,	,	PUNCT
bjos-8650040	384	4	brito	brito	PROPN
bjos-8650040	384	5	ga	ga	PROPN
bjos-8650040	384	6	,	,	PUNCT
bjos-8650040	384	7	cunha	cunha	PROPN
bjos-8650040	384	8	fq	fq	PROPN
bjos-8650040	384	9	,	,	PUNCT
bjos-8650040	384	10	rebouças	rebouças	PROPN
bjos-8650040	384	11	cg	cg	PROPN
bjos-8650040	384	12	,	,	PUNCT
bjos-8650040	384	13	falcão	falcão	PROPN
bjos-8650040	384	14	ba	ba	PROPN
bjos-8650040	384	15	,	,	PUNCT
bjos-8650040	384	16	augusto	augusto	PROPN
bjos-8650040	384	17	rf	rf	PROPN
bjos-8650040	384	18	,	,	PUNCT
bjos-8650040	384	19	et	et	PROPN
bjos-8650040	384	20	al	al	PROPN
bjos-8650040	384	21	.	.	PROPN
bjos-8650040	384	22	,	,	PUNCT
bjos-8650040	384	23	effects	effect	NOUN
bjos-8650040	384	24	of	of	ADP
bjos-8650040	384	25	the	the	DET
bjos-8650040	384	26	tumour	tumour	NOUN
bjos-8650040	384	27	necrosis	necrosis	NOUN
bjos-8650040	384	28	factor	factor	NOUN
bjos-8650040	384	29	-	-	PUNCT
bjos-8650040	384	30	alpha	alpha	NOUN
bjos-8650040	384	31	inhibitors	inhibitor	NOUN
bjos-8650040	384	32	pentoxifylline	pentoxifylline	VERB
bjos-8650040	384	33	and	and	CCONJ
bjos-8650040	384	34	thalidomide	thalidomide	VERB
bjos-8650040	384	35	in	in	ADP
bjos-8650040	384	36	short	short	ADJ
bjos-8650040	384	37	-	-	PUNCT
bjos-8650040	384	38	term	term	NOUN
bjos-8650040	384	39	experimental	experimental	ADJ
bjos-8650040	384	40	oral	oral	ADJ
bjos-8650040	384	41	mucositis	mucositis	NOUN
bjos-8650040	384	42	in	in	ADP
bjos-8650040	384	43	hamsters	hamster	NOUN
bjos-8650040	384	44	.	.	PUNCT
bjos-8650040	385	1	eur	eur	PROPN
bjos-8650040	385	2	j	j	PROPN
bjos-8650040	385	3	oral	oral	PROPN
bjos-8650040	385	4	sci	sci	PROPN
bjos-8650040	385	5	.	.	PROPN
bjos-8650040	385	6	2005	2005	NUM
bjos-8650040	385	7	jun;113(3):210	jun;113(3):210	NOUN
bjos-8650040	385	8	-	-	PUNCT
bjos-8650040	385	9	7	7	NUM
bjos-8650040	385	10	.	.	NOUN
bjos-8650040	385	11	34	34	NUM
bjos-8650040	385	12	.	.	PUNCT
bjos-8650040	386	1	ferra	ferra	PROPN
bjos-8650040	386	2	c	c	PROPN
bjos-8650040	386	3	,	,	PUNCT
bjos-8650040	386	4	de	de	X
bjos-8650040	386	5	sanjose	sanjose	ADJ
bjos-8650040	386	6	s	s	PROPN
bjos-8650040	386	7	,	,	PUNCT
bjos-8650040	386	8	lastra	lastra	PROPN
bjos-8650040	386	9	cf	cf	NOUN
bjos-8650040	386	10	,	,	PUNCT
bjos-8650040	386	11	martí	martí	NOUN
bjos-8650040	386	12	f	f	PROPN
bjos-8650040	386	13	,	,	PUNCT
bjos-8650040	386	14	mariño	mariño	PROPN
bjos-8650040	386	15	el	el	PROPN
bjos-8650040	386	16	,	,	PUNCT
bjos-8650040	386	17	sureda	sureda	VERB
bjos-8650040	386	18	a	a	PRON
bjos-8650040	386	19	,	,	PUNCT
bjos-8650040	386	20	et	et	PROPN
bjos-8650040	386	21	al	al	PROPN
bjos-8650040	386	22	.	.	PROPN
bjos-8650040	386	23	pentoxifylline	pentoxifylline	PROPN
bjos-8650040	386	24	,	,	PUNCT
bjos-8650040	386	25	ciprofloxacin	ciprofloxacin	PROPN
bjos-8650040	386	26	and	and	CCONJ
bjos-8650040	386	27	prednisone	prednisone	PROPN
bjos-8650040	386	28	failed	fail	VERB
bjos-8650040	386	29	to	to	PART
bjos-8650040	386	30	prevent	prevent	VERB
bjos-8650040	386	31	transplant	transplant	NOUN
bjos-8650040	386	32	related	relate	VERB
bjos-8650040	386	33	toxicities	toxicity	NOUN
bjos-8650040	386	34	in	in	ADP
bjos-8650040	386	35	bone	bone	NOUN
bjos-8650040	386	36	marrow	marrow	NOUN
bjos-8650040	386	37	transplant	transplant	NOUN
bjos-8650040	386	38	recipients	recipient	NOUN
bjos-8650040	386	39	and	and	CCONJ
bjos-8650040	386	40	were	be	AUX
bjos-8650040	386	41	associated	associate	VERB
bjos-8650040	386	42	with	with	ADP
bjos-8650040	386	43	an	an	DET
bjos-8650040	386	44	increased	increase	VERB
bjos-8650040	386	45	incidence	incidence	NOUN
bjos-8650040	386	46	of	of	ADP
bjos-8650040	386	47	infectious	infectious	ADJ
bjos-8650040	386	48	complications	complication	NOUN
bjos-8650040	386	49	.	.	PUNCT
bjos-8650040	387	1	bone	bone	NOUN
bjos-8650040	387	2	marrow	marrow	PROPN
bjos-8650040	387	3	transplant	transplant	NOUN
bjos-8650040	387	4	.	.	PUNCT
bjos-8650040	388	1	1997	1997	NUM
bjos-8650040	388	2	dec;20(12):1075	dec;20(12):1075	X
bjos-8650040	388	3	-	-	PUNCT
bjos-8650040	388	4	80	80	NUM
bjos-8650040	388	5	.	.	PUNCT
bjos-8650040	389	1	35	35	NUM
bjos-8650040	389	2	.	.	PUNCT
bjos-8650040	390	1	yeoh	yeoh	PROPN
bjos-8650040	390	2	asj	asj	PROPN
bjos-8650040	390	3	,	,	PUNCT
bjos-8650040	390	4	gibson	gibson	PROPN
bjos-8650040	390	5	rj	rj	PROPN
bjos-8650040	390	6	,	,	PUNCT
bjos-8650040	390	7	yeoh	yeoh	PROPN
bjos-8650040	390	8	e	e	PROPN
bjos-8650040	390	9	,	,	PUNCT
bjos-8650040	390	10	bowen	bowen	PROPN
bjos-8650040	390	11	jm	jm	PROPN
bjos-8650040	390	12	,	,	PUNCT
bjos-8650040	390	13	stringer	stringer	PROPN
bjos-8650040	390	14	am	am	PROPN
bjos-8650040	390	15	,	,	PUNCT
bjos-8650040	390	16	giam	giam	PROPN
bjos-8650040	390	17	ka	ka	PROPN
bjos-8650040	390	18	,	,	PUNCT
bjos-8650040	390	19	et	et	PROPN
bjos-8650040	390	20	al	al	PROPN
bjos-8650040	390	21	.	.	PUNCT
bjos-8650040	391	1	a	a	DET
bjos-8650040	391	2	novel	novel	ADJ
bjos-8650040	391	3	animal	animal	NOUN
bjos-8650040	391	4	model	model	NOUN
bjos-8650040	391	5	to	to	PART
bjos-8650040	391	6	investigate	investigate	VERB
bjos-8650040	391	7	fractionated	fractionated	ADJ
bjos-8650040	391	8	radiotherapy	radiotherapy	NOUN
bjos-8650040	391	9	-	-	PUNCT
bjos-8650040	391	10	induced	induce	VERB
bjos-8650040	391	11	alimentary	alimentary	ADJ
bjos-8650040	391	12	mucositis	mucositis	NOUN
bjos-8650040	391	13	:	:	PUNCT
bjos-8650040	391	14	the	the	DET
bjos-8650040	391	15	role	role	NOUN
bjos-8650040	391	16	of	of	ADP
bjos-8650040	391	17	apoptosis	apoptosis	NOUN
bjos-8650040	391	18	,	,	PUNCT
bjos-8650040	391	19	p53	p53	NOUN
bjos-8650040	391	20	,	,	PUNCT
bjos-8650040	391	21	nuclear	nuclear	ADJ
bjos-8650040	391	22	factor	factor	NOUN
bjos-8650040	391	23	-	-	PUNCT
bjos-8650040	391	24	kb	kb	PROPN
bjos-8650040	391	25	,	,	PUNCT
bjos-8650040	391	26	cox-1	cox-1	X
bjos-8650040	391	27	,	,	PUNCT
bjos-8650040	391	28	and	and	CCONJ
bjos-8650040	391	29	cox-2	cox-2	NOUN
bjos-8650040	391	30	.	.	PUNCT
bjos-8650040	392	1	mol	mol	ADP
bjos-8650040	392	2	cancer	cancer	NOUN
bjos-8650040	392	3	ther	ther	PROPN
bjos-8650040	392	4	.	.	PUNCT
bjos-8650040	393	1	2007	2007	NUM
bjos-8650040	393	2	aug;6(8):2319	aug;6(8):2319	PROPN
bjos-8650040	393	3	-	-	PUNCT
bjos-8650040	393	4	27	27	NUM
bjos-8650040	393	5	.	.	PUNCT
bjos-8650040	394	1	36	36	NUM
bjos-8650040	394	2	.	.	PUNCT
bjos-8650040	394	3	logan	logan	PROPN
bjos-8650040	394	4	rm	rm	PROPN
bjos-8650040	394	5	,	,	PUNCT
bjos-8650040	394	6	stringer	stringer	PROPN
bjos-8650040	394	7	am	am	PROPN
bjos-8650040	394	8	,	,	PUNCT
bjos-8650040	394	9	bowen	bowen	PROPN
bjos-8650040	394	10	jm	jm	PROPN
bjos-8650040	394	11	,	,	PUNCT
bjos-8650040	394	12	yeoh	yeoh	PROPN
bjos-8650040	394	13	as	as	ADP
bjos-8650040	394	14	,	,	PUNCT
bjos-8650040	394	15	gibson	gibson	PROPN
bjos-8650040	394	16	rj	rj	PROPN
bjos-8650040	394	17	,	,	PUNCT
bjos-8650040	394	18	sonis	sonis	PROPN
bjos-8650040	394	19	st	st	PROPN
bjos-8650040	394	20	,	,	PUNCT
bjos-8650040	394	21	et	et	PROPN
bjos-8650040	394	22	al	al	PROPN
bjos-8650040	394	23	.	.	PUNCT
bjos-8650040	395	1	the	the	DET
bjos-8650040	395	2	role	role	NOUN
bjos-8650040	395	3	of	of	ADP
bjos-8650040	395	4	pro	pro	ADJ
bjos-8650040	395	5	-	-	ADJ
bjos-8650040	395	6	inflammatory	inflammatory	ADJ
bjos-8650040	395	7	cytokines	cytokine	NOUN
bjos-8650040	395	8	in	in	ADP
bjos-8650040	395	9	cancer	cancer	NOUN
bjos-8650040	395	10	treatment	treatment	NOUN
bjos-8650040	395	11	-	-	PUNCT
bjos-8650040	395	12	induced	induce	VERB
bjos-8650040	395	13	alimentary	alimentary	ADJ
bjos-8650040	395	14	tract	tract	NOUN
bjos-8650040	395	15	mucositis	mucositis	NOUN
bjos-8650040	395	16	:	:	PUNCT
bjos-8650040	395	17	pathobiology	pathobiology	NOUN
bjos-8650040	395	18	,	,	PUNCT
bjos-8650040	395	19	animal	animal	NOUN
bjos-8650040	395	20	models	model	NOUN
bjos-8650040	395	21	and	and	CCONJ
bjos-8650040	395	22	cytotoxic	cytotoxic	ADJ
bjos-8650040	395	23	drugs	drug	NOUN
bjos-8650040	395	24	.	.	PUNCT
bjos-8650040	396	1	cancer	cancer	NOUN
bjos-8650040	396	2	treat	treat	PROPN
bjos-8650040	396	3	rev	rev	VERB
bjos-8650040	396	4	.	.	PROPN
bjos-8650040	396	5	2007	2007	NUM
bjos-8650040	396	6	aug;33(5):448	aug;33(5):448	NOUN
bjos-8650040	396	7	-	-	SYM
bjos-8650040	396	8	60	60	NUM
bjos-8650040	396	9	.	.	PUNCT
bjos-8650040	397	1	37	37	NUM
bjos-8650040	397	2	.	.	PUNCT
bjos-8650040	398	1	gibson	gibson	PROPN
bjos-8650040	398	2	rj	rj	PROPN
bjos-8650040	398	3	,	,	PUNCT
bjos-8650040	398	4	keefe	keefe	PROPN
bjos-8650040	398	5	dm	dm	PROPN
bjos-8650040	398	6	,	,	PUNCT
bjos-8650040	398	7	thompson	thompson	PROPN
bjos-8650040	398	8	fm	fm	PROPN
bjos-8650040	398	9	,	,	PUNCT
bjos-8650040	398	10	clarke	clarke	PROPN
bjos-8650040	398	11	jm	jm	PROPN
bjos-8650040	398	12	,	,	PUNCT
bjos-8650040	398	13	goland	goland	PROPN
bjos-8650040	398	14	gj	gj	PROPN
bjos-8650040	398	15	,	,	PUNCT
bjos-8650040	398	16	cummins	cummins	PROPN
bjos-8650040	398	17	ag	ag	PROPN
bjos-8650040	398	18	.	.	PROPN
bjos-8650040	398	19	effect	effect	NOUN
bjos-8650040	398	20	of	of	ADP
bjos-8650040	398	21	interleukin-11	interleukin-11	PROPN
bjos-8650040	398	22	on	on	ADP
bjos-8650040	398	23	ameliorating	ameliorate	VERB
bjos-8650040	398	24	intestinal	intestinal	ADJ
bjos-8650040	398	25	damage	damage	NOUN
bjos-8650040	398	26	after	after	ADP
bjos-8650040	398	27	methotrexate	methotrexate	NOUN
bjos-8650040	398	28	treatment	treatment	NOUN
bjos-8650040	398	29	of	of	ADP
bjos-8650040	398	30	breastcancer	breastcancer	NOUN
bjos-8650040	398	31	in	in	ADP
bjos-8650040	398	32	rats	rat	NOUN
bjos-8650040	398	33	.	.	PUNCT
bjos-8650040	399	1	dig	dig	VERB
bjos-8650040	399	2	dis	dis	PROPN
bjos-8650040	399	3	sci	sci	PROPN
bjos-8650040	399	4	.	.	PROPN
bjos-8650040	399	5	2002	2002	NUM
bjos-8650040	399	6	dec;47(12):2751	dec;47(12):2751	PROPN
bjos-8650040	399	7	-	-	PUNCT
bjos-8650040	399	8	7	7	NUM
bjos-8650040	399	9	.	.	NOUN
bjos-8650040	399	10	38	38	NUM
bjos-8650040	399	11	.	.	PUNCT
bjos-8650040	400	1	gibson	gibson	PROPN
bjos-8650040	400	2	rj	rj	PROPN
bjos-8650040	400	3	,	,	PUNCT
bjos-8650040	400	4	bowen	bowen	PROPN
bjos-8650040	400	5	jm	jm	PROPN
bjos-8650040	400	6	,	,	PUNCT
bjos-8650040	400	7	inglis	inglis	PROPN
bjos-8650040	400	8	mr	mr	PROPN
bjos-8650040	400	9	,	,	PUNCT
bjos-8650040	400	10	cummins	cummins	PROPN
bjos-8650040	400	11	ag	ag	PROPN
bjos-8650040	400	12	,	,	PUNCT
bjos-8650040	400	13	keefe	keefe	PROPN
bjos-8650040	400	14	dm	dm	PROPN
bjos-8650040	400	15	.	.	PUNCT
bjos-8650040	400	16	irinotecan	irinotecan	PROPN
bjos-8650040	400	17	braz	braz	PROPN
bjos-8650040	400	18	j	j	PROPN
bjos-8650040	400	19	oral	oral	PROPN
bjos-8650040	400	20	sci	sci	PROPN
bjos-8650040	400	21	.	.	PUNCT
bjos-8650040	401	1	15(4):280	15(4):280	NUM
bjos-8650040	401	2	-	-	PUNCT
bjos-8650040	401	3	286	286	NUM
bjos-8650040	401	4	286cytokine	286cytokine	PROPN
bjos-8650040	401	5	expression	expression	NOUN
bjos-8650040	401	6	in	in	ADP
bjos-8650040	401	7	riom	riom	ADJ
bjos-8650040	401	8	patients	patient	NOUN
bjos-8650040	401	9	causes	cause	VERB
bjos-8650040	401	10	severe	severe	ADJ
bjos-8650040	401	11	small	small	ADJ
bjos-8650040	401	12	intestinal	intestinal	ADJ
bjos-8650040	401	13	damage	damage	NOUN
bjos-8650040	401	14	,	,	PUNCT
bjos-8650040	401	15	as	as	ADV
bjos-8650040	401	16	well	well	ADV
bjos-8650040	401	17	as	as	ADP
bjos-8650040	401	18	colonic	colonic	ADJ
bjos-8650040	401	19	damage	damage	NOUN
bjos-8650040	401	20	,	,	PUNCT
bjos-8650040	401	21	in	in	ADP
bjos-8650040	401	22	the	the	DET
bjos-8650040	401	23	rat	rat	NOUN
bjos-8650040	401	24	with	with	ADP
bjos-8650040	401	25	implanted	implant	VERB
bjos-8650040	401	26	breast	breast	NOUN
bjos-8650040	401	27	cancer	cancer	NOUN
bjos-8650040	401	28	.	.	PUNCT
bjos-8650040	402	1	j	j	PROPN
bjos-8650040	402	2	gastroenterol	gastroenterol	NOUN
bjos-8650040	402	3	hepatol	hepatol	ADJ
bjos-8650040	402	4	.	.	PUNCT
bjos-8650040	403	1	2003	2003	NUM
bjos-8650040	403	2	sep;18(9):1095	sep;18(9):1095	VERB
bjos-8650040	403	3	-	-	PUNCT
bjos-8650040	403	4	100	100	NUM
bjos-8650040	403	5	.	.	PUNCT
bjos-8650040	404	1	39	39	NUM
bjos-8650040	404	2	.	.	PUNCT
bjos-8650040	405	1	gibson	gibson	PROPN
bjos-8650040	405	2	rj	rj	PROPN
bjos-8650040	405	3	,	,	PUNCT
bjos-8650040	405	4	bowen	bowen	PROPN
bjos-8650040	405	5	jm	jm	PROPN
bjos-8650040	405	6	,	,	PUNCT
bjos-8650040	405	7	cummins	cummins	PROPN
bjos-8650040	405	8	ag	ag	PROPN
bjos-8650040	405	9	,	,	PUNCT
bjos-8650040	405	10	keefe	keefe	PROPN
bjos-8650040	405	11	dm	dm	PROPN
bjos-8650040	405	12	.	.	PROPN
bjos-8650040	405	13	relationship	relationship	NOUN
bjos-8650040	405	14	between	between	ADP
bjos-8650040	405	15	dose	dose	PROPN
bjos-8650040	405	16	of	of	ADP
bjos-8650040	405	17	methotrexate	methotrexate	NOUN
bjos-8650040	405	18	,	,	PUNCT
bjos-8650040	405	19	apoptosis	apoptosis	NOUN
bjos-8650040	405	20	,	,	PUNCT
bjos-8650040	405	21	p53	p53	NOUN
bjos-8650040	405	22	/	/	SYM
bjos-8650040	405	23	p21	p21	NOUN
bjos-8650040	405	24	expression	expression	NOUN
bjos-8650040	405	25	and	and	CCONJ
bjos-8650040	405	26	intestinal	intestinal	ADJ
bjos-8650040	405	27	crypt	crypt	NOUN
bjos-8650040	405	28	proliferation	proliferation	NOUN
bjos-8650040	405	29	in	in	ADP
bjos-8650040	405	30	the	the	DET
bjos-8650040	405	31	rat	rat	NOUN
bjos-8650040	405	32	.	.	PROPN
bjos-8650040	405	33	clin	clin	PROPN
bjos-8650040	405	34	exp	exp	PROPN
bjos-8650040	405	35	med	med	PROPN
bjos-8650040	405	36	.	.	PUNCT
bjos-8650040	405	37	2005	2005	NUM
bjos-8650040	406	1	mar;4(4):188	mar;4(4):188	PROPN
bjos-8650040	406	2	-	-	SYM
bjos-8650040	406	3	95	95	NUM
bjos-8650040	406	4	.	.	PUNCT
bjos-8650040	407	1	40	40	NUM
bjos-8650040	407	2	.	.	PUNCT
bjos-8650040	408	1	soares	soares	PROPN
bjos-8650040	408	2	pmg	pmg	PROPN
bjos-8650040	408	3	,	,	PUNCT
bjos-8650040	408	4	mota	mota	PROPN
bjos-8650040	408	5	j	j	PROPN
bjos-8650040	408	6	,	,	PUNCT
bjos-8650040	408	7	souza	souza	PROPN
bjos-8650040	408	8	ep	ep	PROPN
bjos-8650040	408	9	,	,	PUNCT
bjos-8650040	408	10	justino	justino	PROPN
bjos-8650040	408	11	pf	pf	PROPN
bjos-8650040	408	12	,	,	PUNCT
bjos-8650040	408	13	franco	franco	PROPN
bjos-8650040	408	14	ax	ax	NOUN
bjos-8650040	408	15	,	,	PUNCT
bjos-8650040	408	16	cunha	cunha	PROPN
bjos-8650040	408	17	fq	fq	PROPN
bjos-8650040	408	18	,	,	PUNCT
bjos-8650040	408	19	et	et	PROPN
bjos-8650040	408	20	al	al	PROPN
bjos-8650040	408	21	.	.	PUNCT
bjos-8650040	409	1	inflammatory	inflammatory	ADJ
bjos-8650040	409	2	intestinal	intestinal	ADJ
bjos-8650040	409	3	damage	damage	NOUN
bjos-8650040	409	4	induced	induce	VERB
bjos-8650040	409	5	by	by	ADP
bjos-8650040	409	6	5	5	NUM
bjos-8650040	409	7	-	-	PUNCT
bjos-8650040	409	8	fluorouracil	fluorouracil	NOUN
bjos-8650040	409	9	requires	require	VERB
bjos-8650040	409	10	il-4	il-4	PROPN
bjos-8650040	409	11	.	.	PUNCT
bjos-8650040	409	12	cytokine	cytokine	PROPN
bjos-8650040	409	13	.	.	PUNCT
bjos-8650040	410	1	2013	2013	NUM
bjos-8650040	410	2	jan;61(1):46	jan;61(1):46	PROPN
bjos-8650040	410	3	-	-	PUNCT
bjos-8650040	410	4	9	9	NUM
bjos-8650040	410	5	.	.	PUNCT
bjos-8650040	410	6	doi	doi	NOUN
bjos-8650040	410	7	:	:	PUNCT
bjos-8650040	410	8	10.1016	10.1016	NUM
bjos-8650040	410	9	/	/	SYM
bjos-8650040	410	10	j.cyto.2012.10.003	j.cyto.2012.10.003	PROPN
bjos-8650040	410	11	.	.	PROPN
bjos-8650040	410	12	41	41	NUM
bjos-8650040	410	13	.	.	PUNCT
bjos-8650040	411	1	logan	logan	PROPN
bjos-8650040	411	2	rm	rm	PROPN
bjos-8650040	411	3	,	,	PUNCT
bjos-8650040	411	4	stringer	stringer	PROPN
bjos-8650040	411	5	am	am	PROPN
bjos-8650040	411	6	,	,	PUNCT
bjos-8650040	411	7	bowen	bowen	PROPN
bjos-8650040	411	8	jm	jm	PROPN
bjos-8650040	411	9	,	,	PUNCT
bjos-8650040	411	10	gibson	gibson	PROPN
bjos-8650040	411	11	rj	rj	PROPN
bjos-8650040	411	12	,	,	PUNCT
bjos-8650040	411	13	sonis	sonis	PROPN
bjos-8650040	411	14	st	st	PROPN
bjos-8650040	411	15	,	,	PUNCT
bjos-8650040	411	16	keefe	keefe	PROPN
bjos-8650040	411	17	dm	dm	PROPN
bjos-8650040	411	18	.	.	PROPN
bjos-8650040	411	19	is	be	AUX
bjos-8650040	411	20	the	the	DET
bjos-8650040	411	21	pathobiology	pathobiology	NOUN
bjos-8650040	411	22	of	of	ADP
bjos-8650040	411	23	chemotherapy	chemotherapy	NOUN
bjos-8650040	411	24	-	-	PUNCT
bjos-8650040	411	25	induced	induce	VERB
bjos-8650040	411	26	alimentary	alimentary	ADJ
bjos-8650040	411	27	tract	tract	NOUN
bjos-8650040	411	28	mucositis	mucositis	NOUN
bjos-8650040	411	29	influenced	influence	VERB
bjos-8650040	411	30	by	by	ADP
bjos-8650040	411	31	the	the	DET
bjos-8650040	411	32	type	type	NOUN
bjos-8650040	411	33	of	of	ADP
bjos-8650040	411	34	mucotoxic	mucotoxic	ADJ
bjos-8650040	411	35	drug	drug	NOUN
bjos-8650040	411	36	administered	administer	VERB
bjos-8650040	411	37	?	?	PUNCT
bjos-8650040	412	1	cancer	cancer	NOUN
bjos-8650040	412	2	chemother	chemother	PROPN
bjos-8650040	412	3	pharmacol	pharmacol	PROPN
bjos-8650040	412	4	.	.	PUNCT
bjos-8650040	413	1	2009	2009	NUM
bjos-8650040	413	2	jan;63(2):239	jan;63(2):239	NUM
bjos-8650040	413	3	-	-	PUNCT
bjos-8650040	413	4	51	51	PROPN
bjos-8650040	413	5	.	.	PUNCT
bjos-8650040	414	1	doi	doi	NOUN
bjos-8650040	414	2	:	:	PUNCT
bjos-8650040	414	3	10.1007/	10.1007/	NUM
bjos-8650040	414	4	s00280	s00280	PROPN
bjos-8650040	414	5	-	-	PUNCT
bjos-8650040	414	6	008	008	NUM
bjos-8650040	414	7	-	-	PUNCT
bjos-8650040	414	8	0732	0732	NUM
bjos-8650040	414	9	-	-	PUNCT
bjos-8650040	414	10	8	8	NUM
bjos-8650040	414	11	.	.	PUNCT
bjos-8650040	415	1	braz	braz	PROPN
bjos-8650040	415	2	j	j	PROPN
bjos-8650040	415	3	oral	oral	PROPN
bjos-8650040	415	4	sci	sci	PROPN
bjos-8650040	415	5	.	.	PUNCT
bjos-8650040	416	1	15(4):280	15(4):280	NUM
bjos-8650040	416	2	-	-	SYM
bjos-8650040	416	3	286	286	NUM